FGL-3.31.2015-Q2
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
|
| |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2015
OR
|
| |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 001-36227
FIDELITY & GUARANTY LIFE
(Exact name of registrant as specified in its charter)
|
| |
Delaware | 46-3489149 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Two Ruan Center 601 Locust Street, 14th Floor Des Moines, Iowa | 50309 |
(Address of principal executive offices) | (Zip Code) |
(800) 445-6758
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x or No ¨.
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x or No ¨.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
|
| | | | |
Large Accelerated Filer | ¨ | | Accelerated Filer | ¨ |
Non-accelerated Filer | x | (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ or No x
There were 58,737,505 shares of the registrant’s common stock outstanding as of May 4, 2015.
FIDELITY & GUARANTY LIFE AND SUBSIDIARIES
TABLE OF CONTENTS
|
| |
| Page |
PART I. FINANCIAL INFORMATION & FORWARD LOOKING STATEMENTS |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
PART II. OTHER INFORMATION |
| |
| |
| |
| |
| |
| |
| |
| |
| |
PART I: FINANCIAL INFORMATION
| |
Item 1. | Financial Statements |
FIDELITY & GUARANTY LIFE AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions, except share data)
|
| | | | | | | |
| March 31, 2015 | | September 30, 2014 |
| (Unaudited) | | |
ASSETS | | | |
Investments: |
| | |
Fixed maturity securities, available-for-sale, at fair value (amortized cost: March 31, 2015 - $17,161; September 30, 2014 - $16,692) | $ | 18,055 |
| | $ | 17,435 |
|
Equity securities, available-for-sale, at fair value (amortized cost: March 31, 2015 - $574; September 30, 2014 - $679) | 606 |
| | 698 |
|
Derivative investments | 268 |
| | 296 |
|
Commercial mortgage loans | 304 |
| | 136 |
|
Other invested assets | 232 |
| | 237 |
|
Total investments | 19,465 |
| | 18,802 |
|
Related party loans | 75 |
| | 113 |
|
Cash and cash equivalents | 849 |
| | 576 |
|
Accrued investment income | 180 |
| | 182 |
|
Reinsurance recoverable | 3,691 |
| | 3,665 |
|
Intangibles, net | 610 |
| | 515 |
|
Deferred tax assets | 104 |
| | 137 |
|
Other assets | 221 |
| | 163 |
|
Total assets | $ | 25,195 |
| | $ | 24,153 |
|
| | | |
LIABILITIES AND SHAREHOLDERS' EQUITY | | | |
| | | |
Contractholder funds | $ | 17,521 |
| | $ | 16,464 |
|
Future policy benefits | 3,481 |
| | 3,504 |
|
Funds withheld for reinsurance liabilities | 1,329 |
| | 1,331 |
|
Liability for policy and contract claims | 60 |
| | 58 |
|
Debt | 300 |
| | 300 |
|
Other liabilities | 794 |
| | 837 |
|
Total liabilities | 23,485 |
| | 22,494 |
|
| | | |
Commitments and contingencies |
| |
|
| | | |
Shareholders' equity: | | | |
Preferred stock ($.01 par value, 50,000,000 shares authorized, no shares issued at March 31, 2015) | $ | — |
| | $ | — |
|
Common stock ($.01 par value, 500,000,000 shares authorized, 58,739,810 issued and outstanding at March 31, 2015; 58,442,721 shares issued and outstanding at September 30, 2014) | 1 |
| | 1 |
|
Additional paid-in capital | 710 |
| | 702 |
|
Retained earnings | 601 |
| | 607 |
|
Accumulated other comprehensive income | 408 |
| | 349 |
|
Treasury Stock, at cost (463,394 shares at March 31, 2015; no shares at September 30, 2014) | (10 | ) | | — |
|
Total shareholders' equity | 1,710 |
| | 1,659 |
|
Total liabilities and shareholders' equity | $ | 25,195 |
| | $ | 24,153 |
|
| | | |
See accompanying notes to condensed consolidated financial statements.
FIDELITY & GUARANTY LIFE AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except share data)
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
| (Unaudited) | | (Unaudited) |
Revenues: | | | | | | | |
Premiums | $ | 15 |
| | $ | 15 |
| | $ | 26 |
| | $ | 28 |
|
Net investment income | 208 |
| | 184 |
| | 416 |
| | 368 |
|
Net investment (losses) gains | (58 | ) | | (2 | ) | | 1 |
| | 122 |
|
Insurance and investment product fees and other | 22 |
| | 18 |
| | 42 |
| | 33 |
|
Total revenues | 187 |
| | 215 |
| | 485 |
| | 551 |
|
Benefits and expenses: | | | | | | | |
Benefits and other changes in policy reserves | 172 |
| | 179 |
| | 396 |
| | 396 |
|
Acquisition and operating expenses, net of deferrals | 28 |
| | 32 |
| | 57 |
| | 58 |
|
Amortization of intangibles | (7 | ) | | 11 |
| | 9 |
| | 34 |
|
Total benefits and expenses | 193 |
| | 222 |
| | 462 |
| | 488 |
|
Operating (loss) income | (6 | ) | | (7 | ) | | 23 |
| | 63 |
|
Interest expense | (6 | ) | | (6 | ) | | (12 | ) | | (11 | ) |
(Loss) income before income taxes | (12 | ) | | (13 | ) | | 11 |
| | 52 |
|
Income tax expense (benefit) | — |
| | (38 | ) | | 9 |
| | (16 | ) |
Net (loss) income | $ | (12 | ) | | $ | 25 |
| | $ | 2 |
| | $ | 68 |
|
| | | | | | | |
Net (loss) income per common share: | | | | | | | |
| | | | | | | |
Basic | $ | (0.21 | ) | | $ | 0.43 |
| | $ | 0.03 |
| | $ | 1.26 |
|
Diluted | $ | (0.21 | ) | | $ | 0.42 |
| | $ | 0.03 |
| | $ | 1.26 |
|
Weighted average common shares used in computing net income per common share: | | | | | | | |
Basic | 58,033,064 |
| | 58,270,822 |
| | 58,159,572 |
| | 53,656,357 |
|
Diluted | 58,033,064 |
| | 58,447,122 |
| | 58,331,854 |
| | 53,756,814 |
|
| | | | | | | |
Cash dividend per common share | $ | 0.065 |
| | $ | 0.065 |
| | $ | 0.130 |
| | $ | 0.980 |
|
| | | | | | | |
| | | | | | | |
Supplemental disclosures: | | | | | | | |
Total other-than-temporary impairments | $ | (61 | ) | | $ | — |
| | $ | (61 | ) | | $ | — |
|
Portion of other-than-temporary impairments included in other comprehensive income | — |
| | — |
| | — |
| | — |
|
Net other-than-temporary impairments | (61 | ) | | — |
| | (61 | ) | | — |
|
Gains (losses) on derivative instruments | 1 |
| | (8 | ) | | 63 |
| | 103 |
|
Other realized investment gains (losses) | 2 |
| | 6 |
| | (1 | ) | | 19 |
|
Total net investment (losses) gains | $ | (58 | ) | | $ | (2 | ) | | $ | 1 |
| | $ | 122 |
|
See accompanying notes to condensed consolidated financial statements.
FIDELITY & GUARANTY LIFE AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
| (Unaudited) | | (Unaudited) |
Net (loss) income | $ | (12 | ) | | $ | 25 |
| | $ | 2 |
| | $ | 68 |
|
| | | | | | | |
Other comprehensive income (loss): | | | | | | | |
Unrealized investment gains (losses): | | | | | | | |
Change in unrealized investment gains before reclassification adjustment | 111 |
| | 384 |
| | 100 |
| | 375 |
|
Net reclassification adjustment for losses (gains) included in net income | 58 |
| | (10 | ) | | 62 |
| | (19 | ) |
Changes in unrealized investment gains after reclassification adjustment | 169 |
| | 374 |
| | 162 |
| | 356 |
|
Adjustments to intangible assets | (71 | ) | | (113 | ) | | (70 | ) | | (105 | ) |
Changes in deferred income tax asset/liability | (34 | ) | | (92 | ) | | (33 | ) | | (88 | ) |
Net changes to derive comprehensive income for the period | 64 |
| | 169 |
| | 59 |
| | 163 |
|
Comprehensive income, net of tax | $ | 52 |
| | $ | 194 |
| | $ | 61 |
| | $ | 231 |
|
See accompanying notes to condensed consolidated financial statements.
FIDELITY & GUARANTY LIFE AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
(Unaudited) (In millions)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Preferred Stock | | Common Stock | | Additional Paid-in Capital/Contributed Capital | | Retained Earnings | | Accumulated Other Comprehensive Income (Loss) | | Treasury Stock | | Total Shareholders' Equity |
| | | | | | | | | | | | | |
Balance, September 30, 2013 | $ | — |
| | $ | — |
| | $ | 527 |
| | $ | 499 |
| | $ | 113 |
| | $ | — |
| | $ | 1,139 |
|
Dividends | — |
| | — |
| | — |
| | (47 | ) | | — |
| | — |
| | (47 | ) |
Stock Split | — |
| | 1 |
| | (1 | ) | | — |
| | — |
| | — |
| | — |
|
Proceeds from issuance of common stock, net of transaction fees | — |
| | — |
| | 173 |
| | — |
| | — |
| | — |
| | 173 |
|
Net income | — |
| | — |
| | — |
| | 68 |
| | — |
| | — |
| | 68 |
|
Unrealized investment gains, net | — |
| | — |
| | — |
| | — |
| | 163 |
| | — |
| | 163 |
|
Stock compensation | — |
| | — |
| | 2 |
| | — |
| | — |
| | — |
| | 2 |
|
Balance, March 31, 2014 | $ | — |
| | $ | 1 |
| | $ | 701 |
| | $ | 520 |
| | $ | 276 |
| | $ | — |
| | $ | 1,498 |
|
| | | | | | | | | | | | | |
Balance, September 30, 2014 | $ | — |
| | $ | 1 |
| | $ | 702 |
| | $ | 607 |
| | $ | 349 |
| | $ | — |
| | $ | 1,659 |
|
Treasury shares purchased | — |
| | — |
| | — |
| | — |
| | — |
| | (10 | ) | | (10 | ) |
Dividends | — |
| | — |
| | — |
| | (8 | ) | | — |
| | — |
| | (8 | ) |
Net income | — |
| | — |
| | — |
| | 2 |
| | — |
| | — |
| | 2 |
|
Unrealized investment gains, net | — |
| | — |
| | — |
| | — |
| | 59 |
| | — |
| | 59 |
|
Stock compensation | — |
| | — |
| | 8 |
| | — |
| | — |
| | — |
| | 8 |
|
Balance, March 31, 2015 | $ | — |
| | $ | 1 |
| | $ | 710 |
| | $ | 601 |
| | $ | 408 |
| | $ | (10 | ) | | $ | 1,710 |
|
| | | | | | | | | | | | | |
See accompanying notes to condensed consolidated financial statements.
FIDELITY & GUARANTY LIFE AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions) |
| | | | | | | |
| Six months ended |
| March 31, 2015 | | March 31, 2014 |
| (Unaudited) |
Cash flows from operating activities: | | | |
Net income | $ | 2 |
| | $ | 68 |
|
Adjustments to reconcile net income to net cash provided by operating activities: | | | |
Stock based compensation | 8 |
| | 12 |
|
Amortization | (24 | ) | | (16 | ) |
Deferred income taxes | — |
| | (34 | ) |
Interest credited/index credit to contractholder account balances | 330 |
| | 325 |
|
Net recognized (gains) on investments and derivatives | (1 | ) | | (122 | ) |
Charges assessed to contractholders for mortality and administration | (32 | ) | | (21 | ) |
Deferred policy acquisition costs, net of amortization | (165 | ) | | (82 | ) |
Changes in operating assets and liabilities: | | | |
Reinsurance recoverable | (4 | ) | | (14 | ) |
Future policy benefits | (23 | ) | | (23 | ) |
Funds withheld from reinsurers | (11 | ) | | (57 | ) |
Collateral posted | 7 |
| | 37 |
|
Other assets and other liabilities | (56 | ) | | (12 | ) |
Net cash provided by operating activities | 31 |
| | 61 |
|
Cash flows from investing activities: | | | |
Proceeds from available-for-sale investments sold, matured or repaid | 1,806 |
| | 2,676 |
|
Proceeds from derivatives instruments and other invested assets | 233 |
| | 222 |
|
Proceeds from commercial mortgage loans | 32 |
| | — |
|
Cost of available-for-sale investments acquired | (2,218 | ) | | (3,816 | ) |
Costs of derivatives instruments and other invested assets | (181 | ) | | (247 | ) |
Costs of commercial mortgage loans | (200 | ) | | — |
|
Related party loans | 38 |
| | (27 | ) |
Capital expenditures | (3 | ) | | (4 | ) |
Net cash (used in) investing activities | (493 | ) | | (1,196 | ) |
Cash flows from financing activities: | | | |
Treasury stock | (10 | ) | | — |
|
Proceeds from issuance of common stock, net of transaction fees | — |
| | 176 |
|
Dividends paid | (8 | ) | | (47 | ) |
Contractholder account deposits | 1,538 |
| | 1,341 |
|
Contractholder account withdrawals | (785 | ) | | (837 | ) |
Net cash provided by financing activities | 735 |
| | 633 |
|
Change in cash & cash equivalents | 273 |
| | (502 | ) |
Cash & cash equivalents, beginning of period | 576 |
| | 1,204 |
|
Cash & cash equivalents, end of period | $ | 849 |
| | $ | 702 |
|
| | | |
Supplemental disclosures of cash flow information | | | |
Interest paid | $ | 9 |
| | $ | 12 |
|
Taxes paid | $ | 28 |
| | $ | 24 |
|
See accompanying notes to condensed consolidated financial statements.
FIDELITY & GUARANTY LIFE AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(1) Basis of Presentation
Fidelity & Guaranty Life (formerly, Harbinger F&G, LLC (“HFG”)) (“FGL” and, collectively with its subsidiaries, the “Company”) is a subsidiary of HRG Group, Inc. (formerly, Harbinger Group Inc. (“HRG”)). The accompanying unaudited consolidated financial statements are prepared in accordance with United States of America generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. Therefore, the information contained in the Notes to Consolidated Financial Statements included in Fidelity & Guaranty Life and Subsidiaries' Annual Report on Form 10-K, for the year ended September 30, 2014 (“2014 Form 10-K”), should be read in connection with the reading of these interim unaudited consolidated financial statements.
FGL markets products through its wholly-owned insurance subsidiaries, Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) and Fidelity & Guaranty Life Insurance Company of New York (“FGL NY Insurance”), which together are licensed in all fifty states and the District of Columbia.
On April 6, 2015, HRG Group, Inc, the parent of the Company, announced that it is exploring strategic alternatives for Fidelity & Guaranty Life regarding their FGL holdings. Following this announcement, FGL has begun a strategic process involving a potential sale of the Company. There can be no assurance that the exploration of strategic alternatives will result in a transaction or that any transaction, if pursued, will be consummated. The exploration of strategic alternatives may be terminated at any time and without notice. Neither HRG Group nor any of its affiliates - including FGL - intend to disclose developments with respect to this process unless and until the FGL Board of Directors has approved a specific transaction or course of action.
Certain GAAP policies, which significantly affect the determination of financial position, results of operations and cash flows, are summarized in our 2014 Form 10-K.
In the opinion of management, these statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Operating results for the three and six months ended March 31, 2015, are not necessarily indicative of the results that may be expected for the full year ending September 30, 2015. All material inter-company accounts and transactions have been eliminated in consolidation. Amounts reclassified out of other comprehensive income are reflected in net investment gains in the Condensed Consolidated Statements of Operations.
Dollar amounts in the accompanying sections are presented in millions, unless otherwise noted.
(2) Significant Accounting Policies and Practices
Principles of Consolidation
The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all other entities in which FGL has a controlling financial interest (none of which are variable interest entities). All intercompany accounts and transactions have been eliminated in consolidation.
Recent Accounting Pronouncements
Investments in Qualified Affordable Housing Projects
In January 2014, the Financial Accounting Standards Board ("FASB") issued amended guidance (ASU 2014-01, Investments - Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Qualified Affordable Housing Project) which allows investors in Low Income Housing Tax Credit (“LIHTC”) programs that meet specified conditions to present the net tax benefits (net of the amortization of the cost of the investment)
within income tax expense. The cost of the investments that meet the specified conditions will be amortized in proportion to (and over the same period as) the total expected tax benefits, including the tax credits and other tax benefits, as they are realized on the tax return. The guidance is required to be applied retrospectively, if investors elect the proportional amortization method. However, if investors have existing LIHTC investments accounted for under the effective-yield method at adoption, they may continue to apply that method for those existing investments. The Company early adopted this guidance effective October 1, 2014 for all new LIHTC investments made subsequent to that date. Prior LIHTC investments will continue to be accounted for under the effective-yield method. This adoption did not have a material effect on the Company’s consolidated financial position and results of operations.
Share-Based Payments When a Performance Target is achieved after the Requisite Service Period
In June 2014, the FASB issued new guidance on Stock Compensation (ASU 2014-12, Accounting for Share-Based Payments When the Term of an Award Provide that a Performance Target Could Be Achieved after the Requisite Service Period), effective for fiscal years beginning after December 15, 2015 and interim periods within those years. The new guidance requires performance targets that affect vesting and that could be achieved after the requisite service period to be treated as performance conditions. Such performance targets would not be included in the grant-date fair value calculation of the award, rather compensation cost should be recorded when it is probable the performance target will be reached and should represent the compensation cost attributable to period(s) for which the requisite service has already been rendered. This standard may be early adopted and the amendments may be applied either prospectively or retrospectively. The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements.
Amendments to the Consolidation Analysis
In February 2015, the FASB issued amended consolidation guidance (ASU 2015-02, Amendments to the Consolidation Analysis), effective for fiscal years beginning after December 15, 2015. The amended guidance changes the consolidation analysis of reporting entities with variable interest entity ("VIE") relationships by i) modifying the criteria used to evaluate whether limited partnerships and similar legal entities are VIEs or voting interest entities and revising the primary beneficiary determination of a VIE, ii) eliminating the specialized consolidation model and guidance for limited partnerships thereby removing the presumption that a general partner should consolidate a limited partnership, iii) reducing the criteria in the variable interest model contained in Accounting Standards Codification Topic 810, Consolidation, that is used to evaluate whether the fees paid to a decision maker or service provider represents a variable interest, and iv) exempting reporting entities from consolidating money market funds that operate in accordance with Rule 2a-7 of the Investment Company Act of 1940. This standard may be early adopted and the amendments in this Update may be applied with a modified retrospective approach or retrospective approach. The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements.
Presentation of Debt Issuance Costs
In April 2015, the FASB issued amended guidance (ASU 2015-03, Interest-Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs), effective for fiscal years beginning after December 15, 2015 and interim periods within those years. The amended guidance requires debt issuance costs related to a recognized debt liability to be presented on the balance sheet as a direct deduction from the debt liability, similar to the presentation of debt discounts or premiums. The cost of issuing debt will no longer be recorded as a separate asset, except when incurred before the receipt of the funding from the associated debt liability. Instead, debt issuance costs will be presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability, and the costs will be amortized to interest expense using the effective interest method. This standard may be early adopted. The amendments in this Update are required to be applied retrospectively to all prior periods presented in the financial statements. The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements.
(3) Significant Risks and Uncertainties
Use of Estimates and Assumptions
The preparation of the Company’s Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used.
Concentrations of Financial Instruments
As of March 31, 2015 and September 30, 2014, the Company’s most significant investment in one industry, excluding United States ("U.S.") Government securities, was its investment securities in the banking industry with a fair value of $2,274 or 12% and $2,240 or 12%, respectively, of the invested assets portfolio. The Company’s holdings in this industry include investments in 83 different issuers with the top ten investments accounting for 39% of the total holdings in this industry. As of March 31, 2015, the Company had investments in 1 issuer, Wells Fargo & Company that exceeded 10% of shareholders' equity with a total fair value of $188 or 1% of the invested assets portfolio. As of September 30, 2014, the Company had investments in 2 issuers, Wells Fargo & Company and J.P. Morgan Chase, that exceeded 10% of shareholders' equity with a total fair value of $365 or 2% of the invested assets portfolio. Additionally, the Company’s largest concentration in any single issuer as of March 31, 2015 and September 30, 2014 was in Wells Fargo & Company which had a fair value of $188 or 1% and $185 or 1% of the invested assets portfolio, respectively.
Concentrations of Financial and Capital Markets Risk
The Company is exposed to financial and capital markets risk, including changes in interest rates and credit spreads which can have an adverse effect on the Company’s results of operations, financial condition and liquidity. The Company expects to continue to face challenges and uncertainties that could adversely affect its results of operations and financial condition.
The Company’s exposure to interest rate risk relates primarily to the market price and cash flow variability associated with changes in interest rates. A rise in interest rates, in the absence of other countervailing changes, will decrease the net unrealized gain position of the Company’s investment portfolio and, if long-term interest rates rise dramatically within a six to twelve month time period, certain of the Company’s products may be exposed to disintermediation risk. Disintermediation risk refers to the risk that policyholders may surrender their contracts in a rising interest rate environment, requiring the Company to liquidate assets in an unrealized loss position. This risk is mitigated to some extent by the high level of surrender charge protection provided by the Company’s products.
Concentration of Reinsurance Risk
The Company has a significant concentration of reinsurance with Wilton Reassurance Company (“Wilton Re”) and Front Street Re (Cayman) Ltd. ("FSRCI" - an affiliate) that could have a material impact on the Company’s financial position in the event that Wilton Re or FSRCI fail to perform their obligations under the various reinsurance treaties. Wilton Re is a wholly owned subsidiary of Canada Pension Plan Investment Board ("CPPIB"). CPPIB has an AAA credit rating from Standard & Poor's Ratings Services ("S&P") as of March 31, 2015. As of March 31, 2015, the net amount recoverable from Wilton Re was $1,514 and the net amount recoverable from FSRCI was $1,289. The coinsurance agreement with FSRCI is on a funds withheld basis. The Company monitors both the financial condition of individual reinsurers and risk concentration arising from similar geographic regions, activities and economic characteristics of reinsurers to reduce the risk of default by such reinsurers.
(4) Investments
The Company’s debt and equity securities investments have been designated as available-for-sale and are carried at fair value with unrealized gains and losses included in accumulated other comprehensive income (“AOCI”) net of associated adjustments for value of business acquired (“VOBA”), deferred acquisition costs (“DAC”) and deferred income taxes. The Company’s consolidated investments at March 31, 2015 and September 30, 2014 are summarized as follows:
|
| | | | | | | | | | | | | | | | | | | |
| March 31, 2015 |
| Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Carrying Value |
| | | | | | | | | |
Available-for sale securities | | | | | | | | | |
Asset-backed securities | $ | 2,200 |
| | $ | 11 |
| | $ | (19 | ) | | $ | 2,192 |
| | $ | 2,192 |
|
Commercial mortgage-backed securities | 707 |
| | 23 |
| | (1 | ) | | 729 |
| | 729 |
|
Corporates | 9,253 |
| | 648 |
| | (74 | ) | | 9,827 |
| | 9,827 |
|
Equities | 574 |
| | 35 |
| | (3 | ) | | 606 |
| | 606 |
|
Hybrids | 1,303 |
| | 74 |
| | (20 | ) | | 1,357 |
| | 1,357 |
|
Municipals | 1,281 |
| | 157 |
| | (2 | ) | | 1,436 |
| | 1,436 |
|
Residential mortgage-backed securities | 2,108 |
| | 108 |
| | (22 | ) | | 2,194 |
| | 2,194 |
|
U.S. Government | 309 |
| | 11 |
| | — |
| | 320 |
| | 320 |
|
Total available-for-sale securities | 17,735 |
| | 1,067 |
| | (141 | ) | | 18,661 |
| | 18,661 |
|
Derivative investments | 205 |
| | 83 |
| | (20 | ) | | 268 |
| | 268 |
|
Commercial mortgage loans | 304 |
| | — |
| | — |
| | 304 |
| | 304 |
|
Other invested assets | 239 |
| | — |
| | (7 | ) | | 232 |
| | 232 |
|
Total investments | $ | 18,483 |
| | $ | 1,150 |
| | $ | (168 | ) | | $ | 19,465 |
| | $ | 19,465 |
|
|
| | | | | | | | | | | | | | | | | | | |
| September 30, 2014 |
| Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Carrying Value |
| | | | | | | | | |
Available-for-sale securities | | | | | | | | | |
Asset-backed securities | $ | 2,040 |
| | $ | 12 |
| | $ | (20 | ) | | $ | 2,032 |
| | $ | 2,032 |
|
Commercial mortgage-backed securities | 618 |
| | 21 |
| | (2 | ) | | 637 |
| | 637 |
|
Corporates | 9,329 |
| | 499 |
| | (49 | ) | | 9,779 |
| | 9,779 |
|
Equities | 679 |
| | 24 |
| | (5 | ) | | 698 |
| | 698 |
|
Hybrids | 1,279 |
| | 52 |
| | (15 | ) | | 1,316 |
| | 1,316 |
|
Municipals | 1,150 |
| | 117 |
| | (7 | ) | | 1,260 |
| | 1,260 |
|
Residential mortgage-backed securities | 1,985 |
| | 140 |
| | (11 | ) | | 2,114 |
| | 2,114 |
|
U.S. Government | 291 |
| | 7 |
| | (1 | ) | | 297 |
| | 297 |
|
Total available-for-sale securities | 17,371 |
| | 872 |
| | (110 | ) | | 18,133 |
| | 18,133 |
|
Derivatives investments | 178 |
| | 123 |
| | (5 | ) | | 296 |
| | 296 |
|
Commercial mortgage loans | 136 |
| | — |
| | — |
| | 136 |
| | 136 |
|
Other invested assets | 237 |
| | — |
| | — |
| | 237 |
| | 237 |
|
Total investments | $ | 17,922 |
| | $ | 995 |
| | $ | (115 | ) | | $ | 18,802 |
| | $ | 18,802 |
|
Included in AOCI were cumulative unrealized gains of $1 and unrealized losses of $2 related to the non-credit portion of other than temporary impairments ("OTTI") on non-agency residential mortgage-backed securities ("RMBS") at March 31, 2015 and September 30, 2014. The non-agency RMBS unrealized gains and losses represent the difference between amortized cost and fair value on securities that were previously impaired. There have been no impairments or write downs on any of the non-agency RMBS purchased during the six months ended March 31, 2015.
Securities held on deposit with various state regulatory authorities had a fair value of $15,986 and $15,009 at March 31, 2015 and September 30, 2014, respectively. Under Iowa regulations, insurance companies are required to hold securities on deposit in an amount no less than the Company's legal reserve as prescribed by Iowa regulations.
The Company held no non-income producing investments during the three and six months ended March 31, 2015 and 2014.
In accordance with the Company's Federal Home Loan Bank of Atlanta (“FHLB”) agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities. The collateral investments had a fair value of $558 and $573 at March 31, 2015 and September 30, 2014, respectively.
The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.
|
| | | | | | | |
| March 31, 2015 |
| Amortized Cost | | Fair Value |
Corporates, Non-structured Hybrids, Municipal and U.S. Government securities: | | | |
Due in one year or less | $ | 328 |
| | $ | 331 |
|
Due after one year through five years | 2,293 |
| | 2,352 |
|
Due after five years through ten years | 2,894 |
| | 3,027 |
|
Due after ten years | 5,918 |
| | 6,514 |
|
Subtotal | 11,433 |
| | 12,224 |
|
Other securities which provide for periodic payments: | | | |
Asset-backed securities | 2,200 |
| | 2,192 |
|
Commercial mortgage-backed securities | 707 |
| | 729 |
|
Structured hybrids | 713 |
| | 716 |
|
Residential mortgage-backed securities | 2,108 |
| | 2,194 |
|
Subtotal | 5,728 |
| | 5,831 |
|
Total fixed maturity available-for-sale securities | $ | 17,161 |
| | $ | 18,055 |
|
The Company's available-for-sale securities with unrealized losses are reviewed for potential OTTI. In evaluating whether a decline in value is other-than-temporary, the Company considers several factors including, but not limited to the following: (1) the extent and the duration of the decline; (2) the reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening); and (3) the financial condition of and near-term prospects of the issuer. The Company also considers the ability and intent to hold the investment for a period of time to allow for a recovery of value.
The Company analyzes its ability to recover the amortized cost by comparing the net present value of cash flows expected to be collected with the amortized cost of the security. For mortgage-backed and asset-backed securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions, based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. For structured securities, the payment priority within the tranche structure is also considered. For all other debt securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. If the net present value is less than the amortized cost of the investment, an OTTI is recognized. FGL has concluded that the unrealized declines in fair values of the securities presented in the table below were not OTTI as of March 31, 2015.
The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category, were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2015 |
| Less than 12 months | | 12 months or longer | | Total |
| Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses |
Available-for-sale securities | | | | | | | | | | | |
Asset-backed securities | $ | 578 |
| | $ | (8 | ) | | $ | 559 |
| | $ | (11 | ) | | $ | 1,137 |
| | $ | (19 | ) |
Commercial mortgage-backed securities | 51 |
| | (1 | ) | | 8 |
| | — |
| | 59 |
| | (1 | ) |
Corporates | 838 |
| | (32 | ) | | 761 |
| | (42 | ) | | 1,599 |
| | (74 | ) |
Equities | 35 |
| | (1 | ) | | 50 |
| | (2 | ) | | 85 |
| | (3 | ) |
Hybrids | 149 |
| | (8 | ) | | 144 |
| | (12 | ) | | 293 |
| | (20 | ) |
Municipals | 63 |
| | (1 | ) | | 126 |
| | (1 | ) | | 189 |
| | (2 | ) |
Residential mortgage-backed securities | 412 |
| | (10 | ) | | 298 |
| | (12 | ) | | 710 |
| | (22 | ) |
U.S. Government | 70 |
| | — |
| | 50 |
| | — |
| | 120 |
| | — |
|
Total available-for-sale securities | $ | 2,196 |
| | $ | (61 | ) | | $ | 1,996 |
| | $ | (80 | ) | | $ | 4,192 |
| | $ | (141 | ) |
Total number of available-for-sale securities in an unrealized loss position less than twelve months | | | | | | | | | | | 322 |
|
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | | | | | | | | | | | 247 |
|
Total number of available-for-sale securities in an unrealized loss position | | | | | | | | | | | 569 |
|
|
| | | | | | | | | | | | | | | | | | | | | | | |
| September 30, 2014 |
| Less than 12 months | | 12 months or longer | | Total |
| Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses |
Available-for-sale securities | | | | | | | | | | | |
Asset-backed securities | $ | 939 |
| | $ | (13 | ) | | $ | 290 |
| | $ | (7 | ) | | $ | 1,229 |
| | $ | (20 | ) |
Commercial mortgage-backed securities | 160 |
| | (1 | ) | | 1 |
| | (1 | ) | | 161 |
| | (2 | ) |
Corporates | 817 |
| | (16 | ) | | 1,127 |
| | (33 | ) | | 1,944 |
| | (49 | ) |
Equities | 181 |
| | (2 | ) | | 54 |
| | (3 | ) | | 235 |
| | (5 | ) |
Hybrids | 258 |
| | (2 | ) | | 290 |
| | (13 | ) | | 548 |
| | (15 | ) |
Municipals | — |
| | — |
| | 265 |
| | (7 | ) | | 265 |
| | (7 | ) |
Residential mortgage-backed securities | 299 |
| | (6 | ) | | 178 |
| | (5 | ) | | 477 |
| | (11 | ) |
U.S Government | 37 |
| | — |
| | 82 |
| | (1 | ) | | 119 |
| | (1 | ) |
Total available-for-sale securities | $ | 2,691 |
| | $ | (40 | ) | | $ | 2,287 |
| | $ | (70 | ) | | $ | 4,978 |
| | $ | (110 | ) |
Total number of available-for-sale securities in an unrealized loss position less than twelve months | | | | | | | | | | | 324 |
|
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | | | | | | | | | | | 311 |
|
Total number of available-for-sale securities in an unrealized loss position | | | | | | | | | | | 635 |
|
At March 31, 2015 and September 30, 2014, securities in an unrealized loss position were primarily concentrated in investment grade corporate debt instruments.
At March 31, 2015 and September 30, 2014, securities with a fair value of $21 and $0, respectively, were depressed greater than 20% of amortized cost (excluding U.S. Government and U.S. Government sponsored agency securities), which represented less than 1% of the carrying value of all investments.
The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity securities held by the Company for the three and six months ended March 31, 2015 and 2014, for which a portion of the OTTI was recognized in AOCI:
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
Beginning balance | $ | 3 |
| | $ | 3 |
| | $ | 3 |
| | $ | 3 |
|
Increases attributable to credit losses on securities: | | | | | | | |
Other-than-temporary impairment was previously recognized | — |
| | — |
| | — |
| | — |
|
Other-than-temporary impairment was not previously recognized | — |
| | — |
| | — |
| | — |
|
Ending balance | $ | 3 |
| | $ | 3 |
| | $ | 3 |
| | $ | 3 |
|
For the three and six months ended March 31, 2015, the Company recognized $61 of credit impairment losses in operations related to asset-backed, corporate securities and other invested assets with an amortized cost of $116 and a fair value of $55 at March 31, 2015. For the three and six months ended March 31, 2014, the Company recognized no impairment losses in operations.
Details underlying write-downs taken as a result of OTTI that were recognized in net income and included in net realized (losses) gains on securities were as follows:
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
OTTI Recognized in Net Income: | | | | | | | |
Asset-backed securities | $ | 24 |
| | $ | — |
| | $ | 24 |
| | $ | — |
|
Corporates | 2 |
| | — |
| | 2 |
| | — |
|
Other invested assets | 35 |
| | — |
| | 35 |
| | — |
|
Total | $ | 61 |
| | $ | — |
| | $ | 61 |
| | $ | — |
|
The portion of OTTI recognized in AOCI is disclosed in the Statement of Comprehensive Income.
In the second fiscal quarter ended March 31, 2015, the Company recognized credit-related impairment losses of $59 on available-for-sale debt securities, available-for-sale equity securities and other invested assets, net of reinsurance, related to direct and indirect investments in RadioShack Corporation ("RSH") because the Company concluded the decline in the fair value of these investments was other than temporary. A summary to the RSH-related impairments by investment is as follows:
|
| | | | | | |
Type | | Balance Sheet Classification | | Impairment Loss |
Collateralized loan obligations (a) | | Fixed maturities, available-for-sale | | $ | 25 |
|
Preferred equity (a) | | Equity securities, available-for-sale | | 21 |
|
Participations | | Other invested assets | | 35 |
|
Impairment, gross of reinsurance | | | | $ | 81 |
|
Preferred equity (a) | | Equity securities, available-for-sale | | (21 | ) |
Collateralized loan obligations (a) | | Fixed maturities, available-for-sale | | (1 | ) |
Impairment, net of reinsurance | | | | $ | 59 |
|
(a) Preferred equity and a portion of the collateralized loan obligations are included in the FSRCI funds withheld portfolio, accordingly all income on these assets are ceded to FSRCI.
The fair values of the impairments summarized above were determined using the following inputs as follows:
| |
• | Collateralized loan obligations ("CLOs") - The Company utilized a price from a third party pricing service which considered the sufficiency of underlying loan collateral for the RSH loan. |
| |
• | Preferred equity - The Company utilized a price from a third party pricing service which considered the updated fair value estimates of the Salus Capital Partners, LLC ("Salus") CLO and the Salus participation in RSH, both of which Salus owns investment interests. |
| |
• | Participations - The Company considered the sufficiency and recoverability of the underlying loan collateral for RSH. |
The total gross impact of the impairment losses above, excluding reinsurance with FSRCI is $81. RSH filed for bankruptcy on February 5, 2015. In late March 2015, the Court awarded a sale of assets at auction to another bidder, causing our collateral claim to become more junior to other claimants and resulting in our conclusion that the Company had realized an other than temporary impairment. Please refer to "Note 14. Related Party Transactions” to the Company’s Consolidated Financial Statements for more detail on the investments impacted by this impairment.
Mortgage Loans on Real Estate
Commercial mortgage loans ("CMLs") represented approximately 2% and 1% of the Company’s total investments as of March 31, 2015 and September 30, 2014, respectively. The Company primarily makes mortgage loans on income producing properties including hotels, industrial properties, retail buildings, multifamily properties and office buildings. The Company diversifies its CML portfolio by geographic region and property type to reduce concentration risk. Subsequent to origination, the Company continuously evaluates CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables:
|
| | | | | | | | | | | | | |
| March 31, 2015 | September 30, 2014 |
| Gross Carrying Value | | % of Total | | Gross Carrying Value | | % of Total |
Property Type: | | | | | | | |
Industrial - General | $ | 20 |
| | 7 | % | | $ | — |
| | — | % |
Industrial - Warehouse | 47 |
| | 15 | % | | 48 |
| | 35 | % |
Multifamily | 30 |
| | 10 | % | | 38 |
| | 28 | % |
Office | 76 |
| | 25 | % | | 44 |
| | 33 | % |
Retail | 123 |
| | 40 | % | | 6 |
| | 4 | % |
Apartment | 7 |
| | 3 | % | | — |
| | — | % |
Funeral Home | 1 |
| | — | % | | — |
| | — | % |
Total commercial mortgage loans | $ | 304 |
| | 100 | % | | $ | 136 |
| | 100 | % |
| | | | | | | |
US Region: | | | | | | | |
East North Central | $ | 84 |
| | 28 | % | | $ | 28 |
| | 21 | % |
Middle Atlantic | 18 |
| | 6 | % | | 11 |
| | 8 | % |
Pacific | 66 |
| | 21 | % | | 61 |
| | 45 | % |
South Atlantic | 63 |
| | 21 | % | | — |
| | — | % |
West North Central | 6 |
| | 2 | % | | 6 |
| | 4 | % |
West South Central | 20 |
| | 6 | % | | 30 |
| | 22 | % |
Mountain | 42 |
| | 14 | % | | — |
| | — | % |
New England | 5 |
| | 2 | % | | — |
| | — | % |
Total commercial mortgage loans | $ | 304 |
| | 100 | % | | $ | 136 |
| | 100 | % |
The Company has a CML portfolio with 100% of all CMLs having a loan-to-value (“LTV”) ratio of less than 75% at March 31, 2015 and September 30, 2014. As of March 31, 2015, all CMLs are current and have not experienced credit or other events which would require the recording of an impairment loss. The Company has not established a collective or specific CML valuation allowance as of March 31, 2015.
LTV and debt service coverage (“DSC”) ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio, calculated at time of origination, is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the
amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments.
The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at March 31, 2015 and September 30, 2014:
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| Debt-Service Coverage Ratios | | Total Amount | | % of Total | | Estimated Fair Value | | % of Total |
| >1.25 | | 1.00 - 1.25 | | N/A(a) | | | | |
March 31, 2015 | | | | | | | | | | | | | |
LTV Ratios: | | | | | | | | | | | | | |
Less than 50% | $ | 74 |
| | $ | — |
| | $ | 1 |
| | $ | 75 |
| | 25 | % | | $ | 75 |
| | 25 | % |
50% to 60% | 64 |
| | 20 |
| | — |
| | 84 |
| | 28 | % | | 84 |
| | 28 | % |
60% to 75% | 145 |
| | — |
| | — |
| | 145 |
| | 47 | % | | 145 |
| | 47 | % |
Commercial mortgage loans | $ | 283 |
| | $ | 20 |
| | $ | 1 |
| | $ | 304 |
| | 100 | % | | $ | 304 |
| | 100 | % |
September 30, 2014 | | | | | | | | | | | | | |
LTV Ratios: | | | | | | | | | | | | | |
Less than 50% | $ | 44 |
| | $ | — |
| | $ | 1 |
| | $ | 45 |
| | 33 | % | | $ | 45 |
| | 33 | % |
50% to 60% | 20 |
| | — |
| | — |
| | 20 |
| | 15 | % | | 20 |
| | 15 | % |
60% to 75% | 71 |
| | — |
| | — |
| | 71 |
| | 52 | % | | 71 |
| | 52 | % |
Commercial mortgage loans | $ | 135 |
| | $ | — |
| | $ | 1 |
| | $ | 136 |
| | 100 | % | | $ | 136 |
| | 100 | % |
(a) N/A - Current DSC ratio not available.
The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At March 31, 2015, we had no CMLs that were delinquent in principal or interest payments. The following provides the current and past due composition of our CMLs:
|
| | | | | | | |
| March 31, 2015 | | September 30, 2014 |
Current to 30 days | $ | 304 |
| | $ | 136 |
|
Total carrying value | $ | 304 |
| | $ | 136 |
|
A Troubled Debt Restructuring ("TDR") is a situation where we have granted a concession to a borrower for economic or legal reasons related to the borrower's financial difficulties that we would not otherwise consider. A mortgage loan that has been granted new terms, including workout terms as described previously, would be considered a TDR if it meets conditions that would indicate a borrower is experiencing financial difficulty and the new terms constitute a concession on our part. We analyze all loans where we have agreed to workout terms and all loans that we have refinanced to determine if they meet the definition of a TDR. We consider the following factors in determining whether or not a borrower is experiencing financial difficulty:
•borrower is in default,
•borrower has declared bankruptcy,
•there is growing concern about the borrower's ability to continue as a going concern,
•borrower has insufficient cash flows to service debt,
•borrower's inability to obtain funds from other sources, and
•there is a breach of financial covenants by the borrower.
If the borrower is determined to be in financial difficulty, we consider the following conditions to determine if the borrower was granted a concession:
•assets used to satisfy debt are less than our recorded investment,
•interest rate is modified,
•maturity date extension at an interest rate less than market rate,
•capitalization of interest,
•delaying principal and/or interest for a period of three months or more, and
•partial forgiveness of the balance or charge-off.
Mortgage loan workouts, refinances or restructures that are classified as TDRs are individually evaluated and measured for impairment. As of March 31, 2015, our CML portfolio had no impairments, modifications or troubled debt restructuring.
Net investment income
The major sources of “Net investment income” on the accompanying Condensed Consolidated Statements of Operations were as follows:
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
Fixed maturity available-for-sale securities | $ | 194 |
| | $ | 175 |
| | $ | 390 |
| | $ | 351 |
|
Equity available-for-sale securities | 9 |
| | 5 |
| | 18 |
| | 9 |
|
Commercial mortgage loans | 3 |
| | — |
| | 4 |
| | 1 |
|
Related party loans | 1 |
| | 2 |
| | 3 |
| | 4 |
|
Other investments | 5 |
| | 6 |
| | 11 |
| | 10 |
|
Gross investment income | 212 |
| | 188 |
| | 426 |
| | 375 |
|
Investment expense | (4 | ) | | (4 | ) | | (10 | ) | | (7 | ) |
Net investment income | $ | 208 |
| | $ | 184 |
| | $ | 416 |
| | $ | 368 |
|
Net investment (losses) gains
Details underlying “Net investment (losses) gains” reported on the accompanying Condensed Consolidated Statements of Operations were as follows:
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
Net realized (losses) gains on fixed maturity available-for-sale securities | $ | (19 | ) | | $ | 6 |
| | $ | (23 | ) | | $ | 20 |
|
Realized (losses) on equity securities | (3 | ) | | — |
| | (2 | ) | | (1 | ) |
Net realized (losses) gains on securities | (22 | ) | | 6 |
| | (25 | ) | | 19 |
|
Realized gains on certain derivative instruments | 40 |
| | 45 |
| | 81 |
| | 99 |
|
Unrealized (losses) gains on certain derivative instruments | (47 | ) | | (24 | ) | | (46 | ) | | 37 |
|
Change in fair value of reinsurance related embedded derivative | (3 | ) | | (29 | ) | | 16 |
| | (33 | ) |
Change in fair value of other derivatives and embedded derivatives | 11 |
| | — |
| | 12 |
| | — |
|
Realized (losses) gains on derivatives and embedded derivatives | 1 |
| | (8 | ) | | 63 |
| | 103 |
|
Realized losses on other invested assets | (37 | ) | | — |
| | (37 | ) | | — |
|
Net investment (losses) gains | $ | (58 | ) | | $ | (2 | ) | | $ | 1 |
| | $ | 122 |
|
Realized gains and losses on the sale of securities are determined on the specific identification method.
For the three and six months ended March 31, 2015, principal repayments, calls, tenders, and proceeds from the sale of fixed maturity available-for-sale securities totaled $996 and $1,806, gross gains on such sales totaled $10 and $20, and gross losses totaled $29 and $43, respectively.
For the three and six months ended March 31, 2014, principal repayments, calls, tenders, and proceeds from the sale of fixed maturity available-for-sale securities, totaled $964 and $2,628, gross gains on such sales totaled $8 and $23, and gross losses totaled $2 and $3, respectively.
Unconsolidated Variable Interest Entities
We own two investments in VIEs that are not consolidated within the Company’s financial statements. VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. These VIEs are not consolidated in the Company’s financial statements for the following reasons: 1) FGL Insurance does not have any voting rights or notice rights; 2) the Company does not have any rights to remove the investment manager; and 3) the Company was not involved in the design of the investment. These characteristics indicate that FGL Insurance lacks the ability to direct the activities, or otherwise exert control, of the VIEs and is not considered the primary beneficiary of them.
FGL Insurance participates in loans to third parties originated by Salus. Salus is an affiliated, limited liability company indirectly owned by HRG that originates senior secured asset-based loans to unaffiliated third-party borrowers. FGL Insurance also participates in CLOs managed by Salus. Because Salus is not consolidated, the Company’s maximum exposure to loss as a result of its investments in Salus is limited to the carrying value of its investments in Salus which totaled $275 and $304 as of March 31, 2015 and September 30, 2014, respectively. FGL’s investments in Salus are detailed in “Note 14. Related Party Transactions” to the Company’s Consolidated Financial Statements.
FGL Insurance also participates in an investment managed by Fifth Street Management, LLC (“Fifth Street”). Fifth Street Senior Loan Fund II (the “Fund”) invests in loans selected and/or originated by Fifth Street. Fifth Street is an unaffiliated, limited liability company that originates financing for the Fund’s investment activity through CLOs. The Company’s maximum exposure to loss as a result of its investments in Fifth Street is limited to the carrying value of its investments in Fifth Street which totaled $40 at March 31, 2015 and September 30, 2014, respectively.
(5) Derivative Financial Instruments
The carrying amounts of derivative instruments, including derivative instruments embedded in fixed indexed annuity (“FIA”) contracts, is as follows:
|
| | | | | | | |
| March 31, 2015 | | September 30, 2014 |
Assets: | | | |
Derivative investments: | | | |
Call options | $ | 268 |
| | $ | 296 |
|
Other invested assets: | | | |
Other derivatives and embedded derivatives | 25 |
| | 13 |
|
Other assets: | | | |
Reinsurance related embedded derivative | 92 |
| | 77 |
|
| $ | 385 |
| | $ | 386 |
|
|
| | | | | | | |
Liabilities: | | | |
Contractholder funds: | | | |
FIA embedded derivative | $ | 2,217 |
| | $ | 1,908 |
|
Funds withheld for reinsurance liabilities: | | | |
Call options payable to FSRCI | 18 |
| | 23 |
|
Other liabilities: | | | |
Futures contracts | 1 |
| | 1 |
|
| $ | 2,236 |
| | $ | 1,932 |
|
The change in fair value of derivative instruments included in the accompanying Condensed Consolidated Statements of Operations is as follows:
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
Revenues: | | | | | | | |
Net investment (losses) gains: | | | | | | | |
Call options | $ | (7 | ) | | $ | 19 |
| | $ | 31 |
| | $ | 121 |
|
Futures contracts | — |
| | 2 |
| | 4 |
| | 15 |
|
Other derivatives and embedded derivatives | 11 |
| | — |
| | 12 |
| | — |
|
Reinsurance related embedded derivative | (3 | ) | | (29 | ) | | 16 |
| | (33 | ) |
| $ | 1 |
| | $ | (8 | ) | | $ | 63 |
| | $ | 103 |
|
Benefits and other changes in policy reserves | | | | | | | |
FIA embedded derivatives | $ | 77 |
| | $ | 74 |
| | $ | 309 |
| | $ | 175 |
|
Additional Disclosures
Other Derivatives and Embedded Derivatives
On June 16, 2014, FGL Insurance invested in a $35 fund-linked note issued by Nomura International Funding Pte. Ltd. The note provides for an additional payment at maturity based on the value of an embedded derivative in AnchorPath Dedicated Return Fund (the "AnchorPath Fund") of $11 on June 16, 2014 which is based on the actual return of the fund. At March 31, 2015 the fair value of the embedded derivative is $12. At maturity of the fund-linked note, FGL Insurance will receive the $35 face value of the note plus the value of the embedded derivative in the AnchorPath Fund. The additional payment at maturity is an embedded derivative reported in "Other invested assets", while the host is an available-for-sale security reported in "Fixed maturities, available-for-sale".
FGL Insurance participates in loans to third parties originated by Salus, an affiliated VIE, indirectly owned by HRG that provides asset-based financing. Five of the participating loans are denominated in Canadian dollars ("CAD") which is different from FGL Insurance's functional currency. Two of the participating loans include a provision for reimbursement from the borrower to FGL Insurance for any net foreign exchange losses realized by FGL Insurance under the loan in which FGL Insurance has a participation interest. FGL Insurance's ability to recover the foreign exchange losses under these loan participations is such that the Company has established embedded derivatives equal to FGL Insurance's cumulative net foreign exchange loss on these loan participations. The value of the embedded derivatives is reflected in "Other invested assets" as of the balance sheet date with changes in fair value reflected in the Company's Condensed Consolidated Statements of Operations. The value of the embedded derivatives at each balance sheet date is equal to the cumulative net foreign exchange loss recognized on these loan participations at the balance sheet date. The Company had realized gains of $10 and $11, respectively, for the three and six months ended March 31, 2015 related to its foreign exchange embedded derivatives included in other invested assets. The Company had no realized gains or losses for the three and six months ended March 31, 2014 related to its foreign exchange embedded derivatives included in other invested assets.
The remaining three participating loans denominated in CAD also require reimbursement from borrower in CAD but do not include a provision for reimbursement of any net foreign exchange losses from the borrower. Consequently, Salus has executed CAD swap agreements with FGL Insurance to convert the CAD cash flows into USD cash flows. FGL Insurance recognizes the cumulative net foreign exchange loss recognized on these loan participations in “Other invested assets” with the changes in the fair value reflected in the Company’s Condensed Consolidated Statements of Operations. In the second fiscal quarter 2015, we executed CAD swap agreements with Salus for three of the Salus participation interest with Canadian issuers. Under these swap agreements, Salus will reimburse the Company for any foreign exchange losses related to these loan participations since the origination date. As a result, the Company accrued an expected recoverable of $9 and corresponding gain in our Condensed Consolidated Statements of Operations for the amount of cumulative net foreign exchange loss since the origination of the participation.
Credit Risk
The Company is exposed to credit loss in the event of nonperformance by its counterparties on the call options and reflects assumptions regarding this nonperformance risk in the fair value of the call options. The nonperformance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. The Company maintains a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement.
Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | March 31, 2015 | | September 30, 2014 |
Counterparty | | Credit Rating (Fitch/Moody's/S&P) (a) | | Notional Amount | | Fair Value | | Collateral | | Net Credit Risk | | Notional Amount | | Fair Value | | Collateral | | Net Credit Risk |
Merrill Lynch | | A/*/A | | $ | 2,206 |
| | $ | 70 |
| | $ | 35 |
| | $ | 35 |
| | $ | 2,240 |
| | $ | 93 |
| | $ | 53 |
| | $ | 40 |
|
Deutsche Bank | | A+/A3/A | | 3,084 |
| | 101 |
| | 78 |
| | 23 |
| | 2,810 |
| | 108 |
| | 72 |
| | 36 |
|
Morgan Stanley | | */A3/A | | 3,270 |
| | 95 |
| | 65 |
| | 30 |
| | 2,295 |
| | 85 |
| | 63 |
| | 22 |
|
Barclay's Bank | | A/A2/A | | 125 |
| | 2 |
| | — |
| | 2 |
| | 258 |
| | 10 |
| | — |
| | 10 |
|
Total | | | | $ | 8,685 |
| | $ | 268 |
| | $ | 178 |
| | $ | 90 |
| | $ | 7,603 |
| | $ | 296 |
| | $ | 188 |
| | $ | 108 |
|
(a) An * represents credit ratings that were not available.
Collateral Agreements
The Company is required to maintain minimum ratings as a matter of routine practice as part of its over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, the Company has agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open derivative contracts between the parties, at which time any amounts payable by the Company or the counterparty would be dependent on the market value of the underlying derivative contracts. The Company’s current rating allows multiple counterparties the right to terminate ISDA agreements. No ISDA agreements have been terminated, although the counterparties have reserved the right to terminate the ISDA agreements at any time. In certain transactions, the Company and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. These thresholds vary by counterparty and credit rating. As of March 31, 2015 and September 30, 2014, counterparties posted $178 and $188 of collateral of which $143 and $135, respectively, is included in "Cash and cash equivalents" with an associated payable for this collateral included in "Other liabilities" on the Condensed Consolidated Balance Sheets. The remaining $35 and $53 of non-cash collateral was held by a third-party custodian at March 31, 2015 and September 30, 2014, respectively. Accordingly, the maximum amount of loss due to credit risk that the Company would incur if parties to the call options failed completely to perform according to the terms of the contracts was $90 and $108 at March 31, 2015 and September 30, 2014, respectively.
The Company held 1,652 and 2,348 futures contracts at March 31, 2015 and September 30, 2014, respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). The Company provides cash collateral to the counterparties for the initial and variation margin on the futures contracts which is included in "Cash and cash equivalents" in the accompanying Condensed Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $8 and $11 at March 31, 2015 and September 30, 2014, respectively.
(6) Fair Value of Financial Instruments
The Company’s measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset or non-performance risk, which may include the Company’s own credit risk. The Company’s estimate of an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market in the absence of a principal market, for that asset or liability, as opposed to the price that would be paid to acquire the asset or receive a liability (“entry price”). The Company categorizes financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows:
Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date.
Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads and yield curves.
Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances.
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lower level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.
When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. However, Level 3 fair value investments may include, in addition to the unobservable or Level 3 inputs, observable components, which are components that are actively quoted or can be validated to market-based sources.
The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts and debt, are summarized according to the hierarchy previously described, as follows:
|
| | | | | | | | | | | | | | | | | | | |
| March 31, 2015 |
| Level 1 | | Level 2 | | Level 3 | | Fair Value | | Carrying Amount |
Assets | | | | | | | | | |
Cash and cash equivalents | $ | 849 |
| | $ | — |
| | $ | — |
| | $ | 849 |
| | $ | 849 |
|
Fixed maturity securities, available-for-sale: | | | | | | | | | |
Asset-backed securities | — |
| | 2,100 |
| | 92 |
| | 2,192 |
| | 2,192 |
|
Commercial mortgage-backed securities | — |
| | 587 |
| | 142 |
| | 729 |
| | 729 |
|
Corporates | — |
| | 8,902 |
| | 925 |
| | 9,827 |
| | 9,827 |
|
Hybrids | — |
| | 1,357 |
| | — |
| | 1,357 |
| | 1,357 |
|
Municipals | — |
| | 1,396 |
| | 40 |
| | 1,436 |
| | 1,436 |
|
Residential mortgage-backed securities | — |
| | 2,194 |
| | — |
| | 2,194 |
| | 2,194 |
|
U.S. Government | 135 |
| | 185 |
| | — |
| | 320 |
| | 320 |
|
Equity securities available-for-sale | 27 |
| | 561 |
| | 18 |
| | 606 |
| | 606 |
|
Derivative financial instruments | — |
| | 268 |
| | — |
| | 268 |
| | 268 |
|
Reinsurance related embedded derivative, included in other assets | — |
| | 92 |
| | — |
| | 92 |
| | 92 |
|
Other invested assets | — |
| | 13 |
| | 219 |
| | 232 |
| | 232 |
|
Total financial assets at fair value | $ | 1,011 |
| | $ | 17,655 |
| | $ | 1,436 |
| | $ | 20,102 |
| | $ | 20,102 |
|
Liabilities | | | | | | | | | |
Derivatives: | | | | | | | | | |
FIA embedded derivatives, included in contractholder funds | $ | — |
| | $ | — |
| | $ | 2,217 |
| | $ | 2,217 |
| | $ | 2,217 |
|
Derivative instruments - futures contracts | — |
| | 1 |
| | — |
| | 1 |
| | 1 |
|
Investment contracts, included in contractholder funds | — |
| | — |
| | 13,709 |
| | 13,709 |
| | 15,304 |
|
Call options payable for FSRCI, included in funds withheld for reinsurance liabilities | — |
| | 18 |
| | — |
| | 18 |
| | 18 |
|
Debt | — |
| | 315 |
| | — |
| | 315 |
| | 300 |
|
Total financial liabilities at fair value | $ | — |
| | $ | 334 |
| | $ | 15,926 |
| | $ | 16,260 |
| | $ | 17,840 |
|
|
| | | | | | | | | | | | | | | | | | | |
| September 30, 2014 |
| Level 1 | | Level 2 | | Level 3 | | Fair Value | | Carrying Amount |
Assets | | | | | | | | | |
Cash and cash equivalents | $ | 576 |
| | $ | — |
| | $ | — |
| | $ | 576 |
| | $ | 576 |
|
Fixed maturity securities, available-for-sale: | | | | | | | | | |
Asset-backed securities | — |
| | 1,958 |
| | 74 |
| | 2,032 |
| | 2,032 |
|
Commercial mortgage-backed securities | — |
| | 554 |
| | 83 |
| | 637 |
| | 637 |
|
Corporates | — |
| | 8,945 |
| | 834 |
| | 9,779 |
| | 9,779 |
|
Hybrids | — |
| | 1,316 |
| | — |
| | 1,316 |
| | 1,316 |
|
Municipals | — |
| | 1,223 |
| | 37 |
| | 1,260 |
| | 1,260 |
|
Residential mortgage-backed securities | — |
| | 2,114 |
| | — |
| | 2,114 |
| | 2,114 |
|
U.S. Government | 116 |
| | 181 |
| | — |
| | 297 |
| | 297 |
|
Equity securities available-for-sale | 59 |
| | 599 |
| | 40 |
| | 698 |
| | 698 |
|
Derivative financial instruments | — |
| | 296 |
| | — |
| | 296 |
| | 296 |
|
Reinsurance related embedded derivative, included in other assets | — |
| | 76 |
| | — |
| | 76 |
| | 76 |
|
Other invested assets | — |
| | 2 |
| | 235 |
| | 237 |
| | 237 |
|
Total financial assets at fair value | $ | 751 |
| | $ | 17,264 |
| | $ | 1,303 |
| | $ | 19,318 |
| | $ | 19,318 |
|
Liabilities | | | | | | | | | |
Derivatives: | | | | | | | | | |
FIA embedded derivatives, included in contractholder funds | $ | — |
| | $ | — |
| | $ | 1,908 |
| | $ | 1,908 |
| | $ | 1,908 |
|
Derivative instruments - futures contracts | — |
| | 1 |
| | — |
| | 1 |
| | 1 |
|
Investment contracts, included in contractholder funds | — |
| | — |
| | 13,109 |
| | 13,109 |
| | 14,556 |
|
Call options payable for FSRCI, included in funds withheld for reinsurance liabilities | — |
| | 22 |
| | — |
| | 22 |
| | 22 |
|
Debt | — |
| | 317 |
| | — |
| | 317 |
| | 300 |
|
Total financial liabilities at fair value | $ | — |
| | $ | 340 |
| | $ | 15,017 |
| | $ | 15,357 |
| | $ | 16,787 |
|
The carrying amounts of accrued investment income, and portions of other insurance liabilities, approximate fair value due to their short duration and, accordingly, they are not presented in the tables above.
Valuation Methodologies
Fixed Maturity Securities & Equity Securities
The Company measures the fair value of its securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity or equity security, and the Company will then consistently apply the valuation methodology to measure the security’s fair value. The Company's fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include a third-party pricing service, independent broker quotations or pricing matrices. The Company uses observable and unobservable inputs in its valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met. For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant unobservable input used in the fair value measurement of equity securities available-for-sale for which the market-approach valuation technique is employed is yields for comparable securities. Increases (decreases) in the yields would result in lower or higher, respectively, fair value measurements. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. The fair value of the Company's investment in mutual funds is based on the net asset value published by the respective mutual fund and represents the value the Company would have received if it withdrew its investment on the balance sheet date. Management believes the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices.
The Company did not adjust prices received from third parties as of March 31, 2015 and September 30, 2014. However, the Company does analyze the third-party valuation methodologies and its related inputs to perform assessments to determine the appropriate level within the fair value hierarchy.
Derivative Financial Instruments
The fair value of derivative assets and liabilities is based upon valuation pricing models, which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the options, entered into offsetting positions, or exercised the options. Fair values for these instruments are determined externally by an independent consulting firm using market-observable inputs, including interest rates, yield curve volatilities, and other factors. The fair values of the embedded derivatives in the Company’s FIA products are derived using market indices, pricing assumptions and historical data. The fair value of the reinsurance related embedded derivative in the funds withheld reinsurance agreement with FSRCI is estimated based upon the change in the fair value of the assets supporting the funds withheld from reinsurance liabilities. As the fair value of the assets is based on a quoted market price of similar assets (Level 2), the fair value of the embedded derivative is based on market-observable inputs and is classified as Level 2. The fair value of futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements).
Investment contracts include deferred annuities, FIAs, indexed universal life policies (“IULs”) and immediate annuities. The fair value of deferred annuity, FIA, and IUL contracts is based on their cash surrender value (i.e. the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of immediate annuities contracts is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. At March 31, 2015 and September 30, 2014, this resulted in lower fair value reserves relative to the carrying value. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value.
The significant unobservable inputs used in the fair value measurement of FIA embedded derivatives included in contractholder funds are market value of option, interest swap rates, mortality multiplier, surrender rates, and non-performance spread. The mortality multiplier at March 31, 2015 and September 30, 2014 is applied to the Annuity 2000 mortality tables. Significant increases (decreases) in the market value of option in isolation would result in a higher or lower, respectively, fair value measurement. Significant increases or decreases in interest swap rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher, respectively, fair value measurement. Generally, a change in any one unobservable input would not result in a change in any other unobservable input.
Other Invested Assets
Fair value of our loan participation interest securities approximates the unpaid principal balance of the participation interest as of March 31, 2015. In making this assessment, the Company considered the sufficiency of the underlying loan collateral, movements in the benchmark interest rate between origination date and March 31, 2015, the primary market participant for these securities and the short-term maturity of these loans (less than 1 year).
Fair value of our loan participation interest in RSH is based upon a best estimate of the expected liquidation value of the underlying collateral. RSH is in the process of liquidation to satisfy creditor obligations. Valuation of the collateral was based upon a variety of assumptions by asset class depending upon the availability of market-participant indicators of fair value. Where such market data was not available, a best estimate of expected liquidation value as a percentage of book value was calculated based upon experience in similar liquidations. Our best estimate of recovery value is 30% of the par value of the investment based upon the documentation currently available. As the liquidation process continues and more information becomes known about expected or actual sales price/recovery value, our estimates and the evaluation of the fair value and other than temporary impairment will be updated. The actual recovery value from the liquidation process could vary from the estimates that have been used for the current fair value estimation.
Fair value of our embedded derivative is based on an unobservable input, the net asset value of the AnchorPath fund at the balance sheet date. The embedded derivative is similar to a call option on the net asset value of the AnchorPath fund with a strike price of zero since FGL Insurance will not be required to make any additional payments at maturity of the fund-linked note in order to receive the net asset value of the AnchorPath fund on the maturity date. Therefore, the Black Scholes model returns the net asset value of the AnchorPath fund as the fair value of the call option regardless of the values used for the other inputs to the option pricing model. The net asset value of the AnchorPath fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if
it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black Scholes model is the value of the AnchorPath fund. As the value of the AnchorPath fund increases or decreases, the fair value of the embedded derivative will increase or decrease.
Fair value of foreign exchange derivatives and embedded derivatives are based on the quoted United States dollar ("USD")/CAD exchange rates.
Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value
The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments.
Mortgage Loans on Real Estate
The fair value of mortgage loans on real estate is established using a discounted cash flow method based on credit rating, maturity and future income. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt-service coverage, loan-to-value, quality of tenancy, borrower and payment record. The fair value for impaired mortgage loans is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price or the fair value of the collateral if the loan is collateral dependent. The inputs used to measure the fair value of our mortgage loans on real estate are classified as Level 3 within the fair value hierarchy.
In September 2013, the Company initiated a commercial loan program utilizing a third party CML asset manager, Principal Real Estate Investors ("Principal"). Subsequently in October 2014, the Company transitioned this program to CorAmerica, a subsidiary of Harbinger Group, as an additional CML asset manager, and in April 2015 transferred the management and servicing responsibilities of all CMLs to CorAmerica. As part of these programs, the Company has funded CMLs with a fair value of $304 at March 31, 2015, which is equal to amortized cost. None of these loans are past due or have material credit issues and given that there have not been material changes in market interest since origination the Company views amortized cost as representative of fair value. The CML asset managers monitor the status of the payment obligations, the credit quality of the borrower, the condition of the property, and any other events that may impact the performance and principal repayment of the CMLs. Additionally, the Company periodically reviews the asset managers' valuation methodologies and investment processes to ensure the program is performing in line with the objectives of the program. A CML's current standing and payment obligations are material factors in evaluating the CML's carrying value and related fair value. At March 31, 2015, all CMLs are current with no payments past due and there are no credit or other events which would require impairment evaluation.
Policy Loans (included within Other Invested Assets)
Also included in other invested assets are policy loans. Fair values for policy loans are estimated using discounted cash flow analysis, using interest rates currently being offered for loans with similar credit risk. Loans with similar characteristics are aggregated for purposes of the calculations.
Related Party Loans
The related party loans (discussed in "Note 14. Related Party Transactions") carrying value at par approximates fair value, as this is the exit price for the obligation of these loans.
Debt
The fair value of debt is based on quoted market prices. The inputs used to measure the fair value of our outstanding debt are classified as Level 2 within the fair value hierarchy.
Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of March 31, 2015 and September 30, 2014 are as follows:
|
| | | | | | | | | | |
| | Fair Value at | | | | | | Range (Weighted average) |
| | March 31, 2015 | | Valuation Technique | | Unobservable Input(s) | | March 31, 2015 |
Assets | | | | | | | | |
Asset-backed securities | | $ | 31 |
| | Broker-quoted | | Offered quotes | | 100.00% |
Asset-backed securities (Salus CLO equity tranche) | | 40 |
| | Third-Party Valuation
| | Offered quotes | | 59.21% |
| | | | | | Discount rate | | 16.50% |
| | | | | | Constant default rate | | 2.00% |
| | | | | | RSH recovery | | RSH - 30.00% recovery |
Asset-backed securities | | 3 |
| | Matrix Pricing | | Quoted prices | | 109.94% |
Asset-backed securities (Salus CLO) | | 18 |
| | Matrix Pricing | | Quoted prices | | 99.90% |
Commercial mortgage-backed securities
| | 97 |
| | Broker-quoted | | Offered quotes | | 100.00% - 120.75% (114.09%) |
Commercial mortgage-backed securities
| | 45 |
| | Matrix Pricing | | Quoted prices | | 105.75% - 122.50% (115.47%) |
Corporates | | 527 |
| | Broker-quoted | | Offered quotes | | 67.44% - 122.61% (102.44%) |
Corporates | | 398 |
| | Matrix Pricing | | Quoted prices | | 75.00% - 149.80% (103.49%) |
Municipals | | 40 |
| | Broker-quoted | | Offered quotes | | 114.50% |
Equity securities available-for-sale | | 6 |
| | Matrix Pricing | | Quoted prices | | 100.00% |
Equity securities available-for-sale (Salus preferred equity) | | 12 |
| | Market-approach | | Yield | | 9.24% - 10.74% |
| | | | | | RSH recovery | | RSH - 30.00% recovery |
| | | | | | Discount rate | | 27.00% |
| | | | | | Salus CLO equity | | 59.21% |
Other invested assets: | | | | | | | | |
Available-for-sale embedded derivative | | 12 |
| | Black Scholes model | | Market value of AnchorPath fund | | 100.00% |
Salus participations | | 180 |
| | Market Pricing | | Offered quotes | | 100.00% |
Salus participation - RSH Corporation | | 15 |
| | Liquidation Value - 30% recovery estimate | | Sales agreements | | 100.00% |
| | | | | | Cash | | 100.00% |
| | | | | | Inventory | | 50.00% of book value |
| | | | | | Accounts receivable | | 50.00% - 100.00% of book value |
| | | | | | Intellectual property | | 100.00% of appraisal of orderly liquidation value |
| | | | | | Real estate | | Bids; 60.00%-65.00% of book value |
| | | | | | Wind-down expenses | | 100.00% estimated expense |
Total | | $ | 1,424 |
| | | | | | |
Liabilities | | | | | | | | |
Derivatives: | | | | | | | | |
FIA embedded derivatives, included in contractholder funds | | $ | 2,217 |
| | Discounted Cash Flow | | Market value of option | | 0.00% - 42.05% (2.80%) |
| | | | | | SWAP rates | | 1.53% - 2.03% (1.78%) |
| | | | | | Morality multiplier | | 80.00% |
| | | | | | Surrender rates | | 0.50% - 75.00% (7.00%) |
| | | | | | Non-performance spread | | 0.25% |
Total liabilities at fair value | | $ | 2,217 |
| | | | | | |
|
| | | | | | | | | | |
| | Fair Value at | | | | | | Range (Weighted average) |
| | September 30, 2014 | | Valuation Technique | | Unobservable Input(s) | | September 30, 2014 |
Assets | | | | | | | | |
Asset-backed securities | | $ | 74 |
| | Broker-quoted | | Offered quotes | | 95.45% - 109.26% (99.26%) |
Commercial mortgage-backed securities | | 83 |
| | Broker-quoted | | Offered quotes | | 105.25% - 121.00% (118.29%) |
Corporates | | 832 |
| | Broker-quoted | | Offered quotes | | 61.67% - 119.75% (100.04%) |
Corporates | | 2 |
| | Matrix Pricing | | Quoted prices | | 142.30% |
Municipals | | 37 |
| | Broker-quoted | | Offered quotes | | 106.64% |
Equity securities available-for-sale | | 6 |
| | Broker-quoted | | Offered quotes | | 99.75% |
Equity securities available-for-sale | | 34 |
| | Market-approach | | Yield | | 8.31% - 9.81% |
Other invested assets: | | | | | | | | |
Available-for-sale embedded derivative | | 11 |
| | Black scholes model | | Net asset value of AnchorPath fund | | 100.00% |
Salus participations | | 213 |
| | Market Pricing | | Offered quotes | | 100.00% |
Total | | $ | 1,292 |
| | | | | | |
Liabilities | | | | | | | | |
Derivatives: | | | | | | | | |
FIA embedded derivatives, included in contractholder funds | | $ | 1,908 |
| | Discounted Cash Flow | | Market value of option | | 0.00% - 49.82% (3.37%) |
| | | | | | SWAP rates | | 1.93% - 2.64% (2.29%) |
| | | | | | Morality multiplier | | 80.00% |
| | | | | | Surrender rates | | 0.50% - 75.00% (7.00%) |
| | | | | | Non-performance spread | | 0.25% |
Total liabilities at fair value | | $ | 1,908 |
| | | | | | |
Changes in unrealized losses (gains), net in the Company’s FIA embedded derivatives are included in "Benefits and other changes in policy reserves" in the Condensed Consolidated Statements of Operations.
The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three and six months ended March 31, 2015 and 2014, respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31, 2015 |
| Balance at Beginning of Period | | Total Gains (Losses) | | Purchases | | Sales | | Settlements | | Net transfer In (Out) of Level 3 (a) | | Balance at End of Period |
| | Included in Earnings | | Included in AOCI | | | | | |
Assets | | | | | | | | | | | | | | | |
Fixed maturity securities available-for-sale: | | | | | | | | | | | | | | | |
Asset-backed securities | $ | 71 |
| | $ | (25 | ) | | $ | 2 |
| | $ | 63 |
| | $ | (15 | ) | | $ | — |
| | $ | (4 | ) | | $ | 92 |
|
Commercial mortgage-backed securities | 120 |
| | — |
| | 1 |
| | 21 |
| | — |
| | — |
| | — |
| | 142 |
|
Corporates | 901 |
| | 2 |
| | 15 |
| | 62 |
| | — |
| | (31 | ) | | (24 | ) | | 925 |
|
Municipals | 39 |
| | — |
| | 1 |
| | — |
| | — |
| | — |
| | — |
| | 40 |
|
Equity securities available-for-sale | 38 |
| | (21 | ) | | 1 |
| | — |
| | — |
| | — |
| | — |
| | 18 |
|
Other invested assets: | | | | | | | | | | | | | | | |
Available-for-sale embedded derivative | 12 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 12 |
|
Salus participations, included in other invested assets | 237 |
| | (36 | ) | | (4 | ) | | 22 |
| | — |
| | (24 | ) | | — |
| | 195 |
|
Total assets at Level 3 fair value | $ | 1,418 |
| | $ | (80 | ) | | $ | 16 |
| | $ | 168 |
| | $ | (15 | ) | | $ | (55 | ) | | $ | (28 | ) | | $ | 1,424 |
|
Liabilities | | | | | | | | | | | | | | | |
FIA embedded derivatives, included in contractholder funds | $ | 2,140 |
| | $ | 77 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 2,217 |
|
Total liabilities at Level 3 fair value | $ | 2,140 |
| | $ | 77 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 2,217 |
|
| | | | | | | | | | | | | | | |
(a) The net transfers out of Level 3 during the three months ended March 31, 2015 were exclusively to Level 2. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Six months ended March 31, 2015 |
| Balance at Beginning of Period | | Total Gains (Losses) | | Purchases | | Sales | | Settlements | | Net transfer In (Out) of Level 3 (a) | | Balance at End of Period |
| | Included in Earnings | | Included in AOCI | | | | | |
Assets | | | | | | | | | | | | | | | |
Fixed maturity securities available-for-sale: | | | | | | | | | | | | | | | |
Asset-backed securities | $ | 74 |
| | $ | (25 | ) | | $ | 2 |
| | $ | 66 |
| | $ | (15 | ) | | $ | — |
| | $ | (10 | ) | | $ | 92 |
|
Commercial mortgage-backed securities | 83 |
| | — |
| | 2 |
| | 57 |
| | — |
| | — |
| | — |
| | 142 |
|
Corporates | 834 |
| | 2 |
| | 24 |
| | 123 |
| | — |
| | (34 | ) | | (24 | ) | | 925 |
|
Municipals | 37 |
| | — |
| | 3 |
| | — |
| | — |
| | — |
| | — |
| | 40 |
|
Equity securities available-for-sale | 40 |
| | (21 | ) | | (1 | ) | | — |
| | — |
| | — |
| | — |
| | 18 |
|
Other invested assets: | | | | | | | | | | | | | | | |
Available-for-sale embedded derivative | 11 |
| | 1 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 12 |
|
Salus participations, included in other invested assets | 213 |
| | (37 | ) | | (4 | ) | | 78 |
| | — |
| | (55 | ) | | — |
| | 195 |
|
Total assets at Level 3 fair value | $ | 1,292 |
| | $ | (80 | ) | | $ | 26 |
| | $ | 324 |
| | $ | (15 | ) | | $ | (89 | ) | | $ | (34 | ) | | $ | 1,424 |
|
Liabilities | | | | | | | | | | | | | | | |
FIA embedded derivatives, included in contractholder funds | $ | 1,908 |
| | $ | 309 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 2,217 |
|
Total liabilities at Level 3 fair value | $ | 1,908 |
| | $ | 309 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 2,217 |
|
| | | | | | | | | | | | | | | |
(a) The net transfers out of Level 3 during the six months ended March 31, 2015 were exclusively to Level 2. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31, 2014 |
| Balance at Beginning of Period | | Total Gains (Losses) | | Purchases | | Sales | | Settlements | | Net transfer In (Out) of Level 3 (a) | | Balance at End of Period |
| | Included in Earnings | | Included in AOCI | | | | | |
Assets | | | | | | | | | | | | | | | |
Fixed maturity securities available-for-sale: | | | | | | | | | | | | | | | |
Asset-backed securities | $ | 251 |
| | $ | — |
| | $ | (1 | ) | | $ | — |
| | $ | — |
| | $ | — |
| | $ | (203 | ) | | $ | 47 |
|
Commercial mortgage-backed securities | 6 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | (6 | ) | | — |
|
Corporates | 607 |
| | — |
| | 10 |
| | 42 |
| | — |
| | (2 | ) | | — |
| | 657 |
|
Municipals | 34 |
| | — |
| | 2 |
| | — |
| | — |
| | — |
| | — |
| | 36 |
|
Other invested assets: | | | | | | | | | | | | | | | |
Salus preferred equity included in related party | — |
| | — |
| | — |
| | 33 |
| | — |
| | — |
| | — |
| | 33 |
|
Salus participations, included in other invested assets | 200 |
| | — |
| | — |
| | 27 |
| | — |
| | (33 | ) | | — |
| | 194 |
|
Total assets at Level 3 fair value | $ | 1,098 |
| | $ | — |
| | $ | 11 |
| | $ | 102 |
| | $ | — |
| | $ | (35 | ) | | $ | (209 | ) | | $ | 967 |
|
Liabilities | | | | | | | | | | | | | | | |
FIA embedded derivatives, included in contractholder funds | $ | 1,645 |
| | $ | 74 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1,719 |
|
Total liabilities at Level 3 fair value | $ | 1,645 |
| | $ | 74 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1,719 |
|
| | | | | | | | | | | | | | | |
(a) The net transfers out of Level 3 during the three months ended March 31, 2014 were exclusively to Level 2. There was a $6.0 transfer within the Level 3 asset class from commercial mortgage-backed securities to asset-backed securities. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Six months ended March 31, 2014 |
| Balance at Beginning of Period | | Total Gains (Losses) | | Purchases | | Sales | | Settlements | | Net transfer In (Out) of Level 3 (a) | | Balance at End of Period |
| | Included in Earnings | | Included in AOCI | | | | | |
Assets | | | | | | | | | | | | | | | |
Fixed maturity securities available-for-sale: | | | | | | | | | | | | | | | |
Asset-backed securities | $ | 246 |
| | $ | — |
| | $ | (1 | ) | | $ | 5 |
| | $ | — |
| | $ | — |
| | $ | (203 | ) | | $ | 47 |
|
Commercial mortgage-backed securities | 6 |
| | — |
| | — |
| | — |
| | — |
| | — |
| | (6 | ) | | — |
|
Corporates | 461 |
| | — |
| | 4 |
| | 194 |
| | — |
| | (2 | ) | | — |
| | 657 |
|
Municipals | — |
| | — |
| | 1 |
| | 35 |
| | — |
| | — |
| | — |
| | 36 |
|
Other invested assets: | | | | | | | | | | | | | | | |
Salus preferred equity included in related party | — |
| | — |
| | — |
| | 33 |
| | — |
| | — |
| | — |
| | 33 |
|
Salus participations, included in other invested assets | 157 |
| | — |
| | — |
| | 106 |
| | — |
| | (69 | ) | | — |
| | 194 |
|
Total assets at Level 3 fair value | $ | 870 |
| | $ | — |
| | $ | 4 |
| | $ | 373 |
| | $ | — |
| | $ | (71 | ) | | $ | (209 | ) | | $ | 967 |
|
Liabilities | | | | | | | | | | | | | | | |
FIA embedded derivatives, included in contractholder funds | $ | 1,544 |
| | $ | 175 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1,719 |
|
Total liabilities at Level 3 fair value | $ | 1,544 |
| | $ | 175 |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1,719 |
|
| | | | | | | | | | | | | | | |
(a) The net transfers out of Level 3 during the six months ended March 31, 2014 were exclusively to Level 2. There was a $6.0 transfer within the Level 3 asset class from commercial mortgage-backed securities to asset-backed securities. |
The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3, or between other levels, at the beginning fair value for the reporting period in which the changes occur. There were no transfers between Level 1 and Level 2 for the three and six months ended March 31, 2015 and 2014.
Primary market issuance and secondary market activity for certain asset-backed securities during the three and six months ended March 31, 2015 and 2014 increased the market observable inputs used to establish fair values for similar securities. These factors, along with more consistent pricing from third-party sources, resulted in the Company concluding that there is sufficient trading activity in similar instruments to support classifying these securities as Level 2 as of March 31, 2015 and 2014. Accordingly, the Company’s assessment resulted in net transfers out of Level 3 of $28 and $34 related to asset-backed and corporate securities during the three and six months ended March 31, 2015.
During the three and six months ended March 31, 2014, there were net transfers out of Level 3 of $203 related to asset-backed securities.
(7) Intangible Assets
Information regarding VOBA and DAC which includes deferred sales inducement, is as follows:
|
| | | | | | | | | | | | |
| | VOBA | | DAC | | Total |
Balance at September 30, 2014 | | $ | 59 |
| | $ | 456 |
| | $ | 515 |
|
Deferrals | | — |
| | 174 |
| | 174 |
|
Less: Amortization related to: | | | | | | |
Unlocking | | — |
| | (8 | ) | | (8 | ) |
Interest | | 6 |
| | 11 |
| | 17 |
|
Amortization | | (22 | ) | | 4 |
| | (18 | ) |
Add: Adjustment for unrealized investment losses | | (17 | ) | | (53 | ) | | (70 | ) |
Balance at March 31, 2015 | | $ | 26 |
| | $ | 584 |
| | $ | 610 |
|
| | | | | | |
Accumulated amortization | | $ | 370 |
| | | | |
|
| | | | | | | | | | | | |
| | VOBA | | DAC | | Total |
Balance at September 30, 2013 | | $ | 192 |
| | $ | 331 |
| | $ | 523 |
|
Deferrals | | — |
| | 116 |
| | 116 |
|
Less: Amortization related to: | | | | | | |
Unlocking | | 12 |
| | 1 |
| | 13 |
|
Interest | | 7 |
| | 7 |
| | 14 |
|
Amortization | | (39 | ) | | (22 | ) | | (61 | ) |
Add: Adjustment for unrealized investment losses | | (63 | ) | | (42 | ) | | (105 | ) |
Balance at March 31, 2014 | | $ | 109 |
| | $ | 391 |
| | $ | 500 |
|
| | | | | | |
Accumulated amortization | | $ | 323 |
| | | | |
Amortization of VOBA and DAC is based on the amount of gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 4% to 5%. The adjustment for unrealized net investment gains represents the amount of VOBA and DAC that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the statement of operations. As of March 31, 2015 and September 30, 2014, the VOBA balance included cumulative adjustments for net unrealized investment gains/losses of $182 and $164, respectively, and the DAC balances included cumulative adjustments for net unrealized investment gains/losses of $108 and $56, respectively.
The above DAC balances include $37 and $33 of deferred sales inducements, net of shadow adjustments, as of March 31, 2015 and September 30, 2014, respectively.
The weighted average amortization period for VOBA is approximately 4.9 years. Estimated amortization expense for VOBA in future fiscal periods is as follows:
|
| | | | |
| | Estimated Amortization Expense |
Fiscal Year | | VOBA |
2015 | | $ | 19 |
|
2016 | | 35 |
|
2017 | | 29 |
|
2018 | | 23 |
|
2019 | | 19 |
|
Thereafter | | 82 |
|
(8) Debt
The Company's outstanding debt as of March 31, 2015 and September 30, 2014 was as follows:
|
| | | | | | | | |
(dollars in millions) | | March 31, 2015 | | September 30, 2014 |
Debt | | $ | 300 |
| | $ | 300 |
|
Revolving credit facility | | — |
| | — |
|
The interest expense and amortization of debt issuance costs of the Company's debt for the three and six months ended March 31, 2015 and 2014, respectively, were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three months ended | | Six months ended |
| | March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
(dollars in millions) | | Interest Expense | | Amortization | | Interest Expense | | Amortization | | Interest Expense | | Amortization | | Interest Expense | | Amortization |
Debt | | $ | 5 |
| | $ | 1 |
| | $ | 5 |
| | $ | 1 |
| | $ | 9 |
| | $ | 2 |
| | $ | 9 |
| | $ | 2 |
|
Revolving credit facility | | — |
| | — |
| | — |
| | — |
| | — |
| | 1 |
| | — |
| | — |
|
As of August 26, 2014, Fidelity & Guaranty Life Holdings, Inc. ("FGLH"), a wholly owned subsidiary of FGL, as borrower, and the Company as guarantor, entered into a three-year $150 unsecured revolving credit facility (the “Credit Agreement”) with certain lenders and RBC Capital Markets and Credit Suisse Securities (USA) LLC, acting as joint lead arrangers. The loan proceeds from the Credit Agreement may be used for working capital and general corporate purposes. As of March 31, 2015, the Company has not drawn on the revolver. If the Company were to draw on the revolver, the interest rate would be equal to a fluctuating rate per annum equal to the highest of (a) the Federal Funds Rate plus 0.5%, (b) the rate of interest determined by Royal Bank of Canada as its prime commercial lending rate for USD loans in the United States for such day as the "U.S. Prime Rate", and (c) the Eurodollar Rate for an interest period of one month beginning on such day (or if such day is not a business day, the business day immediately preceding such day) plus 1.00% per annum. As of March 31, 2015 and September 30, 2014, the interest rate would be equal to 5.25%, had the Company drawn on the revolver.
(9) Equity
Share Repurchase
On September 2, 2014, the Company’s Board of Directors authorized the repurchase of up to 500 thousand shares of the Company’s outstanding shares of common stock over the next twelve months. As of March 31, 2015, 463 thousand shares of common stock have been repurchased at cost for a total cost of $10, which are held in treasury, of which 451 thousand shares were pursuant to the repurchase program and 12 thousand shares were acquired to satisfy employee income tax withholding pursuant to the Company’s stock compensation plan. Subsequent to the Company's repurchase of shares, HRG indirectly held 47,000 thousand shares of FGL's outstanding common stock, representing an 81% interest at March 31, 2015.
Dividends
On November 18, 2014, FGL’s Board of Directors declared a quarterly cash dividend of $0.065 per share. The dividend was paid on December 15, 2014 to shareholders of record as of the close of business on December 1, 2014 and total cash paid was $4 (based on fully vested, outstanding shares of 58,279 thousand).
On February 10, 2015, FGL’s Board of Directors declared a quarterly cash dividend of $0.065 per share. The dividend was paid on March 9, 2015 to shareholders of record as of the close of business on February 23, 2015 and total cash paid was $4 (based on fully vested, outstanding shares of 57,975 thousand).
On May 1, 2015, FGL’s Board of Directors declared a quarterly cash dividend of $0.065 per share. The dividend is payable on June 1, 2015 to shareholders of record as of the close of business on May 18, 2015.
(10) Stock Compensation
The Company recognized total stock compensation expense related to the FGL Plans and FGLH Plans as follows:
|
| | | | | | | | | | | | | | | | |
| | Three months ended | | Six months ended |
| | March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
FGL Plans | | | | | | | | |
Stock options | | $ | 1 |
| | $ | — |
| | $ | 1 |
| | $ | — |
|
Restricted shares | | 4 |
| | — |
| | 5 |
| | — |
|
Performance restricted stock units | | 1 |
| | 1 |
| | 2 |
| | 1 |
|
Unrestricted shares | | — |
| | — |
| | — |
| | 1 |
|
| | 6 |
| | 1 |
| | 8 |
| | 2 |
|
FGLH Plans | | | | | | | | |
Stock Incentive Plan - stock options | | — |
| | 3 |
| | 1 |
| | 6 |
|
2011 dividend equivalent plan | | — |
| | — |
| | — |
| | 1 |
|
Amended and Restated Stock Incentive Plan - stock options | | — |
| | 3 |
| | 2 |
| | 5 |
|
Amended and Restated Stock Incentive Plan - restricted stock units | | — |
| | 1 |
| | 1 |
| | 1 |
|
2012 dividend equivalent plan | | — |
| | — |
| | — |
| | — |
|
| | — |
| | 7 |
| | 4 |
| | 13 |
|
Total stock compensation expense | | 6 |
| | 8 |
| | 12 |
| | 15 |
|
Related tax benefit | | 2 |
| | 3 |
| | 4 |
| | 5 |
|
Net stock compensation expense | | $ | 4 |
| | $ | 5 |
| | $ | 8 |
| | $ | 10 |
|
The stock compensation expense is included in "Acquisition and operating expenses, net of deferrals" in the Condensed Consolidated Statements of Operations.
Total compensation expense related to the FGL Plans and FGLH Plans not yet recognized as of March 31, 2015 and the weighted-average period over which this expense will be recognized are as follows:
|
| | | | | | |
| | Unrecognized Compensation Expense | | Weighted Average Recognition Period in Years |
FGL Plans | | | | |
Stock options | | $ | 1 |
| | 2 |
Restricted shares | | 4 |
| | 2 |
Performance restricted stock units | | 7 |
| | 2 |
Unrestricted shares | | — |
| | N/A |
| | 12 |
| | |
FGLH Plans | |
|
| | |
Stock Incentive Plan - stock options | | — |
| | N/A |
2011 dividend equivalent plan | | — |
| | N/A |
Amended and Restated Stock Incentive Plan - stock options | | 1 |
| | 1 |
Amended and Restated Stock Incentive Plan - restricted stock units | | 1 |
| | 1 |
2012 dividend equivalent plan | | — |
| | 1 |
| | 2 |
| | |
Total unrecognized stock compensation expense | | $ | 14 |
| | 2 |
FGL Plans
FGL’s Compensation Committee is authorized to grant up to 2,838 thousand equity awards under the FGL Plans. At March 31, 2015, 1,395 thousand equity awards are available for future issuance under the FGL Plans. On December 1, 2014, FGL granted 176 thousand stock options to certain officers, directors and other key employees under the Omnibus Plan. These stock options vest in equal installments over a period of three years and expire
on the seventh anniversary of the grant date. The total fair value of the option grants to certain officers, directors and other employees on the grant date was $1. On February 11, 2014, FGL granted 7 thousand stock options to certain directors under the Omnibus Plan. These stock options vest in equal installments over a period of three years and expire on the seventh anniversary of the grant date. The total fair value of the option grants to certain officers, directors and other employees on the grant date was $0.
On March 31, 2015, the Company entered into an agreement with its former Chief Executive Officer in connection with his resignation pursuant to which the vesting for certain FGL and FGLH equity awards to the former Chief Executive Officer were accelerated. The former Chief Executive Officer forfeited two-thirds of the performance restricted stock units granted in fiscal year 2014, and all other previously awarded equity grants became vested as of March 31, 2015. The exercise date of the outstanding stock options was extended to December 31, 2015. No other terms of the equity awards were modified. The Company recognized total incremental compensation expense of $2 as a result of these modifications.
At March 31, 2015, the intrinsic value of stock options outstanding, exercisable and vested or expected to vest was $1, $1, and $1, respectively. At March 31, 2015, the weighted average remaining contractual term of stock options outstanding, exercisable and vested or expected to vest was 6 years, 6 years and 6 years, respectively.
During the six months ended March 31, 2015 and March 31, 2014, the intrinsic value of stock options exercised, total cash received upon exercise and the related tax benefit realized was $0, $0 and $0, respectively.
A summary of FGL’s outstanding stock options as of March 31, 2015, and related activity during the six months then ended, is as follows (option amount in thousands):
|
| | | | | | | |
Stock Option Awards | | Options | | Weighted Average Exercise Price |
Stock options outstanding at September 30, 2014 | | 242 |
| | $ | 17.00 |
|
Granted | | 182 |
| | 24.87 |
|
Exercised | | (3 | ) | | 17.00 |
|
Forfeited or expired | | (12 | ) | | 20.08 |
|
Stock options outstanding at March 31, 2015 | | 409 |
| | 20.35 |
|
Exercisable at March 31, 2015 | | 221 |
| | 19.52 |
|
Vested or expected to vest at March 31, 2015 | | 397 |
| | 20.30 |
|
The following assumptions were used in the determination of the grant date fair values using the Black-Scholes option pricing model and based on the value of FGL's common stock for stock options granted during the six months ended March 31, 2015:
|
| |
Weighted average fair value per option granted | $5.02 |
Risk-free interest rate | 1.4% |
Assumed dividend yield | 1.2% |
Expected option term | 4.5 years |
Volatility | 25.0% |
The following assumptions were used in the determination of the grant date fair values using the Black-Scholes option pricing model for the former Chief Executive Officer's modified stock options and based on the value of FGL's common stock:
|
| |
Weighted average fair value per option modified | $2.53 |
Risk-free interest rate | 0.2% |
Assumed dividend yield | 1.2% |
Expected option term | 0.75 years |
Volatility | 25.0% |
Expected volatility is based on the historical volatility of FGL’s stock price for awards granted in 2015.
On October 6, 2014, FGL granted 12 thousand restricted shares to a certain officer under the Omnibus Plan. These shares cliff vest in one year. The total fair value of the restricted shares granted to this officer on their grant date was $0.
On November 19, 2014, FGL also granted 100 thousand restricted shares to a certain director under the Omnibus Plan. These shares vest in three tranches; 20% on the first anniversary of the grant date; 50% on the second anniversary of the grant date; and 30% on the third anniversary of the grant date. The total fair value of the restricted shares granted to a certain director on their grant date was $2.
On December 1, 2014, FGL also granted 138 thousand restricted shares to certain directors, officers and other key employees under the Omnibus Plan. These shares vest in equal installments over a period of three years. The total fair value of the restricted shares granted to certain officers, directors and key employees on their grant date was $3.
On February 11, 2015, FGL also granted 48 thousand restricted shares to certain directors under the Omnibus Plan. 40 thousand shares vest in three tranches; 20% on the first anniversary of the grant date; 50% on the second anniversary of the grant date; and 30% on the third anniversary of the grant date and the remaining shares granted on February 11, 2015 vest in equal installments over a period of three years. The total fair value of the restricted shares granted to certain officers, directors and key employees on their grant date was $1.
On March 18, 2015, the expected requisite service periods for board members and executives that received certain FGL restricted shares granted on November 19, 2014 and February 11, 2015 were completed resulting in expense acceleration under the terms of the original awards due to their resignation from the Company’s Board and all related committee positions of the two grantees. The Company recognized additional compensation expense of $3 as a result of the related equity compensation expense acceleration.
A summary of FGL’s restricted shares outstanding as of March 31, 2015, and related activity during the six months then ended, is as follows (share amount in thousands):
|
| | | | | | | |
Restricted Stock Awards | | Shares | | Weighted Average Grant Date Fair Value |
Nonvested restricted shares outstanding at September 30, 2014 | | 172 |
| | $ | 18.18 |
|
Granted | | 298 |
| | 23.81 |
|
Vested | | (228 | ) | | 21.64 |
|
Forfeited or expired | | (13 | ) | | 20.62 |
|
Nonvested restricted shares outstanding at March 31, 2015 | | 229 |
| | 21.96 |
|
On October 6, 2014, FGL also granted 32 thousand performance restricted stock units (“PRSUs”) to a senior executive officer under the Omnibus Plan. These units vest on September 30, 2016, contingent on the satisfaction of performance criteria and on the officer's continued employment unless otherwise noted in the agreement. PRSUs subject to vesting are adjusted based on FGL's financial yearly performance, which is evaluated on two non-GAAP measures: (1) adjusted operating income, and (2) return on equity. Depending on the performance results for each year, the ultimate payout of PRSUs could range from zero to 200% of the target award for each year. One-half of the award is earned based on each year’s results. The total fair value of the PRSUs on the grant date of October 6, 2014 assuming attainment of the target performance level in each year was $1.
A summary of PRSUs outstanding as of March 31, 2015, and related activity during the six months then ended, is as follows (share amount in thousands):
|
| | | | | | | |
Performance Restricted Stock Units (PRSUs) | | Shares | | Weighted Average Grant Date Fair Value |
Nonvested PRSUs outstanding at September 30, 2014 | | 578 |
| | $ | 17.37 |
|
Granted, including 8 additional units based on 2014 financial performance | | 40 |
| | 20.36 |
|
Vested | | (45 | ) | | 17.00 |
|
Forfeited | | (72 | ) | | 17.00 |
|
Nonvested PRSUs outstanding at March 31, 2015 | | 501 |
| | 17.69 |
|
Additionally, on October 6, 2014 and February 11, 2015, FGL granted unrestricted shares totaling 8 thousand and 1 thousand, respectively to certain directors in payment for services rendered. Total fair value of the unrestricted shares on the grant date was $0 and $0, respectively.
FGLH Plans
A summary of FGLH's outstanding stock options as of March 31, 2015, and related activity during the six months then ended, is as follows (share amount in thousands): |
| | | | | | | |
| | FGLH |
Stock Option Awards | | Options | | Weighted Average Exercise Price (a) |
Stock options outstanding at September 30, 2014 | | 225 |
| | $ | 46.19 |
|
Granted | | — |
| | — |
|
Exercised | | (47 | ) | | 43.36 |
|
Forfeited or expired | | (1 | ) | | 49.45 |
|
Stock options outstanding at March 31, 2015 | | 177 |
| | 46.94 |
|
Vested and exercisable at March 31, 2015 | | 149 |
| | 46.45 |
|
Vested or expected to vest at March 31, 2015 | | 175 |
| | 46.91 |
|
| |
(a) | The exercise price is based on the value of FGLH’s common stock, not the value of the Company’s common stock. The fair value of FGLH stock at March 31, 2015 is $103.20 per share. |
At March 31, 2015, the intrinsic value of stock options outstanding, exercisable and vested or expected to vest was $10, $8 and $10, respectively. At March 31, 2015, the weighted average remaining contractual term of stock options outstanding, exercisable and vested or expected to vest was 3 years, 2 years and 3 years, respectively. The intrinsic value of stock options exercised during the six months ended March 31, 2015 and 2014 was $3 and $2, respectively.
A summary of FGLH's restricted stock units outstanding as of March 31, 2015 and related activity during the six months then ended is as follows (share amount in thousands):
|
| | | | | | | |
Restricted Stock Awards | | Shares | | Weighted Average Grant Date Fair Value (a) |
Nonvested restricted shares outstanding at September 30, 2014 | | 26 |
| | $ | 49.55 |
|
Granted | | — |
| | — |
|
Vested | | (14 | ) | | 49.45 |
|
Forfeited | | — |
| | 49.45 |
|
Nonvested restricted stock units outstanding at March 31, 2015 | | 12 |
| | 49.68 |
|
(a) Fair value is based on the value of FGLH’s common stock, not the value of the Company’s common stock.
The primary assumption used in the determination of the fair value of FGLH’s awards is the value of the Company’s common stock, which was $21.20 and $21.35 as of March 31, 2015 and September 30, 2014, respectively, with other assumptions as summarized in our 2014 Form 10-K.
(11) Income Taxes
The provision for income taxes represents federal income taxes. The effective tax rates for the three and six months ended March 31, 2015 were 0% and 82%, respectively. The effective tax rates for the three and six months ended March 31, 2014 were 292% and (31)%, respectively. The effective tax rate on pre-tax income differs from the U.S Federal statutory rate primarily due to current period changes to the Company’s valuation allowance. The largest component impacting the current six month period is the valuation allowance established against non-life losses, which include impairment losses, compared to the prior six month period which did not have any non-life impairment losses.
The Company maintains a valuation allowance against certain U.S. Internal Revenue Code, Section 382 ("Section 382") limited capital loss carry forwards and the deferred tax assets of its non-life insurance company subsidiaries. A valuation allowance has been placed against Section 382 limited capital loss carry forwards to reduce these deferred tax assets to an amount that is more-likely than not to be realized before the attributes expire. The non-life insurance company subsidiaries have a history of losses and insufficient sources of future income in order to recognize any portion of their deferred tax assets. All other deferred tax assets are more likely than not to be realized based on expectations as to our future taxable income and considering all other available evidence, both positive and negative.
The valuation allowance is reviewed quarterly and will be maintained until there is sufficient positive evidence to support a release. At each reporting date, management considers new evidence, both positive and negative, that could impact the future realization of deferred tax assets. Management will consider a release of the valuation allowance once there is sufficient positive evidence that it is more likely than not that the deferred tax assets will be realized. Any release of the valuation allowance will be recorded as a tax benefit increasing net income or other comprehensive income.
During the period ended March 31, 2014, market conditions changed sufficiently that Management determined it was prudent and feasible to adopt a new tax planning strategy. The strategy involved repositioning a portion of the investment portfolio to trigger $100 in net unrealized built-in gains (“NUBIG”). The sale of these assets will result in an increase to the Company’s Section 382 limit (i.e. the “adjusted limit”), enabling the Company to utilize capital loss carry forwards that will offset NUBIG-related gains. This strategy makes it more likely than not that the amount of capital loss carryforwards needed to offset those gains will be utilized. Therefore, a partial release of the valuation allowance offsetting the deferred tax asset related to capital loss carry forwards was recorded at the March 31, 2014 reporting date. Management intends to execute the remaining transactions prior to the expiration of Section 382-limited capital loss carry forwards. As of March 31, 2015, approximately $73 of NUBIG has been recognized locking in $26 in tax benefits. The Company currently has capital loss carry forwards of $245 that will expire December 31, 2015 if unused. The Company expects to utilize $27 of those capital loss carryforwards as part of its tax planning strategy adopted March 31, 2014.
As of March 31, 2015, the Company had a partial valuation allowance of $124 against its gross deferred tax assets of $228. The valuation allowance is an offset to capital loss carryforwards (post tax planning strategy execution) expected to expire, as well as non-life company deferred tax assets that will most likely not be recovered due to lack of forecasted taxable income in the non-life segment.
(12) Commitments and Contingencies
Contingencies
Regulatory and Litigation Matters
FGL is assessed amounts by the state guaranty funds to cover losses to policyholders of insolvent or rehabilitated insurance companies. Those mandatory assessments may be partially recovered through a reduction in future premium taxes in certain states. At March 31, 2015, FGL has accrued $4 for guaranty fund assessments which is expected to be offset by estimated future premium tax deductions of $4.
The Company has received inquiries from a number of state regulatory authorities regarding its use of the U.S. Social Security Administration’s Death Master File (the "Death Master File") and compliance with state claims practices regulation. Legislation requiring insurance companies to use the Death Master File to identify potential claims has been enacted in a number of states. As a result of these legislative and regulatory developments, in May
2012, the Company undertook an initiative to use the Death Master File and other publicly available databases to identify persons potentially entitled to benefits under life insurance policies, annuities and retained asset accounts. In addition, the Company has received audit and examination notices from several state agencies responsible for escheatment and unclaimed property regulation in those states and in some cases has challenged the audits. The Company established a contingency of $2 based on its estimates related to the external legal costs and administrative costs of challenging said audits and examinations of which $2 has been paid through March 31, 2015. Additional costs that cannot be reasonably estimated as of the date of this filing are possible as a result of ongoing regulatory developments and other future requirements related to this matter.
The Company is involved in various pending or threatened legal proceedings, including purported class actions, arising in the ordinary course of business. In some instances, these proceedings include claims for unspecified or substantial punitive damages and similar types of relief in addition to amounts for alleged contractual liability or requests for equitable relief. In the opinion of management and in light of existing insurance and other potential indemnification, reinsurance and established reserves, such litigation is not expected to have a material adverse effect on the Company’s financial position, although it is possible that the results of operations and cash flows could be materially affected by an unfavorable outcome in any one period.
Except for the Eddie L. Cressy v. Fidelity Guaranty [sic] Life Insurance Company, et. al. class action Complaint and the complaint filed by Dale R. Ludwick, discussed below, there has been no material updates to our legal proceedings during the period. See "Note 14. Related Party Transactions", in our 2014 Form 10-K for a detailed discussion of our legal proceedings.
On July 5, 2013, a putative class action Complaint was filed in the Superior Court of California, County of Los Angeles (the "Court"), captioned Eddie L. Cressy v. Fidelity Guaranty [sic] Life Insurance Company, et. al. Case No. BC-514340. The state court Complaint asserts, inter alia, that the Plaintiff and members of the putative class relied on Defendants’ advice in purchasing unsuitable equity-indexed insurance policies.
On April 4, 2014, the Plaintiff, FGL Insurance and the other two defendants signed a Settlement Agreement, pursuant to which FGL Insurance has agreed to pay a total of $5 to settle the claims of a nationwide class consisting, with certain exclusions, of all persons who own or owned an OM Financial/FGL Insurance indexed universal life insurance policy issued from January 1, 2007 through March 31, 2014, inclusive. As part of the settlement, FGL Insurance agreed to certification of the nationwide class for settlement purposes only. An Amended Settlement Agreement was filed with the Court on June 5, 2014.
On January 2, 2015, the Court entered the Final Judgment in Cressy, finally certifying the class for settlement purposes, and finally approving the class settlement. The implementation shall commence on or about August 10, 2015. The parties will advise the Court when the settlement is complete.
At March 31, 2015, the Company estimated the total cost for the settlement, legal fees and other costs related to this class action would be $9 and established a liability for the unpaid portion of the estimate of $3. The Company has incurred and paid $4 related to legal fees and other costs and $2 related to settlement costs as of March 31, 2015. Based on the information currently available the Company does not expect the actual cost for settlement, legal fees and other related costs to differ materially from the amount accrued. The Company is seeking indemnification from OM Group (UK) Limited (“OMGUK”) under the First Amended and Restated Stock Purchase Agreement, dated February 17, 2011 (the “F&G Stock Purchase Agreement”) between HFG and OMGUK related to the settlement and the costs and fees in defending the Cressy litigation in both the federal and state courts. The Company has established an amount recoverable from OMGUK for the amount of $4, the collection of which the Company believes is probable. The actual amount recovered from OMGUK could be greater or less than the Company’s estimate, but the Company anticipates that the amount recovered will not be materially different than its current estimate. The settlement, legal fees and other costs related to this class action and the amount recoverable from OMGUK is presented net in the Condensed Consolidated Statements of Operations in “Benefits and other changes in policy reserves.”
On January 7, 2015, a putative class action complaint was filed in the United States District Court, Western District of Missouri, captioned Dale R. Ludwick, on behalf of Herself and All Others Similarly Situated v. Harbinger Group Inc., Fidelity & Guaranty Life Insurance Company, Raven Reinsurance Company, and Front Street Re (Cayman) Ltd. The complaint asserts claims of violation of the Racketeer Influenced and Corrupt Organizations Act ("RICO") and injunctive and declaratory relief. The complaint seeks unspecified compensatory damages in an amount not presently determinable, treble damages, and injunctive relief, among other forms of relief. The Company believes it has meritorious defenses and intends to vigorously defend the litigation. On April 13, 2015,
the Company joined in the filing of a joint motion to dismiss the complaint that was filed by all of the defendants. As of March 31, 2015, the Company did not have sufficient information to determine that the Company is exposed to any losses that would be either probable or reasonably estimable beyond an expense contingency estimate of $1, which was accrued during the three months ended March 31, 2015. On April 2, 2015, the Court entered a Scheduling Order, which requires the parties to: (i) hold a discovery conference by June 1, 2015; (ii) submit a discovery plan by June 15, 2015, with Plaintiff’s counsel taking the lead “in preparing the proposed plan”; (iii) designate a mediator by June 15, 2015 (unless the discovery conference is held earlier, and then the designation is fourteen days after the conference); (iv) hold a mediation within 75 days after June 1, 2015, which would be approximately August 15, 2015. The Court has not set a trial date.
In light of the inherent uncertainties involved in the matter aforementioned, there can be no assurance that the litigation discussed above, or any other pending or future litigation, will not have a material adverse effect on our business, financial condition, or results of operations.
(13) Reinsurance
The Company reinsures portions of its policy risks with other insurance companies. The use of reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the Company's retention limit is reinsured with other insurers. The Company seeks reinsurance coverage in order to limit its exposure to mortality losses and enhance capital management. The Company follows reinsurance accounting when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. The Company also assumes policy risks from other insurance companies.
The effect of reinsurance on premiums earned, benefits incurred and reserve changes for the three and six months ended March 31, 2015 and 2014 were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
| Net Premiums Earned | | Net Benefits Incurred | | Net Premiums Earned | | Net Benefits Incurred | | Net Premiums Earned | | Net Benefits Incurred | | Net Premiums Earned | | Net Benefits Incurred |
Direct | $ | 64 |
| | $ | 239 |
| | $ | 67 |
| | $ | 256 |
| | $ | 127 |
| | $ | 533 |
| | $ | 134 |
| | $ | 553 |
|
Assumed | 8 |
| | 9 |
| | 10 |
| | 6 |
| | 17 |
| | 16 |
| | 19 |
| | 12 |
|
Ceded | (57 | ) | | (76 | ) | | (62 | ) | | (83 | ) | | (118 | ) | | (153 | ) | | (125 | ) | | (169 | ) |
Net | $ | 15 |
| | $ | 172 |
| | $ | 15 |
| | $ | 179 |
| | $ | 26 |
| | $ | 396 |
| | $ | 28 |
| | $ | 396 |
|
Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. During the three and six months ended March 31, 2015 and 2014, the Company did not write off any reinsurance balances. During the three and six months ended March 31, 2015 and 2014, the Company did not commute any ceded reinsurance.
No policies issued by the Company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance.
The Company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues.
(14) Related Party Transactions
FSRCI
We have reinsured certain of our liabilities and obligations to FSRCI. As we are not relieved of our liability to the ceding companies for this business, the liabilities and obligations associated with the reinsured policies remain on our Condensed Consolidated Balance Sheets with a corresponding reinsurance recoverable from FSRCI. In addition to various remedies that we would have in the event of a default by FSRCI, we continue to hold assets in support of the transferred reserves. At March 31, 2015 and September 30, 2014, the Company's reinsurance recoverable included $1,289 and $1,267, respectively, related to FSRCI and funds withheld for reinsurance liabilities included $1,291 and $1,293, respectively, related to FSRCI.
Below are the ceded operating results to FSRCI for the three and six months ended March 31, 2015 and 2014:
|
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | Six Months Ended |
Revenues: | | March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
Premiums | | $ | — |
| | $ | — |
| | $ | — |
| | $ | 1 |
|
Net investment income | | 17 |
| | 17 |
| | 33 |
| | 32 |
|
Net investment (losses) gains | | (21 | ) | | 4 |
| | (15 | ) | | 11 |
|
Insurance and investment product fees | | 1 |
| | 1 |
| | 2 |
| | 2 |
|
Total revenues | | (3 | ) | | 22 |
| | 20 |
| | 46 |
|
| | | | | | | | |
Benefits and expenses: | | | | | | | | |
Benefits and other changes in policy reserves | | (13 | ) | | (14 | ) | | (28 | ) | | (32 | ) |
Acquisition & operating expenses, net of deferrals | | (1 | ) | | (1 | ) | | (2 | ) | | (4 | ) |
Total benefits and expenses | | (14 | ) | | (15 | ) | | (30 | ) | | (36 | ) |
| | | | | | | | |
Operating (loss) income | | $ | (17 | ) | | $ | 7 |
| | $ | (10 | ) | | $ | 10 |
|
FGL Insurance participates in loans to third parties originated by Salus, an affiliated, limited liability company indirectly owned by HRG. Salus is also considered a VIE as described in “Note 4. Investments” to the Company’s Condensed Consolidated Financial Statements. Salus originates senior secured asset-based loans to unaffiliated third-party borrowers. In addition to the participation in loans originated by Salus, FGL Insurance also agreed to provide Salus with financing in the form of a revolving loan and promissory note. In January 2014, FGL Insurance acquired from FSRCI preferred equity interests in Salus which have a 10% per annum return and a total par value of $30 which is included in the FSRCI funds withheld portfolio. Accordingly all income on this asset is ceded to FSRCI. The Company’s maximum exposure to loss as a result of its investments in Salus is limited to the carrying value of the preferred equity interests, the promissory note and any amounts owed under the revolving loan as reported in its balance sheet. The carrying value of these investments in Salus as of March 31, 2015 and September 30, 2014 are disclosed in the tables below.
On February 27, 2015, FGL Insurance entered into a transaction with Salus whereby Salus transferred $14 of loan participations and $16 of CLO subordinated debt (i.e., equity tranche) to FGL Insurance in exchange for retirement of the $20 promissory note and $10 revolving loan owed by Salus to FGL Insurance resulting in the termination of these facilities. Additionally, FGL Insurance also entered into a transaction with the Salus CLO whereby FGL insurance transferred $29 of loan participations into the CLO in exchange for $27 of CLO subordinated notes (i.e., equity tranche) and a promissory note of $2 from Salus. Both transactions qualified as sales of financial assets accounted for at fair value and therefore did not result in any gain or loss. FGL Insurance also concluded that it is not the primary beneficiary of the Salus CLO before and after these two transactions as FGL Insurance lacks the power to direct the activities that significantly affect the economic performance of the CLO and, to a lesser extent, FGL Insurance continues to own less than a majority ownership of the CLO subordinated notes (46%) after the two transactions.
Please refer to "Note 4. Investments" to the Company’s Consolidated Financial Statements for details on the impairment of the Salus preferred equity interest recognized in the second fiscal quarter 2015.
Please refer to "Note 5. Derivatives" to the Company’s Consolidated Financial Statements for disclosure of a new Canadian dollar foreign exchange swap agreement for one of our Salus loan participations that was executed during the second fiscal quarter 2015.
The Company’s consolidated related party investments as of March 31, 2015 and September 30, 2014, and related net investment income for the three and six months ended March 31, 2015 and 2014 are summarized as follows:
|
| | | | | | | | | | | | | | |
| | | | March 31, 2015 |
Type | | Balance Sheet Classification | | Asset carrying value | | Accrued Investment Income | | Total carrying value |
Salus collateralized loan obligations | | Fixed maturities, available-for-sale | | $ | 260 |
| | $ | 1 |
| | $ | 261 |
|
Fortress Investment Group collateralized loan obligations | | Fixed maturities, available-for-sale | | 203 |
| | 2 |
| | 205 |
|
Salus preferred equity (a) | | Equity securities, available-for-sale | | 12 |
| | — |
| | 12 |
|
Salus participations (b) | | Other invested assets | | 186 |
| | 1 |
| | 187 |
|
Energy & Infrastructure Capital ("EIC") participations | | Other Invested Assets | | 9 |
| | — |
| | 9 |
|
Foreign exchange derivatives and embedded derivatives | | Other invested assets | | 13 |
| | — |
| | 13 |
|
HGI energy loan (c) | | Related party loans | | 70 |
| | 2 |
| | 72 |
|
Salus 2012 participations | | Related party loans | | 1 |
| | — |
| | 1 |
|
Salus promissory note | | Related party loans | | 2 |
| | — |
| | 2 |
|
(a) Salus preferred equity is included in the FSRCI funds withheld portfolio, accordingly all income on this asset is ceded to FSRCI.
(b) Includes loan participations with 21 different borrowers with an average loan fair value of $9 as of March 31, 2015.
(c) $20 of the total HGI energy loan is included in the FSRCI funds withheld portfolio, accordingly the income related to this portion is ceded to FSRCI.
|
| | | | | | | | | | | | | | |
| | | | September 30, 2014 |
Type | | Balance Sheet Classification | | Asset carrying value | | Accrued Investment Income | | Total carrying value |
Salus collateralized loan obligations | | Fixed maturities, available-for-sale | | $ | 239 |
| | $ | 1 |
| | $ | 240 |
|
Fortress Investment Group collateralized loan obligations | | Fixed maturities, available-for-sale | | 195 |
| | 2 |
| | 197 |
|
Salus preferred equity(a) | | Equity securities, available-for-sale | | 34 |
| | — |
| | 34 |
|
Salus participations | | Other invested assets | | 213 |
| | 2 |
| | 215 |
|
Foreign exchange embedded derivative | | Other invested assets | | 2 |
| | — |
| | 2 |
|
HGI energy loan (b) | | Related party loans | | 70 |
| | 2 |
| | 72 |
|
Salus 2012 participations | | Related party loans | | 11 |
| | — |
| | 11 |
|
Salus promissory note | | Related party loans | | 20 |
| | — |
| | 20 |
|
Salus revolver | | Related party loans | | 10 |
| | — |
| | 10 |
|
(a) Salus preferred equity is included in the FSRCI funds withheld portfolio, accordingly all income on this asset is ceded to FSRCI.
(b) $20 of the total HGI energy loan is included in the FSRCI funds withheld portfolio, accordingly the income related to this portion is ceded to FSRCI.
|
| | | | | | | | | | | | | | | | | | |
| | | | Three months ended | | Six months ended |
| | | | March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
Type | | Investment Income Classification | | Net investment income | | Net investment income | | Net investment income | | Net investment income |
Salus collateralized loan obligations | | Fixed maturities | | $ | 3 |
| | $ | 3 |
| | $ | 6 |
| | $ | 6 |
|
Fortress Investment Group collateralized loan obligations | | Fixed maturities | | 2 |
| | — |
| | 4 |
| | — |
|
Salus participations | | Other invested assets | | 3 |
| | 6 |
| | 8 |
| | 10 |
|
HGI energy loan | | Related party loans | | 1 |
| | 1 |
| | 2 |
| | 2 |
|
Salus promissory note | | Related party loans | | — |
| | 1 |
| | 1 |
| | 1 |
|
The Company had realized foreign exchange losses of $1 and $3 for the three and six months ended March 31, 2015 related to its CAD denominated loan participations originated by Salus. Additionally, the Company had foreign exchange derivative and embedded derivative gains of $10 and $11 or the three and six months ended March 31, 2015, respectively, included in other invested assets. The Company had foreign exchange losses of $0 and $0 and no foreign exchange embedded derivative gains or losses for the three and six months ended March 31, 2014, respectively. See "Note 5. Derivatives" for further details.
The Company had realized impairment losses of $24 and $35 included in fixed maturities, available for sale and Other invested assets, respectively due to direct and indirect investments in RSH included within the Salus CLOs and the Salus participations. See "Note 4. Investments" to the Company’s Consolidated Financial Statements for further details.
(15) Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands):
|
| | | | | | | | | | | | | | | |
| Three months ended | | Six months ended |
| March 31, 2015 | | March 31, 2014 | | March 31, 2015 | | March 31, 2014 |
Net (loss) income attributable to common shares - basic | $ | (12 | ) | | $ | 25 |
| | $ | 2 |
| | $ | 68 |
|
| | | | | | | |
Weighted-average common shares outstanding - basic | 58,033 |
| | 58,271 |
| | 58,160 |
| | 53,656 |
|
Dilutive effect of unvested restricted stock & PRSU | — |
| | 149 |
| | 145 |
| | 86 |
|
Dilutive effect of stock options | — |
| | 27 |
| | 27 |
| | 15 |
|
Weighted-average shares outstanding - diluted | 58,033 |
| | 58,447 |
| | 58,332 |
| | 53,757 |
|
| | | | | | | |
Net (loss) income per common share: | | | | | | | |
Basic | $ | (0.21 | ) | | $ | 0.43 |
| | $ | 0.03 |
| | $ | 1.26 |
|
Diluted | $ | (0.21 | ) | | $ | 0.42 |
| | $ | 0.03 |
| | $ | 1.26 |
|
The number of shares of common stock outstanding used in calculating the weighted average thereof reflects the actual number of FGL shares of common stock outstanding, excluding unvested restricted stock and shares held in treasury.
Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our net loss for the three months ended March 31, 2015, we were required to use basic weighted-average common shares outstanding in the calculation of the three months ended March 31, 2015 diluted loss per share, as the inclusion of shares for stock options, restricted stock and PRSUs of 169 would have been antidilutive to the calculation. If we had not incurred a net loss in the three months ended March 31, 2015, dilutive potential common shares would have been 58,202.
The calculation of diluted earnings per share for the three and six months ended March 31, 2015 excludes the incremental effect related to certain outstanding stock options and restricted stock due to their anti-dilutive effect. The number of weighted average equivalent shares excluded is 42 shares for the three months ended March 31, 2015 and 27 shares for the six months ended March 31, 2015. Also, stock-based compensation awards under the FGLH Plans are settled in cash and, therefore, are excluded from the computation of diluted earnings per share.
(16) Insurance Subsidiary Financial Information and Regulatory Matters
FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset which increased Raven Re’s statutory capital and surplus by $239 and $251 at March 31, 2015 and September 30, 2014, respectively. Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance which increased Raven Re’s statutory capital and surplus by $12 and $19 at March 31, 2015 and September 30, 2014, respectively. Without such permitted statutory accounting practices Raven Re’s statutory capital and surplus would be negative $63 and negative $81 as of March 31, 2015 and September 30, 2014, respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by National Association of Insurance Commissioners (“NAIC”) 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent.
| |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
Special Note Regarding Forward-Looking Statements
This quarterly report includes forward-looking statements. Some of the forward-looking statements can be identified by the use of terms such as “believes”, “expects”, “may”, “will”, “should”, “could”, “seeks”, “intends”, “plans”, “estimates”, “anticipates” or other comparable terms. However, not all forward-looking statements contain these identifying words. These forward-looking statements include all matters that are not related to present facts or current conditions or that are not historical facts. They appear in a number of places throughout this report and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our consolidated results of operations, financial condition, liquidity, prospects and growth strategies and the industries in which we operate and including, without limitation, statements relating to our future performance.
Forward-looking statements are subject to known and unknown risks and uncertainties, many of which are beyond our control. We caution you that forward-looking statements are not guarantees of future performance and that our actual consolidated results of operations, financial condition and liquidity, and industry development may differ materially from those made in or suggested by the forward-looking statements contained in this report. In addition, even if our consolidated results of operations, financial condition and liquidity, and industry development are consistent with the forward-looking statements contained in this report, those results or developments may not be indicative of results or developments in subsequent periods. A number of important factors could cause actual results to differ materially from those contained in or implied by the forward-looking statements, including the risks and uncertainties discussed in “Risk Factors” included in our Annual Report on Form 10-K, for the year ended September 30, 2014 (“2014 Form 10-K”), which can be found at the U.S. Securities & Exchange Commission's ("SEC's") website, www.sec.gov. Factors that could cause actual results to differ from those reflected in forward-looking statements relating to our operations and business include:
| |
• | the accuracy of management’s assumptions and estimates; |
| |
• | the accuracy of our assumptions regarding the fair value and future performance of our investments; |
| |
• | our and our insurance subsidiaries’ ability to maintain or improve financial strength ratings; |
| |
• | our and our insurance subsidiaries’ potential need for additional capital to maintain our and their financial strength and credit ratings and meet other requirements and obligations; |
| |
• | the stock of our primary operating subsidiary is subject to the security interest of its former owner; |
| |
• | our ability to manage our business in a highly regulated industry, which is subject to numerous legal restrictions and regulations; |
| |
• | regulatory changes or actions, including those relating to regulation of financial services affecting (among other things) underwriting of insurance products and regulation of the sale, underwriting and pricing of products and minimum capitalization and statutory reserve requirements for insurance companies, or the ability of our insurance subsidiaries to make cash distributions to us (including dividends or payments on surplus notes those subsidiaries issue to us); |
| |
• | the impact of our reinsurers failing to meet or timely meet their assumed obligations, increasing their rates, or becoming subject to adverse developments that could materially adversely impact their ability to provide reinsurance to us at consistent and economical terms; |
| |
• | restrictions on our ability to use captive reinsurers; |
| |
• | being forced to sell investments at a loss to cover policyholder withdrawals; |
| |
• | the impact of interest rate fluctuations; |
| |
• | the availability of credit or other financings and the impact of equity and credit market volatility and disruptions on both our ability to obtain capital and the value and liquidity of our investments; |
| |
• | changes in the federal income tax laws and regulations which may affect the relative income tax advantages of our products; |
| |
• | increases in our valuation allowance against our deferred tax assets, and restrictions on our ability to fully utilize such assets; |
| |
• | being the target or subject of, and our ability to defend ourselves against or respond to, litigation (including class action litigation), enforcement investigations or regulatory scrutiny; |
| |
• | the performance of third parties including distributors, underwriters, actuarial consultants and other service providers; |
| |
• | the loss of key personnel; |
| |
• | interruption or other operational failures in telecommunication, information technology and other operational systems, or a failure to maintain the security, integrity, confidentiality or privacy of sensitive data residing on such systems; |
| |
• | the continued availability of capital required for our insurance subsidiaries to grow; |
| |
• | the impact on our business of new accounting rules or changes to existing accounting rules; |
| |
• | our risk management policies and procedures could leave us exposed to unidentified or unanticipated risk; |
| |
• | general economic conditions and other factors, including prevailing interest and unemployment rate levels and stock and credit market performance which may affect (among other things) our ability to sell our products and the fair value of our investments, which could result in impairments and other than temporary impairments ("OTTI") and certain liabilities, and the lapse rate and profitability of policies; |
| |
• | our ability to protect our intellectual property; |
| |
• | difficulties arising from outsourcing relationships; |
| |
• | the impact on our business of man-made catastrophes, pandemics, and malicious and terrorist acts; |
| |
• | our ability to compete in a highly competitive industry and maintain competitive unit costs; |
| |
• | adverse consequences if the independent contractor status of our independent insurance marketing organizations (“IMOs”) is successfully challenged; |
| |
• | our ability to attract and retain national marketing organizations and independent agents; |
| |
• | adverse tax consequences if we generate passive income in excess of operating expenses; |
| |
• | significant operating and financial restrictions, which may prevent us from capitalizing on business opportunities; |
| |
• | the inability of our subsidiaries and affiliates to generate sufficient cash to service all of their obligations; |
| |
• | our subsidiaries’ ability to pay dividends to us; |
| |
• | the ability to maintain or obtain approval of the Iowa Insurance Division ("IID") and other regulatory authorities as required for our operations and those of our insurance subsidiaries; and |
| |
• | the other factors discussed in “Risk Factors”, of our 2014 Form 10-K. |
You should read this report completely and with the understanding that actual future results may be materially different from expectations. All forward looking statements made in this report are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this report and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments. Comparisons of results for current and any prior periods are not intended to express any future trends, or indications of future performance, unless expressed as such, and should only be viewed as historical data.
Introduction
Management's discussion and analysis reviews our consolidated financial position at March 31, 2015 (unaudited) and September 30, 2014, and the unaudited consolidated results of operations for the three and six months ended March 31, 2015 and 2014 and where appropriate, factors that may affect future financial performance. This analysis should be read in conjunction with our unaudited Consolidated Financial Statements and notes thereto appearing elsewhere in this Form 10-Q and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" of Fidelity & Guaranty Life ("FGL"), which was included with our audited consolidated financial statements for the year ended September 30, 2014 included within the Company’s 2014 Form 10-K. Certain statements we make under this Item 2 constitute "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. See "Forward-Looking Statements" in this report. You should consider our forward-looking statements in light of our unaudited condensed consolidated financial statements, related notes, and other financial information appearing elsewhere in this report, and our filings with the SEC, including our 2014 Form 10-K, which can be found at the SEC website, www.sec.gov. In this Quarterly Report on Form 10-Q we refer to the three months ended March 31, 2015 and 2014 as the "Fiscal 2015 Quarter" and the "Fiscal 2014 Quarter", respectively; and the six months ended March 31, 2015 and 2014 as the "Fiscal 2015 Six Months" and the "Fiscal 2014 Six Months", respectively.
Overview
We provide our principal life and annuity products through our insurance subsidiaries- Fidelity & Guaranty Life Insurance Company ("FGL Insurance") and Fidelity & Guaranty Life Insurance Company of New York ("FGL NY Insurance"). Our customers range across a variety of age groups and are concentrated in the middle-income market. Our fixed indexed annuities (“FIAs”) provide for pre-retirement wealth accumulation and post-retirement income management. Our life insurance provides wealth protection and transfer opportunities through indexed universal life products. Life and annuity products are primarily distributed through independent insurance marketing organizations ("IMOs") and independent insurance agents. We have ceded nearly all of our traditional life insurance business, with the exception of the return of premium rider benefit, to third party reinsurers including Wilton Re.
In setting the features and pricing new FIA products relative to our targeted net margin, we take into account our expectations regarding (1) net investment spread, which is the difference between the net investment income we earn and the sum of the interest credited to policyholders and the cost of hedging our risk on the policies; (2) fees, including surrender charges and rider fees, partly offset by vesting bonuses that we pay our policyholders; and (3) a number of related expenses, including benefits and reserves, acquisition costs, and general and administrative expenses.
Trends and Uncertainties
The following factors represent some of the key trends and uncertainties that have influenced the development of our business and our historical financial performance and that we believe will continue to influence our business and financial performance in the future.
Exploration of Strategic Alternatives
On April 6, 2015, HRG Group, Inc, the parent of the Company, announced that it is exploring strategic alternatives for Fidelity & Guaranty Life regarding their FGL holdings. Following this announcement, FGL has begun a strategic process involving a potential sale of the Company. There can be no assurance that the exploration of strategic alternatives will result in a transaction or that any transaction, if pursued, will be consummated. The exploration of strategic alternatives may be terminated at any time and without notice. Neither HRG Group nor any of its affiliates - including FGL - intend to disclose developments with respect to this process unless and until the FGL Board of Directors has approved a specific transaction or course of action.
Market Conditions
Market volatility has affected and may continue to affect our business and financial performance in varying ways. Volatility can pressure sales and reduce demand as consumers hesitate to make financial decisions. In the long-term, however, we believe that the 2008 through 2010 financial crisis and resultant lingering financial uncertainty will motivate individuals to seek solutions combining elements of capital preservation, income and growth. We believe current market conditions may ultimately enhance the attractiveness of our product portfolio. To enhance the attractiveness and profitability of our products and services, we continually monitor the behavior
of our customers, as evidenced by mortality rates, morbidity rates, annuitization rates and lapse rates, which vary in response to changes in market conditions.
Interest Rate Environment
Certain of our products include guaranteed minimum crediting rates, most notably our fixed rate annuities. As of March 31, 2015, in accordance with accounting principles generally accepted in the United States (“GAAP”) reserves, net of reinsurance, and average crediting rate on our fixed rate annuities were $3 billion and 3%, respectively. We are required to pay these guaranteed minimum crediting rates even if earnings on our investment portfolio decline, which would negatively impact earnings. In addition, we expect more policyholders to hold policies with comparatively high guaranteed rates for a longer period in a low interest rate environment. Conversely, a rise in average yield on our investment portfolio would increase earnings if the average interest rate we pay on our products does not rise correspondingly. Similarly, we expect that policyholders would be less likely to hold policies with existing guarantees as interest rates rise and the relative value of other new business offerings are increased, which would negatively impact our earnings and cash flows.
See “Item 3. Quantitative and Qualitative Disclosures about Market Risk” for a more detailed discussion of interest rate risk.
Aging of the U.S. Population
We believe that the aging of the United States ("U.S.") population will affect the demand for our products. As the “baby boomer” generation prepares for retirement, we believe that demand for retirement savings, growth and income products will grow. The impact of this growth may be offset to some extent by asset outflows as an increasing percentage of the population begins withdrawing assets to convert their savings into income.
Industry Factors and Trends Affecting Our Results of Operations
Demographics and macroeconomic factors are increasing the demand for our FIA and indexed universal life (“IUL”) products, for which demand is large and growing: over 10,000 people will turn 65 each day in the United States over the next 15 years. According to the U.S. Census Bureau, the proportion of the U.S. population over the age of 65 is expected to grow from 15% in 2015 to 20% in 2030.
Due to turbulence in the stock market in 2007 and 2008, many middle-income Americans have grown to appreciate the security these indexed products afford. As a result, the IUL market expanded from $100 million of annual premiums in 2002 to over $1.5 billion of annual premiums in 2014. Similarly, the FIA market grew from nearly $12 billion of sales in 2002 to $47 billion of sales in 2014.
Competition
Our insurance subsidiaries operate in highly competitive markets. We face a variety of large and small industry participants. These companies compete for the growing pool of retirement assets driven by a number of factors, such as the continued aging of the U.S. population and the reduction in financial safety nets provided by governments and corporations. In many segments, product differentiation is difficult as product development and life cycles have shortened.
Our own sales of annuities and IULs by quarter were as follows:
|
| | | | | | | | | | | | | | | | |
| Annuity Sales | IUL Sales |
(in millions) | | Fiscal 2015 | | Fiscal 2014 | | Fiscal 2015 | | Fiscal 2014 |
First fiscal quarter | | $ | 903 |
| | $ | 540 |
| | $ | 7 |
| | $ | 5 |
|
Second fiscal quarter | | 610 |
| | 728 |
| | 7 |
| | 5 |
|
Total | | $ | 1,513 |
| | $ | 1,268 |
| | $ | 14 |
| | $ | 10 |
|
Key Components of Our Historical Results of Operations
Under GAAP, premium collections for fixed indexed annuities, fixed rate annuities, and immediate annuities without life contingency are reported as deposit liabilities (i.e., contractholder funds) not sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income, surrender and other charges deducted from contractholder funds, and net realized gains (losses) on investments.
Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the cost of providing index credits to the policyholder), amortization of deferred acquisition costs (“DAC”) and value of business acquired (“VOBA”), other operating costs and expenses, and income taxes.
Through our insurance subsidiaries, we issue a broad portfolio of deferred annuities (fixed indexed and fixed rate annuities) and immediate annuities. A deferred annuity is a type of contract that accumulates value on a tax deferred basis and typically begins making specified periodic or lump sum payments a certain number of years after the contract has been issued. An immediate annuity is a type of contract that begins making specified payments within one annuity period (e.g., one month or one year) and typically makes payments of principal and interest earnings over a period of time.
The Company hedges certain portions of its exposure to product related equity market risk by entering into derivative transactions. We purchase derivatives consisting predominantly of call options and, to a lesser degree, futures contracts on the equity indices underlying the applicable policy. These derivatives are used to fund the statutory reserve impact of the index credits due to policyholders under the FIA contracts. The majority of all such call options are one-year options purchased to match the funding requirements underlying the FIA contracts. We attempt to manage the cost of these purchases through the terms of our FIA contracts, which permit us to change caps, spread, or participation rates, subject to certain guaranteed minimums that must be maintained. The change in the fair value of the call options and futures contracts is generally designed to offset the equity market related change in the fair value of the FIA contract’s embedded derivative. The call options and futures contracts are marked to fair value with the change in fair value included as a component of net investment gains (losses). The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instruments’ terms or upon early termination and the changes in fair value of open positions.
Earnings from products accounted for as deposit liabilities are primarily generated from the excess of net investment income earned over the sum of interest credited to policyholders and the cost of hedging our risk on FIA policies, known as the net investment spread. With respect to FIAs, the cost of hedging our risk includes the expenses incurred to fund the annual index credits, and where applicable, minimum guaranteed interest credited. Proceeds received upon expiration or early termination of call options purchased to fund annual index credits are recorded as part of the change in fair value of derivatives, and are largely offset by an expense for index credits earned on annuity contractholder fund balances.
Our profitability depends in large part upon the amount of assets under management (“AUM”), the net investment spreads earned on our average assets under management ("AAUM"), our ability to manage our operating expenses and the costs of acquiring new business (principally commissions to agents and bonuses credited to policyholders). As we grow AUM, earnings generally increase. AUM increases when cash inflows, which include sales, exceed cash outflows. Managing net investment spreads involves the ability to manage our investment portfolios to maximize returns and minimize risks on our AUM such as interest rate changes and defaults or impairment of investments, and our ability to manage interest rates credited to policyholders and costs of the options and futures purchased to fund the annual index credits on the FIAs or IULs. We analyze returns on AAUM pre- and post-DAC and VOBA as well as pre- and post-tax to measure our profitability in terms of growth and improved earnings.
Adjusted Operating Income ("AOI")
Management believes that certain non-GAAP financial measures may be useful in certain instances to provide additional meaningful comparisons between current results and results in prior operating periods. Reconciliations of such measures to the most comparable GAAP measures are included herein.
AOI is a non-GAAP economic measure we use to evaluate financial performance each period. AOI is calculated by adjusting net income to eliminate (i) the impact of net investment gains including OTTI losses recognized in operations, but excluding gains and losses on derivatives hedging our indexed annuity policies, (ii) the effect of changes in the rates used to discount the FIA embedded derivative liability, (iii) the effect of change in fair value of reinsurance related embedded derivative, (iv) the effect of class action litigation reserves and (v) residual net income of distributed subsidiaries we no longer own. All adjustments to AOI are net of the corresponding VOBA, DAC and income tax impact related to these adjustments as appropriate. While these adjustments are an integral part of the overall performance of FGL, market conditions impacting these items can overshadow the underlying performance of the business. Accordingly, we believe using a measure which excludes their impact is effective in analyzing the trends of our operations. Our non-GAAP measures may not be comparable to similarly titled measures
of other organizations because other organizations may not calculate such non-GAAP measures in the same manner as we do.
In the second quarter of 2014, we revised our definition of AOI from a pre-tax basis to an after-tax basis to better reflect the basis on which the performance of our business is assessed internally. AOI now includes interest expense and an effective tax rate of 35.0% is now applied to reconciling items made to net income. All prior periods presented have been revised to reflect this new definition. Additionally, during the second quarter of 2014 we revised our definition of AOI to exclude the effect of class action litigation reserves, net of the corresponding VOBA, DAC and income tax impact related to these adjustments. This change has been reflected in Fiscal 2015 AOI. Lastly, during the second quarter of 2014, we revised our definition of AOI to exclude residual net income of distributed subsidiaries; specifically the portion of Front Street Re (Cayman) Ltd. ("FSRCI") income not already accounted for in the AOI adjustments above. From the inception of the reinsurance treaty on December 31, 2012 through August 9, 2013, FSRCI was a fully consolidated subsidiary of FGL. On August 9, 2013 in preparation for the initial public offering ("IPO"), FGL distributed this subsidiary to its parent company. Adjusting for this distribution provides a better view of the underlying performance of FGL as it is now structured post-IPO.
AUM is the sum of (i) total invested assets at amortized cost, excluding derivatives; and including (ii) related party loans and investments and (iii) cash and cash equivalents. AAUM is the sum of AUM at the end of each month in the period divided by the number of months in the period.
Together with net income we believe AOI provides a meaningful financial metric that helps investors understand our underlying results and profitability.
AOI should not be used as a substitute for net income. However, we believe the adjustments made to net income in order to derive AOI provide an understanding of our overall results of operations. For example, we could have strong operating results in a given period, yet report net income that is materially less, if during such period the fair value of our derivative assets hedging the FIA index credit obligations decreased due to general equity market conditions but the embedded derivative liability related to the index credit obligation did not decrease in the same proportion as the derivative assets because of non-equity market factors such as interest rate movements. Similarly, we could also have poor operating results in a given period yet show net income that is materially greater, if during such period the fair value of the derivative assets increases but the embedded derivative liability did not increase in the same proportion as the derivative assets. We hedge our FIA index credits with a combination of static and dynamic strategies, which can result in earnings volatility, the effects of which are generally likely to reverse over time. Our management and board of directors review AOI and net income as part of their examination of our overall financial results. However, these examples illustrate the significant impact derivative and embedded derivative movements can have on our net income. Accordingly, our management and board of directors perform a review and analysis of these items, as part of their review of our hedging results each period.
The adjustments to net income are net of DAC and VOBA amortization and income tax expense related to these adjustments. Amounts attributable to the fair value accounting for derivatives hedging the FIA index credits and the related embedded derivative liability fluctuate from period to period based upon changes in the fair values of call options purchased to fund the annual index credits for FIAs, changes in the interest rates used to discount the embedded derivative liability, and the fair value assumptions reflected in the embedded derivative liability. The accounting standards for fair value measurement require the discount rates used in the calculation of the embedded derivative liability to be based on risk-free interest rates. The impact of the change in risk-free interest rates has been removed from net income. Additionally, in evaluating our operating results, the effect of change in the fair value of the reinsurance related embedded derivative has been removed from net income.
In addition, we regularly monitor and report the production volume metric titled “Sales”. Sales are not derived from any specific GAAP income statement accounts or line items and should not be viewed as a substitute for any financial measure determined in accordance with GAAP. For GAAP purposes annuity sales are recorded as deposit liabilities (i.e. contract holder funds). Management believes that presentation of sales as measured for management purposes enhances the understanding of our business and helps depict longer term trends that may not be apparent in the results of operations due to the timing of sales and revenue recognition.
Critical Accounting Policies and Estimates
The preparation of the Company’s Consolidated Financial Statements requires management to make estimates and judgments that affect the reported amounts of certain assets, liabilities, revenues, expenses and related disclosures regarding contingencies and commitments. Actual results could differ from these estimates. During the three and six months ended March 31, 2015, the Company did not make any material changes in its critical accounting policies as previously disclosed in Management’s Discussion and Analysis in the Company’s 2014 Form 10-K as filed with the SEC.
Recent Accounting Pronouncements
Investments in Qualified Affordable Housing Projects
In January 2014, the Financial Accounting Standards Board ("FASB") issued amended guidance (ASU 2014-01, Investments - Equity Method and Joint Ventures (Topic 323): Accounting for Investments in Qualified Affordable Housing Project) which allows investors in Low Income Housing Tax Credit (“LIHTC”) programs that meet specified conditions to present the net tax benefits (net of the amortization of the cost of the investment) within income tax expense. The cost of the investments that meet the specified conditions will be amortized in proportion to (and over the same period as) the total expected tax benefits, including the tax credits and other tax benefits, as they are realized on the tax return. The guidance is required to be applied retrospectively, if investors elect the proportional amortization method. However, if investors have existing LIHTC investments accounted for under the effective-yield method at adoption, they may continue to apply that method for those existing investments. The Company early adopted this guidance effective October 1, 2014 for all new LIHTC investments made subsequent to that date. Prior LIHTC investments will continue to be accounted for under the effective-yield method. This adoption did not have a material effect on the Company’s consolidated financial position and results of operations.
Share-Based Payments When a Performance Target is achieved after the Requisite Service Period
In June 2014, the FASB issued new guidance on Stock Compensation (ASU 2014-12, Accounting for Share-Based Payments When the Term of an Award Provide that a Performance Target Could Be Achieved after the Requisite Service Period), effective for fiscal years beginning after December 15, 2015 and interim periods within those years. The new guidance requires that performance targets that affect vesting and that could be achieved after the requisite service period to be treated as performance conditions. Such performance targets would not be included in the grant-date fair value calculation of the award, rather compensation cost should be recorded when it is probable the performance target will be reached and should represent the compensation cost attributable to period(s) for which the requisite service has already been rendered. This standard may be early adopted and the amendments in this Update may be applied either prospectively or retrospectively. The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements.
Amendments to the Consolidation Analysis
In February 2015, the FASB issued amended consolidation guidance (ASU 2015-02, Amendments to the Consolidation Analysis), effective for fiscal years beginning after December 15, 2015. The amended guidance changes the consolidation analysis of reporting entities with variable interest entity ("VIE") relationships by i) modifying the criteria used to evaluate whether limited partnerships and similar legal entities are VIEs or voting interest entities and revising the primary beneficiary determination of a VIE, ii) eliminating the specialized consolidation model and guidance for limited partnerships thereby removing the presumption that a general partner should consolidate a limited partnership, iii) reducing the criteria in the variable interest model contained in Accounting Standards Codification Topic 810, Consolidation, that is used to evaluate whether the fees paid to a decision maker or service provider represents a variable interest, and iv) exempting reporting entities from consolidating money market funds that operate in accordance with Rule 2a-7 of the Investment Company Act of 1940. This standard may be early adopted and the amendments in this Update may be applied with a modified retrospective approach or retrospective approach. The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements.
Presentation of Debt Issuance Costs
In April 2015, the FASB issued amended guidance (ASU 2015-03, Interest-Imputation of Interest (Subtopic 835-30), Simplifying the Presentation of Debt Issuance Costs), effective for fiscal years beginning after December 15, 2015 and interim periods within those years. The amended guidance requires debt issuance costs related to a recognized debt liability to be presented on the balance sheet as a direct deduction from the debt liability, similar to the presentation of debt discounts or premiums. The cost of issuing debt will no longer be recorded as a separate asset, except when incurred before the receipt of the funding from the associated debt liability. Instead, debt issuance costs will be presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability, and the costs will be amortized to interest expense using the effective interest method. This standard may be early adopted. The amendments in this Update are required to be applied retrospectively to all prior periods presented in the financial statements. The Company will not early adopt this standard and is currently evaluating the impact of this new accounting guidance on its consolidated financial statements.
Results of Operations
(All amounts presented in millions unless otherwise noted)
The following tables set forth the consolidated results of operations and compares the amount of the change between the fiscal periods: |
| | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Quarter | | | | Fiscal Six Months | | |
| 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
Revenues: | | | | | | | | | | | |
Premiums | $ | 15 |
| | $ | 15 |
| | $ | — |
| | $ | 26 |
| | $ | 28 |
| | $ | (2 | ) |
Net investment income | 208 |
| | 184 |
| | 24 |
| | 416 |
| | 368 |
| | 48 |
|
Net investment (losses) gains | (58 | ) | | (2 | ) | | (56 | ) | | 1 |
| | 122 |
| | (121 | ) |
Insurance and investment product fees and other | 22 |
| | 18 |
| | 4 |
| | 42 |
| | 33 |
| | 9 |
|
Total revenues | 187 |
| | 215 |
| | (28 | ) | | 485 |
| | 551 |
| | (66 | ) |
Benefits and other changes in policy reserves | 172 |
| | 179 |
| | (7 | ) | | 396 |
| | 396 |
| | — |
|
Acquisition and operating expenses, net of deferrals | 28 |
| | 32 |
| | (4 | ) | | 57 |
| | 58 |
| | (1 | ) |
Amortization of intangibles | (7 | ) | | 11 |
| | (18 | ) | | 9 |
| | 34 |
| | (25 | ) |
Total benefits and expenses | 193 |
| | 222 |
| | (29 | ) | | 462 |
| | 488 |
| | (26 | ) |
Operating (loss) income | (6 | ) | | (7 | ) | | 1 |
| | 23 |
| | 63 |
| | (40 | ) |
Interest expense | (6 | ) | | (6 | ) | | — |
| | (12 | ) | | (11 | ) | | (1 | ) |
(Loss) income before income taxes | (12 | ) | | (13 | ) | | 1 |
| | 11 |
| | 52 |
| | (41 | ) |
Income tax expense (benefit) | — |
| | (38 | ) | | 38 |
| | 9 |
| | (16 | ) | | 25 |
|
Net (loss) income | $ | (12 | ) | | $ | 25 |
| | $ | (37 | ) | | $ | 2 |
| | $ | 68 |
| | $ | (66 | ) |
Annuity sales during the Fiscal 2015 Quarter and the Fiscal 2014 Quarter were $610 and $728, respectively, including $600 and $318, respectively, of FIA sales. Annuity sales during the Fiscal 2015 Six Months and the Fiscal 2014 Six Months were $1,513 and $1,268, respectively, including $1,248 and $619, respectively, of FIA sales. The increase in FIA sales period over period is the result of productive partnerships with our independent marketing organizations ("IMO's"), competitive product offerings and continued success of our new products.
Revenues
Premiums
For the Fiscal 2015 Quarter, premiums remained consistent at $15 and decreased $2, or 7%, to $26 for the Fiscal 2015 Six Months from $28 for the Fiscal 2014 Six Months primarily due to a decrease in life-contingent immediate annuity premiums.
Net investment income
Below is a summary of the major components included in net investment income for the Fiscal 2015 Quarter and the Fiscal 2014 Quarter and for the Fiscal 2015 Six Months and the Fiscal 2014 Six Months:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Quarter | | | | Fiscal Six Months | | |
| 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
Fixed maturity available-for-sale securities | $ | 194 |
| | $ | 175 |
| | $ | 19 |
| | $ | 390 |
| | $ | 351 |
| | $ | 39 |
|
Equity available-for-sale securities | 9 |
| | 5 |
| | 4 |
| | 18 |
| | 9 |
| | 9 |
|
Related party loans, invested cash, short-term investments, and other investments | 9 |
| | 8 |
| | 1 |
| | 18 |
| | 15 |
| | 3 |
|
Gross investment income | 212 |
| | 188 |
| | 24 |
| | 426 |
| | 375 |
| | 51 |
|
Investment expense | (4 | ) | | (4 | ) | | — |
| | (10 | ) | | (7 | ) | | (3 | ) |
Net investment income | $ | 208 |
| | $ | 184 |
| | $ | 24 |
| | $ | 416 |
| | $ | 368 |
| | $ | 48 |
|
Our net investment spread and AAUM for the period is summarized as follows (annualized):
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Quarter | | | | Fiscal Six Months | | |
| 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
Yield on AAUM (at amortized cost) | 4.72 | % | | 4.52 | % | | 0.20 | % | | 4.77 | % | | 4.58 | % | | 0.19 | % |
Less: Interest credited and option cost | (2.81 | )% | | (2.89 | )% | | 0.08 | % | | (2.90 | )% | | (2.96 | )% | | 0.06 | % |
Net investment spread | 1.91 | % | | 1.63 | % | | 0.28 | % | | 1.87 | % | | 1.62 | % | | 0.25 | % |
AAUM | $ | 17,616 |
| | $ | 16,314 |
| | $ | 1,302 |
| | $ | 17,434 |
| | $ | 16,042 |
| | $ | 1,392 |
|
| |
• | The increase in net investment income of $24, or 13%, from the Fiscal 2014 Quarter to the Fiscal 2015 Quarter was primarily due to higher investment income on fixed maturity and equity available-for-sale securities driven by higher overall portfolio yields from repositioning activities completed last year and higher AAUM quarter over quarter - Fiscal 2015 Quarter AAUM and earned yield of $18 billion and 4.72% compared to Fiscal 2014 Quarter AAUM and earned yield of $16 billion and 4.52%, respectively. |
| |
• | The increase in net investment income of $48, or 13%, from the Fiscal 2014 Six Months to the Fiscal 2015 Six Months was primarily due to higher investment income on fixed maturity and equity available-for-sale securities driven by higher overall portfolio yields from repositioning activities completed last year and higher AAUM period over period - Fiscal 2015 Six Months AAUM and earned yield of $17 billion and 4.77% compared to Fiscal 2014 Six Months AAUM and earned yield of $16 billion and 4.58%, respectively. |
| |
• | The increase in AAUM of $1 billion or 8% from the Fiscal 2014 Quarter to the Fiscal 2015 Quarter was driven by sales growth during the quarter and stable retention trends. |
| |
• | The increase in AAUM of $1 billion or 9% from the Fiscal 2014 Six Months to the Fiscal 2015 Six Months was driven by sales growth during the year-to-date and stable retention trends. |
| |
• | The increase in earned yields of 20 basis points, or 4%, from the Fiscal 2014 Quarter to the Fiscal 2015 Quarter was driven by portfolio repositioning and re-investment in higher yielding fixed maturity securities in the Fiscal 2015 Quarter. |
| |
• | The increase in earned yields of 19 basis points, or 4%, from the Fiscal 2014 Six Months to the Fiscal 2015 Six Months was driven by portfolio repositioning and re-investment in higher yielding fixed maturity securities in the Fiscal 2015 Six Months. |
The Company’s cash and cash equivalents position is summarized as follows:
|
| | | | | | | |
(in millions) | Fiscal 2015 | | Fiscal 2014 |
First fiscal quarter | $ | 556 |
| | $ | 759 |
|
Second fiscal quarter | 849 |
| | 702 |
|
Net investment (losses) gains
Below is a summary of the major components included in net investment (losses) gains for the Fiscal 2015 Quarter and the Fiscal 2014 Quarter and for the Fiscal 2015 Six Months and the Fiscal 2014 Six Months:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Quarter | | | | Fiscal Six Months | | |
| 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
Net realized (losses) gains on available-for-sale securities | $ | (22 | ) | | $ | 6 |
| | $ | (28 | ) | | $ | (25 | ) | | $ | 19 |
| | $ | (44 | ) |
Realized and unrealized (losses) gains on certain derivative instruments | (7 | ) | | 21 |
| | (28 | ) | | 35 |
| | 136 |
| | (101 | ) |
Change in fair value of reinsurance related embedded derivative | (3 | ) | | (29 | ) | | 26 |
| | 16 |
| | (33 | ) | | 49 |
|
Realized (losses) gains on fair value of other derivatives, embedded derivatives and other invested assets
| (26 | ) | | — |
| | (26 | ) | | (25 | ) | | — |
| | (25 | ) |
Net investment (losses) gains | $ | (58 | ) | | $ | (2 | ) | | $ | (56 | ) | | $ | 1 |
| | $ | 122 |
| | $ | (121 | ) |
| |
• | The quarter over quarter increase in net investment losses was primarily due to credit impairment losses of $59 during the current quarter on available for sale debt securities, available for sale equity securities and other invested assets related to direct and indirect investments in RadioShack Corporation ("RSH"), which filed for bankruptcy in February 2015. Refer to impairment disclosures in "Note 4. Investments" of our unaudited Condensed Consolidated Financial Statements for additional details. |
| |
• | Partially offsetting the quarter over quarter increase in net investment losses was an increase in fair value of reinsurance related embedded derivative due to RSH impairment losses of $22 on assets included in the FSRCI funds withheld portfolio during the Fiscal 2015 Quarter (a decrease in unrealized on FSRCI funds withheld portfolio will result in a corresponding increase in the fair value of the reinsurance related embedded derivative). |
| |
• | The decrease in net investment gains of $121 from the Fiscal 2014 Six Months to the Fiscal 2015 Six Months was primarily due to the credit impairment losses discussed above as well as a decline in realized and unrealized gains on certain derivative instruments. See table below for primary drivers of decreases. |
| |
• | Partially offsetting the year over year decrease in net investment gains was a $16 increase in fair value of reinsurance related embedded derivative during the Fiscal 2015 Six Months compared to a $33 decrease during the Fiscal 2014 Six Months. The $49 year over year increase was primarily due to a $33 decrease in fair value during the Fiscal 2014 Six Months resulting from a decrease in treasury rates during the period and corresponding increase in the unrealized gain position of the FSCRI funds withheld portfolio. |
The components of the realized and unrealized gains on certain derivative instruments hedging our indexed annuity products are as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Quarter | | | | Fiscal Six Months | | |
| 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
Call options: | | | | | | | | | | | |
Gain on option expiration | $ | 35 |
| | $ | 45 |
| | $ | (10 | ) | | $ | 78 |
| | $ | 88 |
| | $ | (10 | ) |
Change in unrealized (loss) gain | (42 | ) | | (26 | ) | | (16 | ) | | (47 | ) | | 33 |
| | (80 | ) |
Futures contracts: | | | | | | | | | | | |
Gain on futures contracts expiration | 5 |
| | — |
| | 5 |
| | 3 |
| | 11 |
| | (8 | ) |
Change in unrealized (loss) gain | (5 | ) | | 2 |
| | (7 | ) | | 1 |
| | 4 |
| | (3 | ) |
Total | $ | (7 | ) | | $ | 21 |
| | $ | (28 | ) | | $ | 35 |
| | $ | 136 |
| | $ | (101 | ) |
| | | | | | | | | | | |
Change in S&P 500 Index during the period | — | % | | 1 | % | | (1 | )% | | 5 | % | | 11 | % | | (6 | )% |
| |
• | The quarter over quarter decrease in net investment gains was primarily due to a decline in unrealized on certain derivative instruments mainly resulting from the performance of the indices upon which the call options and futures contracts are based. We utilize a combination of static (call options) and dynamic (long futures contracts) instruments in our hedging strategy. A substantial portion of the call options and futures contracts are based upon the Standard & Poor's 500 Stock Index ("S&P 500 Index") with the remainder based upon other equity and bond market indices. The S&P 500 Index increased 0% and 1% during the Fiscal 2015 Quarter and the Fiscal 2014 Quarter, respectively (the percentages noted are a fiscal period over period comparison of the growth of the S&P 500 Index only and do not reflect the change for each option buy date). |
| |
• | The year over year decrease in net investment gains was also primarily due to a decline in unrealized on certain derivative instruments. The S&P 500 Index increased 5% and 11% during the Fiscal 2015 Six Months and the Fiscal 2014 Six Months, respectively (the percentages noted are a fiscal period over period comparison of the growth of the S&P 500 Index only and do not reflect the change for each option buy date). |
The average index credits to policyholders were as follows:
|
| | | | | | | | | | | | | | | | | |
| Fiscal Quarter | | | | Fiscal Six Months | | |
| 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
Average Crediting Rate | 4 | % | | 5 | % | | (1 | )% | | 5 | % | | 6 | % | | (1 | )% |
S&P 500 Index: | | | | | | | | | | | |
Point-to-point strategy | 4 | % | | 5 | % | | (1 | )% | | 5 | % | | 5 | % | | — | % |
Monthly average strategy | 5 | % | | 5 | % | | — | % | | 5 | % | | 5 | % | | — | % |
Monthly point-to-point strategy | 4 | % | | 6 | % | | (2 | )% | | 4 | % | | 7 | % | | (3 | )% |
3 year high water mark | 22 | % | | 22 | % | | — | % | | 25 | % | | 20 | % | | 5 | % |
| |
• | The credits for the Fiscal 2015 Six Months and the Fiscal 2015 Quarter were based on comparing the S&P 500 Index on each issue date in these respective periods to the same issue date in the respective prior year periods. The volatility at different points in these periods created lower overall monthly point-to-point credits in the Fiscal 2015 Six Months and the Fiscal 2015 Quarter compared to the S&P 500 Index growth for issue dates in the Fiscal 2014 Six Months and the Fiscal 2014 Quarter, respectively. |
| |
• | Actual amounts credited to contractholder fund balances may differ from the index appreciation due to contractual features in the FIA contracts (caps, spreads, participation rates and asset fees) which allow the Company to manage the cost of the options purchased to fund the annual index credits. |
Insurance and investment product fees and other
Below is a summary of the major components included in Insurance and investment product fees and other for the Fiscal 2015 Quarter and the Fiscal 2014 Quarter and for the Fiscal 2015 Six Months and the Fiscal 2014 Six Months:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Fiscal Quarter | | | | Fiscal Six Months | | |
Insurance and investment product fees and other: | | 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
Surrender charges | | $ | 5 |
| | $ | 5 |
| | $ | — |
| | $ | 9 |
| | $ | 10 |
| | $ | (1 | ) |
Cost of insurance fees and other income | | 17 |
| | 13 |
| | 4 |
| | 33 |
| | 23 |
| | 10 |
|
Total insurance and investment product fees and other | | $ | 22 |
| | $ | 18 |
| | $ | 4 |
| | $ | 42 |
| | $ | 33 |
| | $ | 9 |
|
| |
• | The quarter over quarter and year over year increase was primarily due to an increase in rider fees on FIA policies during the Fiscal 2015 Quarter and Fiscal 2015 Six Months, respectively. Specifically, guaranteed minimum withdrawal benefit ("GMWB") rider fees have increased as a result of FIA sales growth over the past year. |
Benefits and expenses
Benefits and other changes in policy reserves
Below is a summary of the major components included in Benefits and other changes in policy reserves for the Fiscal 2015 Quarter and the Fiscal 2014 Quarter and for the Fiscal 2015 Six Months and the Fiscal 2014 Six Months:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Fiscal Quarter | | | | Fiscal Six Months | | |
| | 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
FIA market value option liability change | | $ | (44 | ) | | $ | (27 | ) | | $ | (17 | ) | | $ | (41 | ) | | $ | 48 |
| | $ | (89 | ) |
FIA present value future credits & guarantee liability change | | 31 |
| | 26 |
| | 5 |
| | 73 |
| | (22 | ) | | 95 |
|
Index credits, interest credited & bonuses | | 131 |
| | 141 |
| | (10 | ) | | 282 |
| | 290 |
| | (8 | ) |
Annuity Payments | | 42 |
| | 44 |
| | (2 | ) | | 89 |
| | 97 |
| | (8 | ) |
Other policy benefits and reserve movements | | 12 |
| | (5 | ) | | 17 |
| | (7 | ) | | (17 | ) | | 10 |
|
Total benefits and other changes in policy reserves | | $ | 172 |
| | $ | 179 |
| | $ | (7 | ) | | $ | 396 |
| | $ | 396 |
| | $ | — |
|
| |
• | The FIA market value option liability decreased $44 during the Fiscal 2015 Quarter compared to a $27 decrease during the Fiscal 2014 Quarter and decreased $41 during the Fiscal 2015 Six Months compared to a $48 increase during the Fiscal 2014 Six Months, respectively. The FIA market value option liability is directly correlated with the change in market value of the derivative assets hedging our FIA policies. Accordingly, the period over period decrease of $17 and $89 for the Fiscal 2015 Quarter and the Fiscal 2015 Six Months, respectively, was primarily due to the equity market movements during these respective quarters (see the net investment (loss) gain discussion above for details on the change in market value of our derivative assets quarter over quarter). |
| |
• | The FIA present value of future credits and guarantee liability change increased $31 during the Fiscal 2015 Quarter compared to a $26 increase during the Fiscal 2014 Quarter. The period over period increase of $5 was primarily driven by a decrease in longer duration risk free rates during the Fiscal 2015 Quarter, which increased reserves by $34 compared to a decrease in rates and corresponding reserve increase of $26 during the Fiscal 2014 Quarter. |
| |
• | The FIA present value of future credits and guarantee liability change increased $73 during the Fiscal 2015 Six Months compared to a $22 decrease during the Fiscal 2014 Six Months. The period over period increase of $95 was primarily driven by a decrease in longer duration risk free rates during the Fiscal 2015 Six Months, which increased reserves by $85 compared to an increase in risk-free rates and corresponding reserve decrease of $9 during the Fiscal 2014 Six Months. |
Acquisition and operating expenses, net of deferrals
Below is a summary of the major components included in acquisition and operating expenses, net of deferrals for the Fiscal 2015 Quarter and the Fiscal 2014 Quarter and for the Fiscal 2015 Six Months and the Fiscal 2014 Six Months:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Fiscal Quarter | | | | Fiscal Six Months | | |
Acquisition and operating expenses, net of deferrals: | | 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
General expenses | | $ | 27 |
| | $ | 29 |
| | $ | (2 | ) | | $ | 55 |
| | $ | 56 |
| | $ | (1 | ) |
Acquisition expenses | | 74 |
| | 60 |
| | 14 |
| | 162 |
| | 107 |
| | 55 |
|
Deferred acquisition costs | | (73 | ) | | (57 | ) | | (16 | ) | | (160 | ) | | (105 | ) | | (55 | ) |
Total acquisition and operating expenses, net of deferrals | | $ | 28 |
| | $ | 32 |
| | $ | (4 | ) | | $ | 57 |
| | $ | 58 |
| | $ | (1 | ) |
| |
• | General expenses decreased as a result of lower premium taxes, licenses and fees which more than offset higher equity compensation expenses driven by acceleration of vesting of equity awards for certain executives which met their requisite service period. |
Amortization of intangibles
Below is a summary of the major components included in amortization of intangibles for the Fiscal 2015 Quarter and the Fiscal 2014 Quarter and for the Fiscal 2015 Six Months and the Fiscal 2014 Six Months:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Fiscal Quarter | | | | Fiscal Six Months | | |
Amortization of intangibles related to: | | 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
Unlocking | | $ | 6 |
| | $ | 2 |
| | $ | 4 |
| | $ | 8 |
| | $ | (13 | ) | | $ | 21 |
|
Interest | | (9 | ) | | (7 | ) | | (2 | ) | | (17 | ) | | (14 | ) | | (3 | ) |
Amortization | | (4 | ) | | 16 |
| | (20 | ) | | 18 |
| | 61 |
| | (43 | ) |
Total amortization of intangibles | | $ | (7 | ) | | $ | 11 |
| | $ | (18 | ) | | $ | 9 |
| | $ | 34 |
| | $ | (25 | ) |
| |
• | Amortization of intangibles is based on historical, current and future expected gross margins (pre-tax operating income before amortization). Accordingly, the period over period decreases were primarily due to lower gross margins during the Fiscal 2015 Quarter and Fiscal 2015 Six Months. The decrease in margins was primarily due impairment losses recognized during the Fiscal 2015 Quarter. Refer to impairment disclosures in "Note 4. Investments", of our unaudited Condensed Consolidated Financial Statements for additional details. |
Other items affecting net income
Interest expense
Interest expense for the Fiscal 2015 Quarter and Fiscal 2015 Six Months was $6 and $12, respectively, compared to $6 and $11 for the Fiscal 2014 Quarter and the Fiscal 2014 Six Months, respectively. The interest expense reflects the interest incurred on the $300 of outstanding 6.375% senior notes (the "Senior Notes") which were issued by FGLH in March 2013. The outstanding Senior Notes pay interest semi-annually at a coupon rate of 6.375%.
Income tax expense (benefit)
Below is a summary of the major components included in Income tax expense (benefit) for the Fiscal 2015 Quarter and the Fiscal 2014 Quarter and for the Fiscal 2015 Six Months and the Fiscal 2014 Six Months:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Fiscal Quarter | | | | Fiscal Six Months | | |
| | 2015 | | 2014 | | Increase (Decrease) | | 2015 | | 2014 | | Increase (Decrease) |
(Loss) income before taxes | | $ | (12 | ) | | $ | (13 | ) | | $ | 1 |
| | $ | 11 |
| | $ | 52 |
| | $ | (41 | ) |
| | | | | | | | | | | | |
Income tax (benefit) before VA | | (3 | ) | | (3 | ) | | — |
| | 5 |
| | 19 |
| | (14 | ) |
Change in valuation allowance | | 3 |
| | (35 | ) | | 38 |
| | 4 |
| | (35 | ) | | 39 |
|
Income tax (benefit) | | $ | — |
| | $ | (38 | ) | | $ | 38 |
| | $ | 9 |
| | $ | (16 | ) | | $ | 25 |
|
Effective Rate | | — | % | | 292 | % | | | | 82 | % | | (31 | )% | | |
| |
• | Income tax expense for the Fiscal 2015 Quarter was $0, which includes a valuation allowance expense of $3, compared to an income tax benefit of $38 for the Fiscal 2014 Quarter, net of a valuation allowance release of $35. The increase in income tax expense of $38 quarter over quarter was primarily due to the prior year quarter containing a valuation allowance release of $35 from a tax planning strategy and $2 in additional valuation allowance established against non-life impairment losses in the current quarter. |
| |
• | Income tax expense for the Fiscal 2015 Six Months was $9, which includes a valuation allowance expense of $4, compared to an income tax benefit of $16 for the Fiscal 2014 Six Months, net of a valuation allowance release of $35. The increase in income tax expense of $25 quarter over quarter was primarily due to the $35 tax planning strategy valuation allowance release in the Fiscal 2014 six month period and $2 in additional valuation allowance established against non-life impairment losses in the current period, partially offset by a the tax benefit on lower pre-tax income of $41. |
AOI
The table below shows the adjustments made to reconcile net income to our AOI:
|
| | | | | | | | | | | | | | | | | | | | | | | | |
| | Fiscal Quarter | | | | Fiscal Six Months | | |
Reconciliation from Net Income to AOI: | | 2015 | | 2014 | | Increase / (Decrease) | | 2015 | | 2014 | | Increase / (Decrease) |
Net (loss) income | | $ | (12 | ) | | $ | 25 |
| | $ | (37 | ) | | $ | 2 |
| | $ | 68 |
| | $ | (66 | ) |
Adjustments to arrive at AOI: | | | | | |
|
| | | | | |
|
|
Effect of investment (gains) losses, net of offsets | | 21 |
| | (4 | ) | | 25 |
| | 23 |
| | (10 | ) | | 33 |
|
Effect of change in FIA embedded derivative discount rate, net of offsets | | 15 |
| | 11 |
| | 4 |
| | 35 |
| | (4 | ) | | 39 |
|
Effect of change in fair value of reinsurance related embedded derivative, net of offsets | | (1 | ) | | 15 |
| | (16 | ) | | (9 | ) | | 18 |
| | (27 | ) |
Effects of class action litigation reserves, net of offsets | | — |
| | 1 |
| | (1 | ) | | (1 | ) | | 1 |
| | (2 | ) |
Residual net income of distributed subsidiaries | | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
AOI | | $ | 23 |
| | $ | 48 |
| | $ | (25 | ) | | $ | 50 |
| | $ | 73 |
| | $ | (23 | ) |
| |
• | AOI for the Fiscal 2015 Quarter was $23 compared to $48 for the Fiscal 2014 Quarter, a quarter over quarter decrease of $25. The current quarter results included $2 of incentive compensation expense primarily related to executive departures and $1 of project expenses. Results in the prior period reflected $35 benefit from a tax planning strategy, which reduced a tax valuation allowance previously offsetting the Company's capital loss carry forward position. This favorable tax benefit in the prior period was offset by $4 expense related to legacy compensation plans, and miscellaneous reserve and expense items totaling $5. |
| |
• | AOI for the Fiscal 2015 Six Months was $50 compared to $73 for the Fiscal 2014 Six Months, a year over year decrease of $23. Results in the prior period reflected the aforementioned $35 tax benefit which is the primary driver of the period over period decrease. Partially offsetting this period over period decrease was higher investment income due to AAUM growth and an increase in the portfolio's earned yield as discussed above. |
Investment Portfolio
The types of assets in which we may invest are influenced by various state laws, which prescribe qualified investment assets applicable to insurance companies. Within the parameters of these laws, we invest in assets giving consideration to four primary investment objectives: (i) maintain robust absolute returns; (ii) provide reliable yield and investment income; (iii) preserve capital and (iv) provide liquidity to meet policyholder and other corporate obligations.
Our investment portfolio is designed to contribute stable earnings and balance risk across diverse asset classes and is primarily invested in high quality fixed income securities.
As of March 31, 2015 and September 30, 2014, the carrying value of our investment portfolio was approximately $19 billion and was divided among the following asset class and sectors:
|
| | | | | | | | | | | | | | |
(dollars in millions) | | March 31, 2015 | | September 30, 2014 |
| | Carrying Value | | Percent | | Carrying Value | | Percent |
| | | | | | | | |
Fixed maturity securities, available-for-sale: | | | | | | | |
United States Government full faith and credit | $ | 320 |
| | 2 | % | | $ | 297 |
| | 2 | % |
United States Government sponsored entities | 98 |
| | 1 | % | | 107 |
| | 1 | % |
United States municipalities, states and territories | 1,436 |
| | 7 | % | | 1,260 |
| | 7 | % |
Corporate securities: | | |
|
| | | | |
Finance, insurance and real estate | 4,909 |
| | 25 | % | | 4,743 |
| | 25 | % |
Manufacturing, construction and mining | 792 |
| | 4 | % | | 883 |
| | 5 | % |
Utilities and related sectors | 1,906 |
| | 10 | % | | 1,922 |
| | 10 | % |
Wholesale/retail trade | 1,072 |
| | 5 | % | | 1,088 |
| | 6 | % |
Services, media and other | 1,148 |
| | 6 | % | | 1,143 |
| | 6 | % |
Hybrid securities | 1,357 |
| | 7 | % | | 1,316 |
| | 7 | % |
Non-agency residential mortgage-backed securities | 2,096 |
| | 11 | % | | 2,007 |
| | 10 | % |
Commercial mortgage-backed securities | 729 |
| | 4 | % | | 637 |
| | 3 | % |
Asset-backed securities | 2,192 |
| | 11 | % | | 2,032 |
| | 11 | % |
Total fixed maturity available-for-sale securities | 18,055 |
| | 93 | % | | 17,435 |
| | 93 | % |
Equity securities (a) | 606 |
| | 3 | % | | 698 |
| | 3 | % |
Commercial mortgage loans | 304 |
| | 2 | % | | 136 |
| | 1 | % |
Other (primarily derivatives and policy loans) | 500 |
| | 2 | % | | 533 |
| | 3 | % |
Total investments | $ | 19,465 |
| | 100 | % | | $ | 18,802 |
| | 100 | % |
(a) Includes investment grade non-redeemable preferred stocks ($523 and $538, respectively) and Federal Home Loan Bank of Atlanta common stock ($37 and $38, respectively).
Insurance statutes regulate the type of investments that our life insurance subsidiaries are permitted to make and limit the amount of funds that may be used for any one type of investment. In light of these statutes and regulations, and our business and investment strategy, we generally seek to invest in (i) corporate securities rated investment grade by established nationally recognized statistical rating organizations (each, an “NRSRO”), (ii) U.S. Government and government-sponsored agency securities, or (iii) securities of comparable investment quality, if not rated.
As of March 31, 2015 and September 30, 2014, our fixed maturity available-for-sale ("AFS") securities portfolio was approximately $18 billion and $17 billion, respectively. The following table summarizes the credit quality, by NRSRO rating, of our fixed income portfolio:
|
| | | | | | | | | | | | | | |
(dollars in millions) | | March 31, 2015 | | September 30, 2014 |
Rating | | Fair Value | | Percent | | Fair Value | | Percent |
AAA | | $ | 1,785 |
| | 10 | % | | $ | 1,754 |
| | 10 | % |
AA | | 2,032 |
| | 11 | % | | 1,909 |
| | 11 | % |
A | | 4,060 |
| | 23 | % | | 3,873 |
| | 22 | % |
BBB | | 7,409 |
| | 41 | % | | 7,042 |
| | 40 | % |
BB (a) | | 741 |
| | 4 | % | | 786 |
| | 5 | % |
B and below (b) | | 2,028 |
| | 11 | % | | 2,071 |
| | 12 | % |
Total | | $ | 18,055 |
| | 100 | % | | $ | 17,435 |
| | 100 | % |
(a) Includes $52 and $47 at March 31, 2015 and September 30, 2014, respectively, of non-agency residential mortgage-backed securities ("RMBS") that carry a National Association of Insurance Commissioners (“NAIC”) 1 designation.
(b) Includes $1,793 and $1,677 at March 31, 2015 and September 30, 2014, respectively, of non-agency RMBS that carry a NAIC 1 designation.
As of March 31, 2015 and September 30, 2014, included in our fixed maturity AFS securities portfolio are the collateral assets of the funds withheld coinsurance agreement with FSRCI of $1 billion. The following table summarizes the credit quality, by NRSRO rating, of FSRCI fixed income portfolio:
|
| | | | | | | | | | | | | | |
(dollars in millions) | | March 31, 2015 | | September 30, 2014 |
Rating | | Fair Value | | Percent | | Fair Value | | Percent |
AAA | | $ | 109 |
| | 12 | % | | $ | 92 |
| | 9 | % |
AA | | 88 |
| | 10 | % | | 93 |
| | 9 | % |
A | | 104 |
| | 11 | % | | 95 |
| | 9 | % |
BBB | | 308 |
| | 34 | % | | 304 |
| | 30 | % |
BB | | 116 |
| | 12 | % | | 86 |
| | 8 | % |
B and below | | 193 |
| | 21 | % | | 366 |
| | 35 | % |
Total | | $ | 918 |
| | 100 | % | | $ | 1,036 |
| | 100 | % |
The NAIC’s Securities Valuation Office ("SVO") is responsible for the day-to-day credit quality assessment and valuation of securities owned by state regulated insurance companies. Insurance companies report ownership of securities to the SVO when such securities are eligible for regulatory filings. The SVO conducts credit analysis on these securities for the purpose of assigning an NAIC designation or unit price. Typically, if a security has been rated by an NRSRO, the SVO utilizes that rating and assigns an NAIC designation based upon the following system:
|
| | |
NAIC Designation | | NRSRO Equivalent Rating |
1 | | AAA/AA/A |
2 | | BBB |
3 | | BB |
4 | | B |
5 | | CCC and lower |
6 | | In or near default |
The NAIC adopted revised designation methodologies for non-agency RMBS, including RMBS backed by subprime mortgage loans and for commercial mortgage-backed securities ("CMBS"). The NAIC’s objective with the revised designation methodologies for these structured securities was to increase accuracy in assessing expected losses and to use the improved assessment to determine a more appropriate capital requirement for such structured securities. The NAIC designations for structured securities, including subprime and Alternative A-paper ("Alt-A"), RMBS, are based upon a comparison of the bond’s amortized cost to the NAIC’s loss expectation for each security. Securities where modeling results in no expected loss in all scenarios are given the highest designation of NAIC 1. A large percentage of our RMBS securities carry a NAIC 1 designation while the NRSRO rating indicates below investment grade. The revised methodologies reduce regulatory reliance on rating agencies and allow for greater regulatory input into the assumptions used to estimate expected losses from such structured
securities. In the tables below, we present the rating of structured securities based on ratings from the revised NAIC rating methodologies described above (which in some cases do not correspond to rating agency designations). All NAIC designations (e.g., NAIC 1-6) are based on the revised NAIC methodologies.
The tables below present our fixed maturity securities by NAIC designation as of March 31, 2015 and September 30, 2014:
|
| | | | | | | | | | | |
(dollars in millions) | | March 31, 2015 |
NAIC Designation | | Amortized Cost | | Fair Value | | Percent of Total Fair Value |
1 | | $ | 9,853 |
| | $ | 10,421 |
| | 58 | % |
2 | | 6,589 |
| | 6,923 |
| | 38 | % |
3 | | 468 |
| | 465 |
| | 3 | % |
4 | | 203 |
| | 198 |
| | 1 | % |
5 | | 48 |
| | 48 |
| | — | % |
6 | | — |
| | — |
| | — | % |
Total | | $ | 17,161 |
| | $ | 18,055 |
| | 100 | % |
| | | | | | |
| | September 30, 2014 |
NAIC Designation | | Amortized Cost | | Fair Value | | Percent of Total Fair Value |
1 | | $ | 9,409 |
| | $ | 9,861 |
| | 56 | % |
2 | | 6,312 |
| | 6,579 |
| | 38 | % |
3 | | 549 |
| | 575 |
| | 3 | % |
4 | | 320 |
| | 319 |
| | 2 | % |
5 | | 102 |
| | 101 |
| | 1 | % |
6 | | — |
| | — |
| | — | % |
Total | | $ | 16,692 |
| | $ | 17,435 |
| | 100 | % |
The tables below present the collateral assets of the funds withheld coinsurance agreement with FSRCI which were included in our fixed maturity securities as of March 31, 2015 and September 30, 2014:
|
| | | | | | | | | | | |
(dollars in millions) | | March 31, 2015 |
NAIC Designation | | Amortized Cost | | Fair Value | | Percent of Total Fair Value |
1 | | $ | 390 |
| | $ | 397 |
| | 43 | % |
2 | | 276 |
| | 277 |
| | 30 | % |
3 | | 99 |
| | 98 |
| | 11 | % |
4 | | 140 |
| | 138 |
| | 15 | % |
5 | | 9 |
| | 8 |
| | 1 | % |
6 | | — |
| | — |
| | — | % |
Total | | $ | 914 |
| | $ | 918 |
| | 100 | % |
| | | | | | |
| | September 30, 2014 |
NAIC Designation | | Amortized Cost | | Fair Value | | Percent of Total Fair Value |
1 | | $ | 361 |
| | $ | 378 |
| | 36 | % |
2 | | 271 |
| | 275 |
| | 27 | % |
3 | | 48 |
| | 48 |
| | 5 | % |
4 | | 255 |
| | 254 |
| | 24 | % |
5 | | 81 |
| | 81 |
| | 8 | % |
6 | | — |
| | — |
| | — | % |
Total | | $ | 1,016 |
| | $ | 1,036 |
| | 100 | % |
Investment Industry Concentration
The tables below present the top ten industry categories of our AFS securities, including the fair value and percent of total AFS securities fair value as of March 31, 2015 and September 30, 2014:
|
| | | | | | | |
(dollar in millions) | | March 31, 2015 |
Top 10 Industry Concentration | | Fair Value | | Percent of Total Fair Value |
Banking | | $ | 2,274 |
| | 12 | % |
ABS Collateralized Loan Obligation ("CLO") | | 1,935 |
| | 10 | % |
Municipal | | 1,462 |
| | 8 | % |
Life | | 1,104 |
| | 6 | % |
Electric | | 934 |
| | 5 | % |
CMBS | | 904 |
| | 5 | % |
Whole Loan Collateralized Mortgage Obligation Other | | 833 |
| | 5 | % |
Property and Casualty | | 803 |
| | 4 | % |
Other Financial Inst | | 750 |
| | 4 | % |
Pipelines | | 571 |
| | 3 | % |
Total | | $ | 11,570 |
| | 62 | % |
|
| | | | | | | |
| | September 30, 2014 |
Top 10 Industry Concentration | | Fair Value | | Percent of Total Fair Value |
Banking | | $ | 2,240 |
| | 12 | % |
ABS Other | | 1,996 |
| | 12 | % |
Municipal | | 1,313 |
| | 7 | % |
Life | | 1,087 |
| | 6 | % |
Electric | | 959 |
| | 5 | % |
CMBS | | 836 |
| | 5 | % |
Property and Casualty | | 832 |
| | 5 | % |
Whole Loan Collateralized Mortgage Obligation Other
| | 807 |
| | 4 | % |
Other Financial Inst | | 726 |
| | 4 | % |
Pipelines | | 561 |
| | 3 | % |
Total | | $ | 11,357 |
| | 63 | % |
The amortized cost and fair value of fixed maturity AFS securities by contractual maturities as of March 31, 2015 and September 30, 2014, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations.
|
| | | | | | | | | | | | | | | | |
| | March 31, 2015 | | September 30, 2014 |
(in millions) | | Amortized Cost | | Fair Value | | Amortized Cost | | Fair Value |
Corporate, Non-structured Hybrids, Municipal and U.S. Government securities: | | | | | | | | |
Due in one year or less | | $ | 328 |
| | $ | 331 |
| | $ | 370 |
| | $ | 373 |
|
Due after one year through five years | | 2,293 |
| | 2,352 |
| | 2,298 |
| | 2,360 |
|
Due after five years through ten years | | 2,894 |
| | 3,027 |
| | 3,129 |
| | 3,233 |
|
Due after ten years | | 5,918 |
| | 6,514 |
| | 5,778 |
| | 6,213 |
|
Subtotal | | $ | 11,433 |
| | $ | 12,224 |
| | $ | 11,575 |
| | $ | 12,179 |
|
Other securities which provide for periodic payments: | | | | | | | | |
Asset-backed securities | | $ | 2,200 |
| | $ | 2,192 |
| | $ | 2,040 |
| | $ | 2,032 |
|
Commercial-mortgage-backed securities | | 707 |
| | 729 |
| | 618 |
| | 637 |
|
Structured hybrids | | 713 |
| | 716 |
| | 474 |
| | 473 |
|
Residential mortgage-backed securities | | 2,108 |
| | 2,194 |
| | 1,985 |
| | 2,114 |
|
Subtotal | | $ | 5,728 |
| | $ | 5,831 |
| | $ | 5,117 |
| | $ | 5,256 |
|
Total fixed maturity available-for-sale securities | | $ | 17,161 |
| | $ | 18,055 |
| | $ | 16,692 |
| | $ | 17,435 |
|
Non-Agency RMBS Exposure
In late 2011 and 2012, following stabilization in the housing market, and a review of the loss severity methodology utilized by the NAIC, which took into account home price appreciation vectors, rather than NRSRO ratings criteria, we began to increase exposure to non-agency RMBS securities across the spectrum. These investment decisions were driven by rigorous analysis of the underlying collateral, as well as considerations of structural characteristics associated with these positions.
In all cases, we have been buyers of non-agency RMBS securities in the secondary market. We do not originate non-agency whole loans, regardless of underlying collateral.
Our investment in non-agency RMBS securities is predicated on the conservative and adequate cushion between purchase price and NAIC 1 rating, favorable capital characteristics, general lack of sensitivity to interest rates, positive convexity to prepayment rates and correlation between the price of the securities and the unfolding recovery of the housing market.
The fair value of our investments in subprime and Alt-A RMBS securities was $563 and $1,213 as of March 31, 2015, respectively, and $568 and $1,131 as of September 30, 2014, respectively.
The following tables summarize our exposure to subprime and Alt-A RMBS by credit quality using NAIC designations, NRSRO ratings and vintage year as of March 31, 2015 and September 30, 2014:
|
| | | | | | |
| | March 31, 2015 | | September 30, 2014 |
NAIC Designation: | | | | |
1 | | 99 | % | | 98 | % |
2 | | 1 | % | | 1 | % |
3 | | — | % | | 1 | % |
4 | | — | % | | — | % |
5 | | — | % | | — | % |
6 | | — | % | | — | % |
Total | | 100 | % | | 100 | % |
| | | | |
NRSRO: | | | | |
AAA | | 4 | % | | 4 | % |
AA | | 1 | % | | 1 | % |
A | | 4 | % | | 5 | % |
BBB | | 2 | % | | 2 | % |
BB and below | | 89 | % | | 88 | % |
Total | | 100 | % | | 100 | % |
| | | | |
Vintage: | | | | |
2008 | | — | % | | — | % |
2007 | | 22 | % | | 24 | % |
2006 | | 39 | % | | 35 | % |
2005 and prior | | 39 | % | | 41 | % |
Total | | 100 | % | | 100 | % |
ABS Exposure
As of March 31, 2015, our asset-backed security ("ABS") exposure was largely composed of NAIC 1 rated tranches of CLOs, which comprised 88% of all ABS holdings. These exposures are generally senior tranches of CLOs which have leveraged loans as their underlying collateral. The remainder of our ABS exposure was largely diversified by underlying collateral and issuer type, including credit card and automobile receivables.
The following tables summarize our ABS exposure. The non-CLO exposure represents 12% of total ABS assets, or 1% of total invested assets. As of March 31, 2015, the CLO and non-CLO positions were trading at a net unrealized loss position of $10 and a net unrealized gain position of $2, respectively.
The non-CLO exposure as of September 30, 2014 represented 8% of total ABS assets, or 1%, of total invested assets. As of September 30, 2014, the CLO positions were trading at a net unrealized loss position of $9 and non-CLO positions were trading at a net unrealized gain position of $1.
|
| | | | | | | | | | | | | | |
(dollars in millions) | | March 31, 2015 | | September 30, 2014 |
Asset Class | | Fair Value | | Percent | | Fair Value | | Percent |
ABS CLO | | $ | 1,935 |
| | 88 | % | | $ | 1,867 |
| | 92 | % |
ABS Auto | | 23 |
| | 1 | % | | 18 |
| | 1 | % |
ABS Home Equity | | — |
| | — | % | | 3 |
| | — | % |
ABS Other | | 234 |
| | 11 | % | | 141 |
| | 7 | % |
ABS Utility | | — |
| | — | % | | 3 |
| | — | % |
Total ABS | | $ | 2,192 |
| | 100 | % | | $ | 2,032 |
| | 100 | % |
Unrealized Losses
The amortized cost and fair value of the fixed maturity securities and the equity securities that were in an unrealized loss position as of March 31, 2015 and September 30, 2014 were as follows:
|
| | | | | | | | | | | | | | |
| March 31, 2015 |
(in millions) | Number of securities | | Amortized Cost | | Unrealized Losses | | Fair Value |
Fixed maturity securities, available-for-sale: | | | | | | | |
United States Government full faith and credit | 2 |
| | $ | 120 |
| | $ | — |
| | $ | 120 |
|
United States Government sponsored agencies | 20 |
| | 26 |
| | — |
| | 26 |
|
United States municipalities, states and territories | 30 |
| | 191 |
| | (2 | ) | | 189 |
|
Corporate securities: | | | | | | | |
Finance, insurance and real estate | 44 |
| | 392 |
| | (11 | ) | | 381 |
|
Manufacturing, construction and mining | 43 |
| | 428 |
| | (27 | ) | | 401 |
|
Utilities and related sectors | 35 |
| | 330 |
| | (15 | ) | | 315 |
|
Wholesale/retail trade | 51 |
| | 379 |
| | (16 | ) | | 363 |
|
Services, media and other | 21 |
| | 144 |
| | (5 | ) | | 139 |
|
Hybrid securities | 17 |
| | 313 |
| | (20 | ) | | 293 |
|
Non-agency residential mortgage-backed securities | 127 |
| | 706 |
| | (22 | ) | | 684 |
|
Commercial mortgage-backed securities | 21 |
| | 60 |
| | (1 | ) | | 59 |
|
Asset-backed securities | 147 |
| | 1,156 |
| | (19 | ) | | 1,137 |
|
Total fixed maturity available-for-sale securities | 558 |
| | 4,245 |
| | (138 | ) | | 4,107 |
|
Equity securities | 11 |
| | 88 |
| | (3 | ) | | 85 |
|
Total | 569 |
| | $ | 4,333 |
| | $ | (141 | ) | | $ | 4,192 |
|
|
| | | | | | | | | | | | | | |
| September 30, 2014 |
(in millions) | Number of securities | | Amortized Cost | | Unrealized Losses | | Fair Value |
Fixed maturity securities, available-for-sale: | | | | | | | |
United States Government full faith and credit | 6 |
| | $ | 120 |
| | $ | (1 | ) | | $ | 119 |
|
United States Government sponsored agencies | 19 |
| | 26 |
| | — |
| | 26 |
|
United States municipalities, states and territories | 41 |
| | 272 |
| | (7 | ) | | 265 |
|
Corporate securities: | | | | | | | |
Finance, insurance and real estate | 89 |
| | 676 |
| | (14 | ) | | 662 |
|
Manufacturing, construction and mining | 39 |
| | 353 |
| | (14 | ) | | 339 |
|
Utilities and related sectors | 55 |
| | 386 |
| | (9 | ) | | 377 |
|
Wholesale/retail trade | 31 |
| | 251 |
| | (4 | ) | | 247 |
|
Services, media and other | 42 |
| | 327 |
| | (8 | ) | | 319 |
|
Hybrid securities | 41 |
| | 563 |
| | (15 | ) | | 548 |
|
Non-agency residential mortgage-backed securities | 83 |
| | 462 |
| | (11 | ) | | 451 |
|
Commercial mortgage-backed securities | 24 |
| | 163 |
| | (2 | ) | | 161 |
|
Asset-backed securities | 140 |
| | 1,249 |
| | (20 | ) | | 1,229 |
|
Total fixed maturity available-for-sale securities | 610 |
| | 4,848 |
| | (105 | ) | | 4,743 |
|
Equity securities | 25 |
| | 240 |
| | (5 | ) | | 235 |
|
Total | 635 |
| | $ | 5,088 |
| | $ | (110 | ) | | $ | 4,978 |
|
The gross unrealized loss position on the portfolio as of March 31, 2015 was $141, an increase of $31 from $110 as of September 30, 2014. The increase was primarily due to weakness in the energy sector which negatively impacted security pricing in related industries, construction and mining segment. As a result, the unrealized loss in this segment almost doubled during the period, increasing from $14 to $27. Additionally, our non-agency RMBS securities, which are primarily floating rate, also showed price deterioration of $11 primarily due to a decline in interest rates during the year. However, the increase in gross unrealized loss position of the portfolio was offset by a $195 increase in the gross unrealized gain position of the portfolio primarily due to decline in US Treasury rates during the year. As of March 31, 2015 the portfolio was in a net unrealized gain position of $957.
Our municipal bond exposure is a combination of general obligation bonds (fair value of $356 and an amortized cost of $319 as of March 31, 2015) and special revenue bonds (fair value of $1,080 and amortized cost of $962 as of March 31, 2015). Across all municipal bonds, the largest issuer represented 7% of the category, and the largest single municipal bond issuer represents less than 1% of the entire portfolio and is rated NAIC 1. Our focus within municipal bonds is on NAIC 1 rated instruments, and 99% of our municipal bond exposure is rated NAIC 1.
The amortized cost and fair value of fixed maturity securities and equity securities (excluding U.S. Government and U.S. Government-sponsored agency securities) in an unrealized loss position greater than 20% and the number of months in an unrealized loss position with fixed maturity investment grade securities (NRSRO rating of BBB/Baa or higher) as of March 31, 2015 and September 30, 2014, were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2015 | | September 30, 2014 |
| Number of securities | | Amortized Cost | | Fair Value | | Gross Unrealized Losses | | Number of securities | | Amortized Cost | | Fair Value | | Gross Unrealized Losses |
Investment grade: | | | | | | | | | | | | | | | |
Less than six months | 1 |
| | $ | 15 |
| | $ | 11 |
| | $ | (4 | ) | | — |
| | $ | — |
| | $ | — |
| | $ | — |
|
Six months or more and less than twelve months | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
Twelve months or greater | 3 |
| | 13 |
| | 10 |
| | (3 | ) | | 2 |
| | 1 |
| | — |
| | (1 | ) |
Total investment grade | 4 |
| | 28 |
| | 21 |
| | (7 | ) | | 2 |
| | 1 |
| | — |
| | (1 | ) |
| | | | | | | | | | | | | | | |
Below investment grade: | | | | | | | | | | | | | | | |
Less than six months | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | — |
|
Six months or more and less than twelve months | — |
| | — |
| | — |
| | — |
| | 1 |
| | — |
| | — |
| | — |
|
Twelve months or greater | 3 |
| | — |
| | — |
| | — |
| | 4 |
| | — |
| | — |
| | — |
|
Total below investment grade | 3 |
| | — |
| | — |
| | — |
| | 5 |
| | — |
| | — |
| | — |
|
Total | 7 |
| | $ | 28 |
| | $ | 21 |
| | $ | (7 | ) | | 7 |
| | $ | 1 |
| | $ | — |
| | $ | (1 | ) |
OTTI and Watch List
We have a policy and process in place to identify securities in our investment portfolio each quarter for which we should recognize impairments.
At each balance sheet date, we identify invested assets which have characteristics that create uncertainty as to our future assessment of an OTTI (i.e. significant unrealized losses compared to amortized cost and industry trends). As part of this assessment, we review not only a change in current price relative to the asset's amortized cost, but also the issuer’s current credit rating and the probability of full recovery of principal based upon the issuer’s financial strength. Specifically, for corporate issues, we evaluate the financial stability and quality of asset coverage for the securities relative to the term to maturity for the issues we own. On a quarterly basis, we review structured securities for changes in default rates, loss severities and expected cash flows for the purpose of assessing potential OTTI and related credit losses to be recognized in operations. A security which has a 20% or greater change in market price relative to its amortized cost and a possibility of a loss of principal will be included on a list which is referred to as our watch list. At March 31, 2015 and September 30, 2014, our watch list included only nine and nine securities, respectively, in an unrealized loss position with an amortized cost of $28 and $1, unrealized losses of $7 and $1, and a fair value of $21 and $0, respectively. Our analysis of these securities, which included cash flow testing results, demonstrated the March 31, 2015 and September 30, 2014 carrying values were fully recoverable.
There were seven structured securities on the watch list to which we had potential credit exposure as of both March 31, 2015 and September 30, 2014. Our analysis of these structured securities, which included cash flow testing results, demonstrated the March 31, 2015 and September 30, 2014 carrying values were fully recoverable.
Exposure to International Sovereign Debt
Our investment portfolio had no direct exposure to European sovereign debt as of March 31, 2015 or September 30, 2014.
Available-For-Sale Securities
For additional information regarding our AFS securities, including the amortized cost, gross unrealized gains (losses), and fair value of AFS securities as well as the amortized cost and fair value of fixed maturity AFS securities by contractual maturities as of March 31, 2015, refer to "Note 4. Investments" to our unaudited Condensed Consolidated Financial Statements.
Net Investment Income and Net Investment Gains
For discussion regarding our net investment income and net investment gains refer to "Note 4. Investments" to our unaudited Condensed Consolidated Financial Statements.
Concentrations of Financial Instruments
For detail regarding our concentration of financial instruments refer to "Note 3. Significant Risks and Uncertainties" to our unaudited Condensed Consolidated Financial Statements.
Derivatives
We are exposed to credit loss in the event of nonperformance by our counterparties on call options. We attempt to reduce this credit risk by purchasing such options from large, well-established financial institutions.
We also hold cash and cash equivalents received from counterparties for call option collateral, as well as U.S. Government securities pledged as call option collateral, if our counterparty’s net exposures exceed pre-determined thresholds. See "Note 5. Derivatives" to our unaudited Condensed Consolidated Financial Statements for additional information regarding our derivatives and our exposure to credit loss on call options.
Liquidity and Capital Resources
Liquidity refers to the ability of an enterprise to generate adequate amounts of cash from its normal operations to meet cash requirements with a prudent margin of safety. Our principal sources of cash flow from operating activities are insurance premiums and fees and investment income, while sources of cash flows from investing activities result from maturities and sales of invested assets. Our operating activities provided cash of $31 and $61 in the Fiscal 2015 Six Months and the Fiscal 2014 Six Months, respectively. When considering our liquidity and cash flow, it is important to distinguish between the needs of our insurance subsidiaries and the needs of the holding company, FGL. As a holding company with no operations of its own, FGL derives its cash primarily from its insurance subsidiaries and FGLH, a downstream holding company that provides additional sources of liquidity. Dividends from our insurance subsidiaries flow through FGLH to FGL.
The sources of liquidity of the holding company are principally comprised of dividends from subsidiaries, bank lines of credit (at FGLH level) and the ability to raise long-term public financing under an SEC-filed registration statement. These sources of liquidity and cash flow support the general corporate needs of the holding company, including its common stock dividends, interest and debt service, funding acquisitions and investment in core businesses.
Our cash flows associated with collateral received from and posted with counterparties change as the market value of the underlying derivative contract changes. As the value of a derivative asset declines (or increases), the collateral required to be posted by our counterparties would also decline (or increase). Likewise, when the value of a derivative liability declines (or increases), the collateral we are required to post to our counterparties would also decline (or increase).
Discussion of Consolidated Cash Flows
Summary of Consolidated Cash Flows
Presented below is a table that summarizes the cash provided or used in our activities and the amount of the respective increases or decreases in cash provided or used from those activities between the fiscal periods (in millions):
|
| | | | | | | | | | | | |
| | Fiscal Six Months | | |
Cash provided by (used in): | | 2015 | | 2014 | | Increase / (Decrease) |
| | | | | | |
Operating activities | | $ | 31 |
| | $ | 61 |
| | $ | (30 | ) |
Investing activities | | (493 | ) | | (1,196 | ) | | 703 |
|
Financing activities | | 735 |
| | 633 |
| | 102 |
|
Net increase (decrease) in cash and cash equivalents | | $ | 273 |
| | $ | (502 | ) | | $ | 775 |
|
Operating Activities
Cash provided by operating activities totaled $31 for the Fiscal 2015 Six Months compared to cash provided by operating activities of $61 for the Fiscal 2014 Six Months. The $30 decrease was principally due to $58 increase in acquisition costs as a result of higher sales during the current period and $30 decrease in cash and short-term collateral from our derivative counterparties, offset by a $60 increase of investment income receipts period over period.
Investing Activities
Cash used in investing activities was $493 for the Fiscal 2015 Six Months, as compared to cash used in investing activities of $1,196 for the Fiscal 2014 Six Months. The $703 improvement in cash provided in investing activities is principally due to an increase in purchases of fixed maturity securities and other investments, net of cash proceeds from sales, maturities and repayments.
Financing Activities
Cash provided by financing activities was $735 for Fiscal 2015 Six Months compared to cash provided by financing activities of $633 for Fiscal 2014 Six Months. The issuance of investment contracts and pending new production, including annuity and universal life insurance contracts, net of redemptions and benefit payments resulted in an increase in net cash of $249 quarter over quarter. Additionally, dividends paid decreased $39 primarily due to dividends paid to our parent company, HRG, in the Fiscal 2014 Six Months. During the Fiscal 2014 Six Months, there were net cash proceeds of $176 from the issuance of common stock in connection with our IPO, which offset the overall period over period cash increase.
Off-Balance Sheet Arrangements
The F&G Stock Purchase Agreement between HFG and OM Group (UK) Limited (“OMGUK”) includes a Guarantee and Pledge Agreement which creates certain obligations for FGLH as a grantor and also grants a security interest to OMGUK of our equity interest in FGLH and FGLH’s equity interest in FGL Insurance in the event that HFG fails to perform in accordance with the terms of the F&G Stock Purchase Agreement. We are not aware of any events or transactions that resulted in non-compliance with the Guarantee and Pledge Agreement.
As of August 26, 2014, FGLH, a wholly owned subsidiary of FGL, as borrower, and the Company as guarantor, entered into a three-year $150 unsecured revolving credit facility (the “Credit Agreement”) with certain lenders and RBC Capital Markets and Credit Suisse Securities (USA) LLC, acting as joint lead arrangers. The loan proceeds from the Credit Agreement may be used for working capital and general corporate purposes.
We have no material unfunded investment commitments as of the date of this filing.
| |
Item 3. | Quantitative and Qualitative Disclosures about Market Risk |
Market Risk Factors
Market risk is the risk of the loss of fair value resulting from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates, commodity prices and equity prices. Market risk is directly influenced by the volatility and liquidity in the markets in which the related underlying financial instruments are traded. We have significant holdings in financial instruments and are naturally exposed to a variety of market risks. We are primarily exposed to interest rate risk and equity price risk and have some exposure to credit risk and counterparty risk, which affect the fair value of financial instruments subject to market risk.
Enterprise Risk Management
For information about our enterprise risk management see "Part II - Item 7a Quantitative and Qualitative Disclosures about Market Risk" included our 2014 Form 10-K.
Interest Rate Risk
Interest rate risk is our primary market risk exposure. We define interest rate risk as the risk of an economic loss due to adverse changes in interest rates. This risk arises from our holdings in interest sensitive assets and liabilities, primarily as a result of investing life insurance premiums and fixed annuity deposits received in interest-sensitive assets and carrying these funds as interest-sensitive liabilities. Substantial and sustained increases or decreases in market interest rates can affect the profitability of the insurance products and the fair value of our investments, as the majority of our insurance liabilities are backed by fixed maturity securities.
The profitability of most of our products depends on the spreads between interest yield on investments and rates credited on insurance liabilities. We have the ability to adjust the rates credited, primarily caps and credit rates, on the majority of the annuity liabilities at least annually, subject to minimum guaranteed values. In addition, the majority of the annuity products have surrender and withdrawal penalty provisions designed to encourage persistency and to help ensure targeted spreads are earned. However, competitive factors, including the impact of the level of surrenders and withdrawals, may limit our ability to adjust or maintain crediting rates at the levels necessary to avoid a narrowing of spreads under certain market conditions.
In order to meet our policy and contractual obligations, we must earn a sufficient return on our invested assets. Significant changes in interest rates exposes us to the risk of not earning the anticipated spreads between the interest rate earned on our investments and the credited interest rates paid on outstanding policies and contracts. Both rising and declining interest rates can negatively affect interest earnings, spread income and the attractiveness of certain of our products.
During periods of increasing interest rates, we may offer higher crediting rates on interest-sensitive products, such as IUL insurance and fixed annuities, and we may increase crediting rates on in-force products to keep these products competitive. A rise in interest rates, in the absence of other countervailing changes, will result in a decline in the market value of our investment portfolio.
As part of our asset liability management (“ALM”) program, we have made a significant effort to identify the assets appropriate to different product lines and ensure investing strategies match the profile of these liabilities. Our ALM strategy is designed to align the expected cash flows from the investment portfolio with the expected liability cash flows. As such, a major component of our effort to manage interest rate risk has been to structure the investment portfolio with cash flow characteristics that are consistent with the cash flow characteristics of the insurance liabilities. We use actuarial models to simulate the cash flows expected from the existing business under various interest rate scenarios. These simulations enable us to measure the potential gain or loss in the fair value of interest rate-sensitive financial instruments, to evaluate the adequacy of expected cash flows from assets to meet the expected cash requirements of the liabilities and to determine if it is necessary to lengthen or shorten the average life and duration of our investment portfolio. The “duration” of a security is the time weighted present value of the security’s expected cash flows. Duration is used to measure a security’s sensitivity to changes in interest rates. When the durations of assets and liabilities are similar, exposure to interest rate risk is minimized because a change in the value of assets could be expected to be largely offset by a change in the value of liabilities.
The duration of the investment portfolio, excluding cash and cash equivalents, derivatives and policy loans, as of March 31, 2015, is summarized as follows:
|
| | | | | | | |
(dollars in millions) | | | | |
Duration | | Amortized Cost |
| | % of Total |
|
0-4 | | $ | 7,874 |
| | 45 | % |
5-9 | | 5,482 |
| | 32 | % |
10-14 | | 3,639 |
| | 21 | % |
15-20 | | 379 |
| | 2 | % |
Total | | $ | 17,374 |
| | 100 | % |
Credit Risk and Counterparty Risk
We are exposed to the risk that a counterparty will default on its contractual obligation resulting in financial loss. The major source of credit risk arises predominantly in our insurance operations’ portfolios of debt and similar securities. The carrying value of our fixed maturity portfolio totaled $18 billion and $17 billion at March 31, 2015 and September 30, 2014, respectively. Our credit risk materializes primarily as impairment losses. We are exposed to occasional cyclical economic downturns, during which impairment losses may be significantly higher than the long-term historical average. This is offset by years where we expect the actual impairment losses to be substantially lower than the long-term average. Credit risk in the portfolio can also materialize as increased capital requirements as assets migrate into lower credit qualities over time. The effect of rating migration on our capital requirements is also dependent on the economic cycle and increased asset impairment levels may go hand in hand with increased asset related capital requirements.
We manage the risk of default and rating migration by applying disciplined credit evaluation and underwriting standards and limiting allocations to lower quality, higher risk investments. In addition, we diversify our exposure by issuer and country, using rating based issuer and country limits. We also set investment constraints that limit our exposure by industry segment. To limit the impact that credit risk can have on earnings and capital adequacy levels, we have portfolio-level credit risk constraints in place. Limit compliance is monitored on a daily or, in some cases, monthly basis.
In connection with the use of call options, we are exposed to counterparty credit risk-the risk that a counterparty fails to perform under the terms of the derivative contract. We have adopted a policy of only dealing with credit worthy counterparties and obtaining sufficient collateral where appropriate, as a means of mitigating the financial loss from defaults. The exposure and credit rating of the counterparties are continuously monitored and the aggregate value of transactions concluded is spread amongst five different approved counterparties to limit the concentration in one counterparty. Our policy allows for the purchase of derivative instruments from nationally recognized investment banking institutions with the equivalent of a Standard & Poor's Ratings Services ("S&P") rating of A- or higher. Collateral support documents are negotiated to further reduce the exposure when deemed necessary. See "Note 5. Derivatives" to our Condensed Consolidated Financial Statements for additional information regarding our exposure to credit loss.
Information regarding the Company's exposure to credit loss on the call options it holds is presented in the following table:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | March 31, 2015 | | September 30, 2014 |
Counterparty | | Credit Rating (Fitch/Moody's/S&P) (a) | | Notional Amount | | Fair Value | | Collateral | | Net Credit Risk | | Notional Amount | | Fair Value | | Collateral | | Net Credit Risk |
Merrill Lynch | | A/*/A | | $ | 2,206 |
| | $ | 70 |
| | $ | 35 |
| | $ | 35 |
| | $ | 2,240 |
| | $ | 93 |
| | $ | 53 |
| | $ | 40 |
|
Deutsche Bank | | A+/A3/A | | 3,084 |
| | 101 |
| | 78 |
| | 23 |
| | 2,810 |
| | 108 |
| | 72 |
| | 36 |
|
Morgan Stanley | | */A3/A | | 3,270 |
| | 95 |
| | 65 |
| | 30 |
| | 2,295 |
| | 85 |
| | 63 |
| | 22 |
|
Barclay's Bank | | A/A2/A | | 125 |
| | 2 |
| | — |
| | 2 |
| | 258 |
| | 10 |
| | — |
| | 10 |
|
Total | | | | $ | 8,685 |
| | $ | 268 |
| | $ | 178 |
| | $ | 90 |
| | $ | 7,603 |
| | $ | 296 |
| | $ | 188 |
| | $ | 108 |
|
(a) An * represents credit ratings that were not available.
We also have credit risk related to the ability of reinsurance counterparties to honor their obligations to pay the contract amounts under various agreements. To minimize the risk of credit loss on such contracts, we diversify our exposures among many reinsurers and limit the amount of exposure to each based on credit rating. We also generally limit our selection of counterparties with which we do new transactions to those with an “A-” credit rating or above or that are appropriately collateralized and provide credit for reinsurance. When exceptions are made to that principle, we ensure that we obtain collateral to mitigate our risk of loss. The following table presents our reinsurance recoverable balances and financial strength ratings for our five largest reinsurance recoverable balances as of March 31, 2015:
|
| | | | | | | | |
(in millions) | | | | Financial Strength Rating |
Parent Company/Principal Reinsurers | | Reinsurance Recoverable (a) | | AM Best | | S&P | | Moody's |
Wilton Reinsurance | | $1,514 | | A | | Not Rated | | Not Rated |
Front Street Re | | 1,289 | | Not Rated | | Not Rated | | Not Rated |
Security Life of Denver | | 171 | | A | | A | | A2 |
Scottish Re | | 142 | | Not Rated | | Not Rated | | Not Rated |
London Life | | 109 | | A | | Not Rated | | Not Rated |
In the normal course of business, certain reinsurance recoverables are subject to reviews by the reinsurers. We are not aware of any material disputes arising from these reviews or other communications with the counterparties as of March 31, 2015 that would require an allowance for uncollectible amounts.
Equity Price Risk
We are primarily exposed to equity price risk through certain insurance products, specifically those products with GMWB. We offer a variety of FIA contracts with crediting strategies linked to the performance of indices such as the S&P 500 Index, Dow Jones Industrials or the NASDAQ 100 Index. The estimated cost of providing GMWB incorporates various assumptions about the overall performance of equity markets over certain time periods. Periods of significant and sustained downturns in equity markets, increased equity volatility or reduced interest rates could result in an increase in the valuation of the future policy benefit or policyholder account balance liabilities associated with such products, resulting in a reduction in our net income. The rate of amortization of intangibles related to FIA products and the cost of providing GMWB could also increase if equity market performance is worse than assumed.
To economically hedge the equity returns on these products, we purchase derivatives to hedge the FIA equity exposure. The primary way we hedge FIA equity exposure is to purchase over the counter equity index call options from broker-dealer derivative counterparties who generally have a minimum credit rating of Baa2 from Moody’s and A- from S&P. The second way to hedge FIA equity exposure is by purchasing exchange traded equity index
futures contracts. Our hedging strategy enables us to reduce our overall hedging costs and achieve a high correlation of returns on the call options purchased relative to the index credits earned by the FIA contractholders. The majority of the call options are one-year options purchased to match the funding requirements underlying the FIA contracts. These hedge programs are limited to the current policy term of the FIA contracts, based on current participation rates. Future returns, which may be reflected in FIA contracts’ credited rates beyond the current policy term, are not hedged. We attempt to manage the costs of these purchases through the terms of our FIA contracts, which permit us to change caps or participation rates, subject to certain guaranteed minimums that must be maintained.
The derivatives are used to fund the FIA contract index credits and the cost of the call options purchased is treated as a component of spread earnings. While the FIA hedging program does not explicitly hedge GAAP income volatility, the FIA hedging program tends to mitigate a significant portion of the GAAP reserve changes associated with movements in the equity market and risk-free rates. This is due to the fact that a key component in the calculation of GAAP reserves is the market valuation of the current term embedded derivative. Due to the alignment of the embedded derivative reserve component with hedging of this same embedded derivative, there should be a reasonable match between changes in this component of the reserve and changes in the assets backing this component of the reserve. However, there may be an interim mismatch due to the fact that the hedges which are put in place are only intended to cover exposures expected to remain until the end of an indexing term. To the extent index credits earned by the contractholder exceed the proceeds from option expirations and futures income, we incur a raw hedging loss.
See "Note 5. Derivatives" to our Condensed Consolidated Financial Statements for additional details on the derivatives portfolio.
Fair value changes associated with these investments are intended to, but do not always, substantially offset the increase or decrease in the amounts added to policyholder account balances for index products. When index credits to policyholders exceed option proceeds received at expiration related to such credits, any shortfall is funded by our net investment spread earnings and futures income. For the Fiscal Six Months, the annual index credits to policyholders on their anniversaries were $171. Proceeds received at expiration on options related to such credits were $139. This shortfall is funded by futures income and our net investment spread earnings.
Other market exposures are hedged periodically depending on market conditions and our risk tolerance. The FIA hedging strategy economically hedges the equity returns and exposes us to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. We use a variety of techniques including direct estimation of market sensitivities and value-at-risk to monitor this risk daily. We intend to continue to adjust the hedging strategy as market conditions and risk tolerance change.
Sensitivity Analysis
The analysis below is hypothetical and should not be considered a projection of future risks. Earnings projections are before tax and non-controlling interest.
Interest Rate Risk
We assess interest rate exposures for financial assets, liabilities and derivatives using hypothetical test scenarios that assume either increasing or decreasing 100 basis point parallel shifts in the yield curve, reflecting changes in either credit spreads or risk-free rates.
If interest rates were to increase 100 basis points from levels at March 31, 2015, the estimated fair value of our fixed maturity securities would decrease by approximately $1,055 of which $47 relates to the FSRCI funds withheld assets. The fair values of the reinsurance related embedded derivative would increase by the amount of the FSRCI funds withheld assets and be reflected in the Company’s Consolidated Statement of Operations. The impact on shareholders’ equity of such decrease, net of income taxes and intangibles adjustments, and the change in reinsurance related derivative would be a decrease of $466 in AOCI and a decrease of $442 in total shareholders’ equity. If interest rates were to decrease by 100 basis points from levels at March 31, 2015, the estimated impact on the FIA embedded derivative liability of such a decrease would be an increase of $166.
The actuarial models used to estimate the impact of a one percentage point change in market interest rates incorporate numerous assumptions, require significant estimates and assume an immediate and parallel change in interest rates without any management of the investment portfolio in reaction to such change. Consequently, potential changes in value of financial instruments indicated by these simulations will likely be different from the actual changes experienced under given interest rate scenarios, and the differences may be material. Because we
actively manage our investments and liabilities, the net exposure to interest rates can vary over time. However, any such decreases in the fair value of fixed maturity securities, unless related to credit concerns of the issuer requiring recognition of an OTTI, would generally be realized only if we were required to sell such securities at losses prior to their maturity to meet liquidity needs. Our liquidity needs are managed using the surrender and withdrawal provisions of the annuity contracts and through other means.
Equity Price Risk
Assuming all other factors are constant, we estimate that a decline in equity market prices of 10% would cause the market value of our equity investments to decrease by approximately $61, our call option investments to decrease by approximately $13 based on equity positions and our FIA embedded derivative liability to decrease by approximately $26 as of March 31, 2015. Because our equity investments are classified as AFS, the 10% decline would not affect current earnings except to the extent that it reflects OTTI. These scenarios consider only the direct effect on fair value of declines in equity market levels and not changes in asset-based fees recognized as revenue, or changes in our estimates of total gross profits used as a basis for amortizing DAC and VOBA.
| |
Item 4. | Controls and Procedures |
Evaluation of Disclosure Controls and Procedures
An evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this report. Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that, as of March 31, 2015, the Company’s disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Controls over Financial Reporting
An evaluation was performed under the supervision and with the participation of the Company’s management, including the CEO and CFO, of whether any change in the Company’s internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) occurred during the quarter ended March 31, 2015.
Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that no significant changes in the Company’s internal controls over financial reporting occurred during the quarter ended March 31, 2015 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
See "Note 12. Commitments and Contingencies" to the Company’s Condensed Consolidated Financial Statements included in Part I—Item 1. Financial Statements.
A detailed discussion of our risk factors can be found in our 2014 Form 10-K, which can be found at the SEC's website www.sec.gov. With the exception of the following risk factors, there have been no material changes to the risk factors disclosed in our Annual Report.
Our controlling shareholder HRG has announced the exploration of strategic alternatives for the Company. Following this announcement, FGL has begun a strategic process involving a potential sale of the Company. There can be no assurance that it will be successful in identifying or consummating a strategic alternative.
On April 6, 2015, HRG, our controlling shareholder, announced that it was exploring strategic alternatives for FGL regarding their FGL holdings. Following this announcement, FGL has begun a strategic process involving a potential sale of the Company. There can be no assurance that the exploration of strategic alternatives will result in the identification or consummation of any transaction or if any such transaction is consummated, its timing or terms or the effects thereof on the shareholders of the Company. This process will, at times, require the attention and resources of management and the Company, which may be disruptive to our business operations. We cannot provide guidance on the timing of such action, if any, at this time.
Our business is highly regulated and subject to numerous legal restrictions and regulations.
State Regulation
Our business is subject to government regulation in each of the states in which we conduct business. Such regulation is vested in state agencies having broad administrative and discretionary, authority with respect to many aspects of our business, which may include, among other things, premium rates and increases thereto, underwriting practices, reserve requirements, marketing practices, advertising, privacy, policy forms, reinsurance reserve requirements, acquisitions, mergers and capital adequacy, and is concerned primarily with the protection of policyholders and other customers rather than shareholders. At any given time, we and our insurance subsidiaries may be the subject of a number of ongoing financial or market conduct, audits or inquiries. From time to time, regulators raise issues during such examinations or audits that could, if determined adversely, have a material impact on our business.
We have received inquiries from a number of state regulatory authorities regarding our use of the U.S. Social Security Administration’s Death Master File (“Death Master File”) and compliance with state claims practices regulations and unclaimed property or escheatment laws. The New York State Department of Financial Services (“NYDFS”) issued a letter and subsequent regulation requiring life insurers doing business in New York to use the Death Master File or similar databases to determine if benefits were payable under life insurance policies, annuities and retained asset accounts. Other states have enacted laws which will impose requirements on insurers to periodically compare their in-force life insurance policies and annuities against the Death Master File or similar databases, investigate any identified potential matches to confirm the death of the insured and determine whether benefits are due and attempt to locate the beneficiaries of any benefits that are due or, if no beneficiary can be located, escheat the benefit to the state as unclaimed property. We have received notice of escheatment audits from several states. We have filed suit in federal and state court to challenge the audit policies of the California controller and the applicability of California’s unclaimed property laws to FGL generally. It is possible that these requirements will result in additional payments to beneficiaries, additional escheatment of funds deemed abandoned under state laws or administrative penalties and expenses. While we believe that we have established sufficient reserves with respect to these matters, it is possible that third parties could dispute these amounts and additional payments or
additional unreported claims or liabilities could be required or identified given the ongoing regulatory developments, the effects of which could be significant and could have a material adverse effect on our results of operations in any one period.
State insurance departments conduct periodic examinations of the books and records, financial reporting, policy and rate filings, market conduct and business practices of insurance companies domiciled in their states, generally once every three to five years. The regulator in FGLIC’s previous state of domicile, the Maryland Insurance Administration (“MIA”), completed a routine financial examination of FGLIC for the three-year period ended December 31, 2012. The NYDFS is completing a routine financial examination of FGL NY Insurance for the three-year periods ended December 31, 2009 and December 31, 2012, and the Vermont Department of Financial Regulation completed a routine financial examination of Raven Re for the period from April 7, 2011 (commencement of business) through December 31, 2012. FGLIC is currently the subject of ten ongoing market conduct examinations in various states. While FGLIC does not believe that any of the current market conduct examinations it is subject to will result in any fines or remediation orders that will be material to its business, market conduct examinations can result in monetary fines or remediation and generally require FGLIC to devote significant resources to the management of such examinations. As a result of its re-domestication to Iowa, FGLIC will become subject to financial and market conduct examinations by the IID, the primary regulatory authority for Iowa domestic life insurance companies.
NAIC
Although our business is subject to regulation in each state in which we conduct business, in many instances the state regulatory models emanate from the NAIC. State insurance regulators and the NAIC regularly re-examine existing laws and regulations applicable to insurance companies and their products. Changes in these laws and regulations, or interpretations thereof, are often made for the benefit of the consumer and at the expense of the insurer and, thus, could have a material adverse effect on our business, operations and financial condition. We are also subject to the risk that compliance with any particular regulator’s interpretation of a legal or accounting issue may not result in compliance with another regulator’s interpretation of the same issue, particularly when compliance is judged in hindsight. Under insurance guaranty fund laws in most states, insurance companies doing business therein can be assessed up to prescribed limits for policyholder losses incurred by insolvent companies. We cannot predict the amount or timing of any such future assessments. There is an additional risk that any particular regulator’s interpretation of a legal or accounting issue may change over time to our detriment, or that changes to the overall legal or market environment, even absent any change of interpretation by a particular regulator, may cause us to change our views regarding the actions we need to take from a legal risk management perspective, which could necessitate changes to our practices that may, in some cases, limit our ability to grow and improve profitability.
Some of the NAIC pronouncements, particularly as they affect accounting issues, take effect automatically in the various states without affirmative action by the states. Statutes, regulations and interpretations may be applied with retroactive impact, particularly in areas such as accounting and reserve requirements. Also, regulatory actions with prospective impact can potentially have a significant impact on currently sold products. The NAIC continues to work to reform state regulation in various areas, including comprehensive reforms relating to life insurance reserves with respect to which it may take action as early as summer 2015.
Both the NAIC and certain state insurance regulators have in recent months announced intentions to review the trend of hedge fund and private equity acquisitions of life insurance and annuity companies. Such reviews are ongoing and preliminary and they may result in stricter regulatory scrutiny or additional regulatory restrictions that could be adverse to our ability to grow through acquisitions or to our business generally.
Federal Regulation
We may also be subject to regulation by the U.S. Department of Labor (“DOL”) when providing a variety of products and services to employee benefit plans governed by the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). In April 2015, the DOL released a notice of proposed rulemaking to revamp the ERISA conflict of interest rules. The proposed rule would impose fiduciary duties on anyone getting paid for advice related to a retirement investment decision, which would include insurance agents. In addition, we have become aware that in April 2015, U.S. Senator Elizabeth Warren sent letters to fifteen annuity providers, which inquired about perquisites and other incentives they give to third-party brokers, dealers and agents who sell their products. We did not receive such a letter, however, we cannot predict the outcome of Ms. Warren’s inquiry. Severe penalties are imposed for breaches of duty under ERISA, and we cannot predict whether the proposed DOL rule
will ultimately be adopted, what changes may be made to it prior to adoption, or how the rule would impact our business if it were adopted.
Other Regulation
Other types of regulation that could affect us include insurance company investment laws and regulations, state adopted statutory accounting principles, antitrust laws, minimum solvency requirements, federal privacy laws, insurable interest laws and federal anti-money laundering and anti-terrorism laws.
Compliance with applicable laws and regulations is time-consuming and personnel-intensive, and changes in laws and regulations may materially increase the cost of compliance and other expenses of doing business. There are a number of risks that may arise where applicable regulations may be unclear, subject to multiple interpretations or under development or where regulations may conflict with one another, where regulators revise their previous guidance or courts overturn previous rulings, which could result in our failure to meet applicable standards. Regulators and other authorities have the power to bring administrative or judicial proceedings against us, which could result, among other things, in suspension or revocation of our licenses, cease and desist orders, fines, civil penalties, criminal penalties or other disciplinary action, which could materially harm our results of operations and financial condition. If we fail to address, or appear to fail to address, appropriately any of these matters, our reputation could be harmed and we could be subject to additional legal risk, which could increase the size and number of claims and damages asserted against us or subject us to enforcement actions, fines and penalties. See “Business-Regulation” for further discussion of the impact of regulations on our business.
We cannot predict what form any future changes in these or other areas of regulation affecting the insurance industry might take or what effect, if any, such proposals might have on us if enacted into law. In addition, because our activities are relatively concentrated in a small number of lines of business, any change in law or regulation affecting one of those lines of business could have a disproportionate impact on us as compared to other more diversified insurance companies.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Share Repurchases
On September 2, 2014, we announced that our Board of Directors authorized the repurchase of up to 500,000 shares of the Company's outstanding shares of common stock over the next 12 months. The following table sets forth information with respect to purchases of the Company’s common stock made during the three months ended March 31, 2015:
|
| | | | | | | | | | | | | |
Period | | Total Number of Shares Purchased | | Average Price Paid per Share (including fees) | | Total Number of Shares Purchased as part of Publicly Announced Plans or Programs | | Number of Shares that May Yet Be Purchased Under the Plans or Programs |
| | | | | | | | |
January 1, 2015 through January 31, 2015 | | 245,258 |
| | $ | 22.59 |
| | 245,258 |
| | 216,018 |
|
February 1, 2015 through February 28, 2015 | | 149,147 |
| | 21.52 |
| | 149,147 |
| | 66,871 |
|
March 1, 2015 through March 31, 2015 | | 17,874 |
| | 20.96 |
| | 17,874 |
| | 48,997 |
|
| | 412,279 |
| | $ | 22.13 |
| | 412,279 |
| | 48,997 |
|
Item 3. Defaults upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
None.
|
| | |
Exhibit No. | | Description of Exhibits |
| | |
3.1 | | Amended and Restated Certificate of Incorporation of Fidelity & Guaranty Life (incorporated by reference to our Registration Statement on Form S-8, filed on December 13, 2013 (File No. 333-192849)). |
3.2 | | Second Amended and Restated Bylaws of Fidelity & Guaranty Life (incorporated by reference to our Current Report on Form 8-K, filed on October 7, 2014 (File No. 001-36227)). |
4.1 | | Reference is made to Exhibits 3.1 and 3.2. |
4.2 | | Form of Common Stock Certificate (incorporated by reference to our Registration Statement on Form S-1/A, filed on December 3, 2013 (File No. 333-190880)). |
4.3 | | Indenture, dated March 27, 2013, among Fidelity & Guaranty Life Holdings, Inc., as issuer, the Subsidiary Guarantors from time to time parties thereto and Wells Fargo Bank, National Association, as trustee, relating to the 6.375% Senior Notes due 2021 (incorporated by reference to our Registration Statement on Form S-1/A, filed on October 17, 2013 (File No. 333-190880)). |
4.4 | | First Supplemental Indenture, dated March 27, 2013, among Fidelity & Guaranty Life Holdings, Inc., as issuer, the Subsidiary Guarantors from named therein and Wells Fargo Bank, National Association, relating to the 6.375% Senior Notes due 2021 (incorporated by reference to our Registration Statement on Form S-1/A, filed on October 17, 2013 (File No. 333-190880)). |
4.5 | | Registration Rights Agreement, dated December 18, 2013, between Fidelity & Guaranty Life, and Harbinger Group, Inc. (incorporated by reference to our Quarterly Report on Form 10-Q, filed on February 7, 2014 (file No. 001-36227)). |
10.1 | | Omnibus Amendment to Equity Award Agreements by and among Fidelity & Guaranty Life, Fidelity & Guaranty Life Business Services, Inc. and Leland C. Launer Jr. dated as of March 31, 2015 (incorporated by reference to our Form 8-K, filed on April 2, 2015 (File No. 001-36227)). |
31.1 * | | Certification of Chief Executive Officer, pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
31.2 * | | Certification of Chief Financial Officer, pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
32.1 * | | Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
32.2 * | | Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| | |
101.INS * | | XBRL Instance Document. |
| | |
101.SCH * | | XBRL Taxonomy Extension Schema. |
| | |
101.CAL * | | XBRL Taxonomy Extension Calculation Linkbase. |
| | |
101.DEF * | | XBRL Taxonomy Definition Linkbase. |
| | |
101.LAB * | | XBRL Taxonomy Extension Label Linkbase. |
| | |
101.PRE * | | XBRL Taxonomy Extension Presentation Linkbase. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
| | | |
| | FIDELITY & GUARANTY LIFE (Registrant) |
| | | |
Dated: | May 6, 2015 | By: | /s/ Dennis Vigneau |
| | | Executive Vice President and Chief Financial Officer |
| | | (on behalf of the Registrant and as Principal Financial Officer) |